Pyrido[2,3-b]pyrazine derivatives useful as herbicidal compounds

ABSTRACT

The present invention relates to a method of controlling plants or inhibiting plant growth which comprises applying to the plants or to the locus thereof a herbicidally effective amount of a compound of formula (I) wherein R 1 , R 2 , R 3 , R 4  and R 5  are as defined in claim  1 ; or salts or N-oxides thereof. Furthermore, the present invention relates to processes for preparing compounds of formula (I), to herbicidal compositions comprising compounds of formula (I) and to certain novel pyrido[2,3-b]pyrazines.

The present invention relates to novel herbicidal pyrido[2,3-b]pyrazines, to processes for their preparation, to compositions comprising those compounds, and to their use in controlling plants or in inhibiting plant growth.

Pyrido[2,3-b]pyrazines were disclosed as intermediates in the synthesis of fungicidal compounds, for example, in WO 04/056825, WO 05/123698 and WO 05/123733. Pyrido[2,3-b]pyrazines were disclosed as fungicidal compounds in WO 05/010000.

It has now surprisingly been found that certain pyrido[2,3-b]pyrazines display excellent herbicidal and growth-inhibiting properties.

The present invention therefore provides a method of controlling plants which comprises applying to the plants or to the locus thereof a herbicidally effective amount of a compound of formula (I)

wherein R¹ and R² are independently hydrogen, C₁-C₄alkyl, C₁-C₄haloalkyl, halo, cyano, hydroxy, C₁-C₄alkoxy, C₁-C₄alkylthio, aryl or aryl substituted by one to five R⁶, which may be the same or different, or heteroaryl or heteroaryl substituted by one to five R⁶, which may be the same or different; R³ is hydrogen, C₁-C₁₀alkyl, C₂-C₁₀alkenyl, C₂-C₁₀alkynyl, C₃-C₁₀cycloalkyl, C₃-C₁₀cycloalkyl-C₁-C₆alkyl-, C₁-C₁₀alkoxy-C₁-C₆alkyl-, C₁-C₁₀cyanoalkyl-, C₁-C₁₀alkoxy-carbonyl-C₁-C₆alkyl-, N—C₁-C₃alkyl-aminocarbonyl-C₁-C₆alkyl-, N,N-di-(C₁-C₃alkyl)-aminocarbonyl-C₁-C₆alkyl-, aryl-C₁-C₆alkyl- or aryl-C₁-C₆alkyl- wherein the aryl moiety is substituted by one to three R⁷, which may be the same or different, or heterocyclyl-C₁-C₆alkyl- or heterocyclyl-C₁-C₆alkyl- wherein the heterocyclyl moiety is substituted by one to three R⁷, which may be the same or different; R⁴ is aryl or aryl substituted by one to five R⁸, which may be the same or different, or heteroaryl or heteroaryl substituted by one to four R⁸, which may be the same or different; R⁵ is hydroxy, R⁹-oxy-, R¹⁰-carbonyloxy-, tri-R¹¹-silyloxy- or R¹²-sulfonyloxy-, each R⁶, R⁷ and R⁸ is independently halo, cyano, nitro, C₁-C₁₀alkyl, C₁-C₄haloalkyl, C₂-C₁₀alkenyl, C₂-C₁₀alkynyl, hydroxy, C₁-C₁₀alkoxy, C₁-C₄haloalkoxy, C₁-C₁₀alkoxy-C₁-C₄alkyl-, C₃-C₇cycloalkyl, C₃-C₇cycloalkoxy, C₃-C₇cycloalkyl-C₁-C₄alkyl-, C₃-C₇cycloalkyl-C₁-C₄alkoxy-, C₁-C₆alkylcarbonyl-, formyl, C₁-C₄alkoxycarbonyl-, C₁-C₄alkylcarbonyloxy-, C₁-C₁₀alkylthio-, C₁-C₄haloalkylthio-, C₁-C₁₀alkylsulfinyl-, C₁-C₄haloalkylsulfinyl-, C₁-C₁₀alkylsulfonyl-, C₁-C₄haloalkylsulfonyl-, amino, C₁-C₁₀alkylamino-, di-C₁-C₁₀alkylamino-, C₁-C₁₀alkylcarbonylamino-, aryl or aryl substituted by one to three R¹³, which may be the same or different, heteroaryl or heteroaryl substituted by one to three R¹³, which may be the same or different, aryl-C₁-C₄alkyl- or aryl-C₁-C₄alkyl- wherein the aryl moiety is substituted by one to three R¹³, which may be the same or different, heteroaryl-C₁-C₄alkyl- or heteroaryl-C₁-C₄alkyl- wherein the heteroaryl moiety is substituted by one to three R¹³, which may be the same or different, aryloxy- or aryloxy- substituted by one to three R¹³, which may be the same or different, heteroaryloxy- or heteroaryloxy- substituted by one to three R¹³, which may be the same or different, arylthio- or arylthio- substituted by one to three R¹³, which may be the same or different, or heteroarylthio- or heteroarylthio- substituted by one to three R¹³, which may be the same or different; R⁹ is C₁-C₁₀alkyl, C₂-C₁₀alkenyl, C₂-C₁₀alkynyl or aryl-C₁-C₄alkyl- or aryl-C₁-C₄alkyl-wherein the aryl moiety is substituted by one to five substituents independently selected from halo, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl or C₁-C₆alkoxy; R¹⁰ is C₁-C₁₀alkyl, C₃-C₁₀cycloalkyl, C₃-C₁₀cycloalkyl-C₁-C₁₀alkyl-, C₁-C₁₀haloalkyl, C₂-C₁₀alkenyl, C₂-C₁₀alkynyl, C₁-C₄alkoxy-C₁-C₁₀alkyl-, C₁-C₄alkylthio-C₁-C₄alkyl-, C₁-C₁₀alkoxy, C₂-C₁₀alkenyloxy, C₂-C₁₀alkynyloxy, C₁-C₁₀alkylthio-, N—C₁-C₄alkyl-amino-, N,N-di-(C₁-C₄alkyl)-amino-, aryl or aryl substituted by one to three R¹⁴, which may be the same or different, heteroaryl or heteroaryl substituted by one to three R¹⁴, which may be the same or different, aryl-C₁-C₄alkyl- or aryl-C₁-C₄alkyl- wherein the aryl moiety is substituted by one to three R¹⁴, which may be the same or different, heteroaryl-C₁-C₄alkyl- or heteroaryl-C₁-C₄alkyl- wherein the heteroaryl moiety is substituted by one to three R¹⁴, which may be the same or different, aryloxy- or aryloxy-three R¹⁴, which may be the same or different, heteroaryloxy-substituted by one to three R¹⁴, which may be the same or different, arylthio- or arylthio-substituted by one to three R¹⁴, which may be the same or different, or heteroarylthio- or heteroarylthio- substituted by one to three R¹⁴, which may be the same or different; each R¹¹ is independently C₁-C₁₀alkyl or phenyl or phenyl substituted by one to five substituents independently selected from halo, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl or C₁-C₆alkoxy; R¹² is C₁-C₁₀alkyl or phenyl or phenyl substituted by one to five substituents independently selected from halo, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl or C₁-C₆alkoxy; each R¹³ is independently halo, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl or C₁-C₆alkoxy; and each R¹⁴ is independently halo, cyano, nitro, C₁-C₁₀alkyl, C₁-C₄haloalkyl, C₁-C₁₀alkoxy, C₁-C₄alkoxycarbonyl-, C₁-C₄haloalkoxy, C₁-C₁₀alkylthio-, C₁-C₄haloalkylthio-, C₁-C₁₀alkylsulfinyl-, C₁-C₄haloalkylsulfinyl-, C₁-C₁₀alkylsulfonyl-, C₁-C₄haloalkylsulfonyl-, aryl or aryl substituted by one to five substituents independently selected from halo, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl or C₁-C₆alkoxy, or heteroaryl or heteroaryl substituted by one to four substituents independently selected from halo, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl or C₁-C₆alkoxy; or salts or N-oxides thereof.

The compounds of formula (I) may exist in different geometric or optical isomers or tautomeric forms. This invention covers all such isomers and tautomers and mixtures thereof in all proportions as well as isotopic forms such as deuterated compounds.

For example, a compound of formula (Ia), i.e. a compound of formula (I) wherein R³ is hydrogen and R⁵ is hydroxy, can be drawn in at least five tautomeric forms.

For example, a compound of formula (Ib), i.e. a compound of formula (I) wherein R³ is hydrogen and R⁵ is as defined for compounds of formula (I) other than hydroxy, can be drawn in at least two tautomeric forms.

A compound of formula (Ic), i.e. a compound of formula (I) wherein R³ is as defined for compounds of formula (I) other than hydrogen and R⁵ is as defined for compounds of formula (I) other than hydroxy, can be drawn in only one tautomeric form.

A compound of formula (Id), i.e. a compound of formula (I) wherein R³ is as defined for compounds of formula (I) other than hydrogen and R⁵ is hydroxy, can be drawn in three tautomeric forms.

Each alkyl moiety (either alone or as part of a larger group, such as alkoxy, alkoxycarbonyl, alkylcarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl) is a straight or branched chain and is, for example, methyl, ethyl, n-propyl, n-butyl, n-pentyl, n-hexyl, iso-propyl, n-butyl, sec-butyl, iso-butyl, tert-butyl or neo-pentyl. The alkyl groups are preferably C₁ to C₆ alkyl groups, more preferably C₁-C₄ and most preferably C₁-C₃ alkyl groups.

Alkenyl and alkynyl moieties (either alone or as part of a larger group, such as alkenyloxy or alkynyloxy) can be in the form of straight or branched chains, and the alkenyl moieties, where appropriate, can be of either the (E)- or (Z)-configuration. Examples are vinyl, allyl and propargyl. The alkenyl and alkynyl groups are preferably C₂ to C₆ alkenyl or alkynyl groups, more preferably C₂-C₄ and most preferably C₂-C₃ alkenyl or alkynyl groups.

Halogen is fluorine, chlorine, bromine or iodine.

Haloalkyl groups (either alone or as part of a larger group, such as haloalkoxy or haloalkylthio) are alkyl groups which are substituted with one or more of the same or different halogen atoms and are, for example, —CF₃, —CF₂Cl, —CH₂CF₃ or —CH₂CHF₂. Haloalkenyl and haloalkynyl groups (either alone or as part of a larger group, such as haloalkenyloxy or haloalkynyloxy) are alkenyl and alkynyl groups, respectively, which are substituted with one or more of the same or different halogen atoms and are, for example, —CH═CF₂, —CCl═CClF or —C≡CCl.

Cyanoalkyl groups are alkyl groups which are substituted with one or more cyano groups, for example, cyanomethyl or 1,3-dicyanopropyl.

Cycloalkyl groups can be in mono- or bi-cyclic form and may optionally be substituted by one or more methyl groups. The cycloalkyl groups preferably contain 3 to 8 carbon atoms, more preferably 3 to 6 carbon atoms. Examples of monocyclic cycloalkyl groups are cyclopropyl, 1-methylcyclopropyl, 2-methylcyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl.

In the context of the present specification the term “aryl” refers to a ring system which may be mono-, bi- or tricyclic. Examples of such rings include phenyl, naphthalenyl, anthracenyl, indenyl or phenanthrenyl. A preferred aryl group is phenyl.

The term “heteroaryl” refers to an aromatic ring system containing at least one heteroatom and consisting either of a single ring or of two or more fused rings. Preferably, single rings will contain up to three and bicyclic systems up to four heteroatoms which will preferably be chosen from nitrogen, oxygen and sulfur. Examples of such groups include pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, furanyl, thiophenyl, oxazolyl, isoxazolyl, oxadiazolyl, thiazolyl, isothiazolyl, thiadiazolyl, pyrrolyl, pyrazolyl, imidazolyl, triazolyl and tetrazolyl. A preferred heteroaryl group is pyridine. Examples of bicyclic groups are benzothiophenyl, benzimidazolyl, benzothiadiazolyl, quinolinyl, cinnolinyl, quinoxalinyl and pyrazolo[1,5-a]pyrimidinyl.

The term “heterocyclyl” is defined to include heteroaryl and in addition their unsaturated or partially unsaturated analogues such as 4,5,6,7-tetrahydro-benzothiophenyl, chromen-4-onyl, 9H-fluorenyl, 3,4-dihydro-2H-benzo-1,4-dioxepinyl, 2,3-dihydro-benzofuranyl, piperidinyl, 1,3-dioxolanyl, 1,3-dioxanyl, 4,5-dihydro-isoxazolyl, tetrahydrofuranyl and morpholinyl.

The term “herbicide” as used herein means a compound that controls or modifies the growth of plants. The term “herbicidally effective amount” means the quantity of such a compound or combination of such compounds that is capable of producing a controlling or modifying effect on the growth of plants. Controlling or modifying effects include all deviation from natural development, for example: killing, retardation, leaf burn, albinism, dwarfing and the like. The term “plants” refers to all physical parts of a plant, including seeds, seedlings, saplings, roots, tubers, stems, stalks, foliage, and fruits. The term “locus” is intended to include soil, seeds, and seedlings, as well as established vegetation.

Preferred values of R¹, R², R³, R⁴, R⁵, R⁶, R⁷, R⁸, R⁹, R¹⁰, R¹¹, R¹², R¹³ and R¹⁴ are, in any combination, as set out below.

Preferably R¹ is hydrogen, C₁-C₄alkyl, C₁-C₄haloalkyl, halo, cyano, hydroxy or C₁-C₄alkoxy.

More preferably R¹ is hydrogen, C₁-C₄alkyl, halo, cyano or hydroxy.

Even more preferably R¹ is hydrogen, methyl, chloro or bromo.

Yet even more preferably R¹ is hydrogen or chloro.

Most preferably R¹ is hydrogen.

Preferably R² is hydrogen, C₁-C₄alkyl, C₁-C₄haloalkyl, halo, cyano, hydroxy or C₁-C₄alkoxy.

More preferably R² is hydrogen, C₁-C₄alkyl, halo, cyano or hydroxy.

Even more preferably R² is hydrogen, methyl, chloro or bromo.

Yet even more preferably R² is hydrogen or chloro.

Most preferably R² is hydrogen.

Preferably R³ is hydrogen, C₁-C₁₀alkyl, C₂-C₁₀alkenyl, C₂-C₁₀alkynyl, C₃-C₁₀cycloalkyl, C₃-C₁₀cycloalkyl-C₁-C₆alkyl-, C₁-C₁₀alkoxy-C₁-C₆alkyl-, C₁-C₁₀cyanoalkyl-, C₁-C₁₀alkoxycarbonyl-C₁-C₆alkyl-, N—C₁-C₃alkyl-aminocarbonyl-C₁-C₆alkyl-, N,N-di-(C₁-C₃alkyl)-aminocarbonyl-C₁-C₆alkyl-, benzyl or benzyl wherein the phenyl moiety is substituted by one to three R⁷, which may be the same or different, or phenethyl- or phenethyl- wherein the phenyl moiety is substituted by one to three R⁷, which may be the same of different.

More preferably R³ is hydrogen, C₁-C₄alkyl, C₂-C₄alkenyl, C₂-C₄alkynyl, C₃-C₆cycloalkyl, C₃-C₆cycloalkyl-C₁-C₂alkyl-, C₁-C₃alkoxy-C₁-C₂alkyl-, C₁-C₄cyanoalkyl-, C₁-C₃alkoxycarbonyl-C₁-C₂alkyl-, N—C₁-C₃alkyl-aminocarbonyl-C₁-C₂alkyl-, N N-di-(C₁-C₃alkyl)-aminocarbonyl-C₁-C₂alkyl-, benzyl or benzyl substituted by one to three R⁷, which may be the same or different, or phenethyl- or phenethyl- substituted by one to three R⁷, which may be the same or different. Examples of such preferred groups for R³ are hydrogen, methyl, ethyl, n-propyl, iso-propyl, n-butyl, 2-methyl-propyl, allyl, but-3-en-1-yl, propargyl, cyclopropyl, cyclobutyl, cyclopropyl-methyl-, cyclobutyl-methyl-, methoxymethyl-, ethoxymethyl-, 2-methoxy-ethyl-, cyanomethyl- or benzyl.

Even more preferably R³ is hydrogen, C₁-C₄alkyl, C₂-C₄alkenyl or C₂-C₄alkynyl. Examples of such most preferred groups for R³ are hydrogen, methyl, ethyl, n-propyl, iso-propyl, n-butyl, 2-methyl-propyl, allyl, but-3-en-1-yl or propargyl.

Most preferably R³ is hydrogen or C₁-C₂alkyl. Examples of such most preferred groups for R³ are hydrogen, methyl or ethyl.

Preferably R⁴ is aryl or aryl substituted by one to five R⁸, which may be the same or different. Examples of such groups for R⁴ are 3-bromo-2-chloro-6-fluoro-phenyl, 2-bromo-4-fluoro-phenyl, 2-bromo-phenyl, 2-bromo-4-trifluoromethyl-phenyl, 2-chloro-3,6-difluoro-5-nitro-phenyl, 2-chloro-3,6-difluoro-phenyl, 2-chloro-4,5-difluoro-phenyl, 2-chloro-6-fluoro-3-methyl-phenyl, 2-chloro-6-fluoro-5-methyl-phenyl, 2-chloro-6-fluoro-3-nitro-phenyl, 2-chloro-4-fluoro-phenyl, 2-chloro-5-fluoro-phenyl, 2-chloro-6-fluoro-phenyl, 2-chloro-phenyl, 3-chloro-phenyl, 4-chloro-phenyl, 2-chloro-3-trifluoromethyl-phenyl, 2-chloro-5-trifluoromethyl-phenyl, 5-chloro-2-trifluoromethyl-phenyl, 6-chloro-2-trifluoromethyl-phenyl, 2,3-dichloro-6-fluoro-phenyl, 2,4-dichloro-5-fluoro-phenyl, 3,5-dichloro-2-methoxy-phenyl, 2,3-dichloro-phenyl, 2,4-dichloro-phenyl, 2,5-dichloro-phenyl, 2,6-dichloro-phenyl, 3,4-dichloro-phenyl, 2,6-dichloro-4-trifluoro-methoxy-phenyl, 2,6-dichloro-4-trifluoromethyl-phenyl, 2,6-diethyl-4-methyl-phenyl, 2-difluoromethoxy-phenyl, 2,3-dimethoxy-phenyl, 2,4-dimethoxy-phenyl, 2,5-dimethyl-phenyl, 3,5-di(trifluoromethyl)-phenyl, 2-fluoro-phenyl, 4-fluoro-2-trifluoromethyl-phenyl, 6-fluoro-2-trifluoromethyl-phenyl, 2-iodo-phenyl, 2-methoxy-phenyl, 2-30 methoxy-5-trifluoromethoxy-phenyl, 6-methyl-2-nitro-phenyl, 2-methyl-phenyl, naphth-2-yl, naphth-3-yl, phenyl, 2-nitro-4-trifluoromethyl-phenyl, 2,3,5-trichloro-phenyl, 2,3,6-trichloro-phenyl, 2-trifluoromethoxy-phenyl, 2-trifluoromethyl-phenyl, 2,3,6-trifluoro-phenyl and 2,4,6-trimethyl-phenyl.

More preferably R⁴ is aryl substituted by one to four R⁸, which may be the same or different. Examples of such groups for R⁴ are 3-bromo-2-chloro-6-fluoro-phenyl, 2-chloro-3,6-difluoro-phenyl, 2-chloro-6-fluoro-3-methyl-phenyl, 2-chloro-6-fluoro-5-methyl-phenyl, 2-chloro-4-fluoro-phenyl, 2-chloro-5-fluoro-phenyl, 2-chloro-phenyl, 2-chloro-3-trifluoromethyl-phenyl, 2-chloro-5-trifluoromethyl-phenyl, 6-chloro-2-trifluoromethyl-phenyl, 2,3-dichloro-6-fluoro-phenyl, 2,4-dichloro-5-fluoro-phenyl, 3,5-dichloro-2-methoxy-phenyl, 2,3-dichloro-phenyl, 2,4-dichloro-phenyl, 2,5-dichloro-phenyl, 2,6-dichloro-phenyl, 2,6-dichloro-4-trifluoromethoxy-phenyl, 2,6-dichloro-4-trifluoromethyl-phenyl, 2,6-diethyl-4-methyl-phenyl, 2,3-dimethoxy-phenyl, 2-fluoro-phenyl, 2-methoxy-phenyl, 2-methoxy-5-trifluoromethoxy-phenyl, 2-methyl-phenyl, 2-trifluoromethoxy-phenyl, 2-trifluoromethyl-phenyl and 2,4,6-trimethyl-phenyl.

Most preferably R⁴ is aryl substituted by two to three R⁸, which may be the same or different. Examples of such groups for R⁴ are 3-bromo-2-chloro-6-fluoro-phenyl, 2-chloro-3,6-difluoro-phenyl, 2,4-dichloro-phenyl, 2,6-dichloro-phenyl and 2,6-dichloro-4-trifluoromethoxy-phenyl.

Preferably R⁵ is hydroxy, R⁹-oxy- or R¹⁰-carbonyloxy-.

More preferably R⁵ is hydroxy, C₁-C₄alkoxy, C₁-C₄alkylcarbonyloxy-, C₃-C₆cycloalkylcarbonyloxy-, C₃-C₁₀cycloalkyl-C₁-C₁₀alkylcarbonyloxy-, C₁-C₄haloalkylcarbonyloxy-, C₂-C₄alkenylcarbonyloxy-, C₂-C₄alkynylcarbonyloxy-, C₁-C₄alkoxy-C₁-C₄alkylcarbonyloxy-, C₁-C₄alkylthio-C₁-C₄alkylcarbonyloxy-, C₁-C₄alkoxycarbonyloxy-, C₂-C₄alkenyloxycarbonyloxy-, C₂-C₄alkynyloxycarbonyloxy-, C₁-C₄alkylthiocarbonyloxy-, N—C₁-C₄alkyl-aminocarbonyloxy-, N,N-di-(C₁-C₄alkyl)-aminocarbonyloxy-, arylcarbonyloxy- or arylcarbonyloxy- substituted by one to three R¹⁴, which may be the same or different, heteroarylcarbonyloxy- or heteroarylcarbonyloxy- substituted by one to three R¹⁴, which may be the same or different, aryl-C₁-C₄alkylcarbonyloxy- or aryl-C₁-C₄alkylcarbonyloxy- wherein the aryl moiety is substituted by one to three R¹⁴, which may be the same or different, heteroaryl-C₁-C₄alkylcarbonyloxy- or heteroaryl-C₁-C₄alkylcarbonyloxy- wherein the heteroaryl moiety is substituted by one to three R¹⁴, which may be the same or different, aryloxycarbonyloxy- or aryloxycarbonyloxy- substituted by one to three R¹⁴, which may be the same or different, heteroaryloxycarbonyloxy- or heteroaryloxycarbonyloxy-substituted by one to three R¹⁴, which may be the same or different, arylthiocarbonyloxy- or arylthiocarbonyloxy- substituted by one to three R¹⁴, which may be the same or different, or heteroarylthiocarbonyloxy- or heteroarylthiocarbonyloxy- substituted by one to three R¹⁴, which may be the same or different. Examples of preferred groups for R⁵ are hydroxy, methoxy, ethoxy, methylcarbonyloxy-, ethylcarbonyloxy-, iso-propyl-carbonyloxy-, n-propylcarbonyloxy-, but-2-ylcarbonyloxy-, 2-methyl-propylcarbonyloxy-, tert-butylcarbonyloxy-, cyclopropylcarbonyloxy-, cyclopentyl-methylcarbonyloxy-, chloromethylcarbonyloxy-, trifluoromethylcarbonyloxy-, allylcarbonyloxy-, (E)-prop-1-en-1-ylcarbonyloxy-, 2-methyl-prop-1-en-1-ylcarbonyl-oxy-, methoxymethylcarbonyloxy-, ethoxycarbonyloxy-, tert-butoxycarbonyloxy-, but-2-yn-1-yloxycarbonyloxy-, N,N-diethylaminocarbonyloxy-, phenylcarbonyloxy-, 3-methoxy-phenylcarbonyloxy-, 4-nitro-phenylcarbonyloxy-, benzylcarbonyloxy-, furan-2-ylcarbonyloxy-, 2,5-dimethyl-furan-3-ylcarbonyloxy-, thiophen-2-ylcarbonyloxy-, 3,5-dimethyl-isoxazol-4-ylcarbonyloxy- and 1-phenyl-prop-1-ylcarbonyloxy-.

More preferably R⁵ is hydroxy, C₁-C₄alkylcarbonyloxy-, C₃-C₆cyclo-alkylcarbonyloxy-, C₂-C₄alkenylcarbonyloxy-, C₂-C₄alkynylcarbonyloxy-, C₁-C₄alkoxycarbonyloxy-, C₂-C₄alkenyloxycarbonyloxy- or C₂-C₄alkynyloxycarbonyloxy-. Examples of more preferred groups for R⁵ are hydroxy, methylcarbonyloxy-, ethylcarbonyloxy-, iso-propylcarbonyloxy-, n-propylcarbonyloxy-, but-2-ylcarbonyloxy-, 2-methyl-propylcarbonyloxy-, tert-butylcarbonyloxy-, cyclopropylcarbonyloxy-, allylcarbonyloxy-, (E)-prop-1-en-1-ylcarbonyloxy-, 2-methyl-prop-1-en-1-ylcarbonyl-oxy-, ethoxycarbonyloxy-, tert-butoxycarbonyloxy- or but-2-yn-1-yloxycarbonyloxy-.

Most preferably R⁵ is hydroxy, C₁-C₄alkylcarbonyloxy- or C₁-C₄alkoxycarbonyloxy-. Examples of most preferred groups for R⁵ are hydroxy, methylcarbonyloxy-, ethylcarbonyloxy-, iso-propylcarbonyloxy-, n-propylcarbonyloxy-, but-2-ylcarbonyloxy-, 2-methyl-propylcarbonyloxy-, tert-butylcarbonyloxy-, ethoxycarbonyloxy- or tert-butoxycarbonyloxy-.

Preferably R⁵ is C₁-C₄alkylsulfonyloxy-. Examples of preferred groups for R⁵ are methylsulfonyloxy- and iso-propylsulfonyloxy-.

Preferably R⁵ is tri-(C₁-C₄alkyl)-silyloxy-. An example of preferred groups for R⁵ is dimethyl-tert-butyl-silyloxy-.

Preferably each R⁶ is independently halo, C₁-C₄alkyl, C₁-C₄haloalkyl, C₁-C₄alkoxy or C₁-C₄haloalkoxy. Examples of such preferred groups for R⁶ are chloro, fluoro, methyl, ethyl, trifluoromethyl, methoxy or trifluoromethoxy.

Preferably each R⁷ is independently halo, C₁-C₄alkyl, C₁-C₄haloalkyl, C₁-C₄alkoxy or C₁-C₄haloalkoxy. Examples of such preferred groups for R⁷ are chloro, fluoro, methyl, ethyl, trifluoromethyl, methoxy and trifluoromethoxy.

Most preferably each R⁷ is independently halo, C₁-C₄alkyl, C₁-C₄haloalkyl or C₁-C₄alkoxy. Examples of such preferred groups for R⁷ are chloro, fluoro, methyl, ethyl, trifluoromethyl and methoxy.

Preferably each R⁸ is independently halo, cyano, nitro, C₁-C₁₀alkyl, C₁-C₄haloalkyl, C₁-C₁₀alkoxy, C₁-C₄alkoxycarbonyl-, C₁-C₄haloalkoxy, C₁-C₁₀alkylthio-, C₁-C₄haloalkylthio-, C₁-C₁₀alkylsulfinyl-, C₁-C₄haloalkylsulfinyl-, C₁-C₁₀alkylsulfonyl- or C₁-C₄haloalkylsulfonyl-.

More preferably each R⁸ is independently halo, cyano, nitro, C₁-C₁₀alkyl, C₁-C₄haloalkyl, C₁-C₁₀alkoxy, C₁-C₄alkoxycarbonyl- or C₁-C₄haloalkoxy.

Most preferably each R⁸ is independently halo, C₁-C₁₀alkyl, C₁-C₄haloalkyl, C₁-C₁₀alkoxy or C₁-C₄haloalkoxy. Examples of such preferred groups for R⁸ are fluoro, chloro, methyl, ethyl, trifluoromethyl, methoxy or trifluoromethoxy.

Preferably R⁹ is C₁-C₁₀alkyl.

More preferably R⁹ is C₁-C₄alkyl.

Even more preferably R⁹ is methyl or ethyl.

Most preferably R⁹ is methyl.

Preferably R¹⁰ is C₁-C₁₀alkyl, C₃-C₁₀cycloalkyl, C₁-C₁₀haloalkyl, C₂-C₁₀alkenyl, C₂-C₁₀alkynyl, C₁-C₄alkoxy-C₁-C₁₀alkyl-, C₁-C₄alkylthio-C₁-C₄alkyl-, C₁-C₁₀alkoxy, C₁-C₁₀alkylthio-, N—C₁-C₄alkyl-amino-, N,N-di-(C₁-C₄alkyl)-amino-, phenyl or phenyl substituted by one to three R¹⁴, which may be the same or different, benzyl or benzyl wherein the phenyl moiety is substituted by one to three R¹⁴, which may be the same or different, thienyl or thienyl substituted by one to three R¹⁴, which may be the same or different, pyridyl or pyridyl substituted by one to three R¹⁴, which may be the same or different, phenoxy or phenoxy substituted by one to three R¹⁴, which may be the same or different, or phenylthio or phenylthio substituted by one to three R¹⁴, which may be the same or different.

Preferably each R¹¹ is independently C₁-C₄alkyl.

Preferably R¹² is C₁-C₄alkyl.

Preferably each R¹³ is independently halo, nitro, C₁-C₄alkyl, C₁-C₄haloalkyl or C₁-C₄alkoxy. Examples of such preferred groups are chloro, fluoro, nitro, methyl, ethyl, trifluoromethyl and methoxy.

Preferably each R¹⁴ is halo, nitro, C₁-C₄alkyl, C₁-C₄haloalkyl, C₁-C₄alkoxy or C₁-C₄haloalkoxy. Examples of such preferred groups are chloro, fluoro, nitro, methyl, ethyl, trifluoromethyl, methoxy and trifluoromethoxy.

In one embodiment the invention provides a method of controlling plants which comprises applying to the plants or to the locus thereof a herbicidally effective amount of a compound of formula (Ix)

wherein R¹, R², R⁴ and R⁵ are as defined for compounds of formula (I) and R³ is C₁-C₁₀alkyl, C₂-C₁₀alkenyl, C₂-C₁₀alkynyl, C₃-C₁₀cycloalkyl, C₃-C₁₀cycloalkyl-C₁-C₆alkyl-, C₁-C₁₀alkoxy-C₁-C₆alkyl-, C₁-C₁₀cyanoalkyl-, C₁-C₁₀alkoxycarbonyl-C₁-C₆alkyl-, N—C₁-C₃alkyl-aminocarbonyl-C₁-C₆alkyl-, N N-di-(C₁-C₃alkyl)-aminocarbonyl-C₁-C₆alkyl-, aryl-C₁-C₆alkyl- or aryl-C₁-C₆alkyl- wherein the aryl moiety is substituted by one to three R⁷, which may be the same or different, or heterocyclyl-C₁-C₆alkyl- or heterocyclyl-C₁-C₆alkyl- wherein the heterocyclyl moiety is substituted by one to three R⁷, which may be the same or different; or salts or N-oxides thereof. The preferences for R¹, R², R⁴, R⁵, R⁶, R⁷, R⁸, R⁹, R¹⁰, R¹¹, R¹², R¹³ and R¹⁴ are the same as the preferences set out for the corresponding substituents of compounds of the formula (I). The preferences for R³ are the same as the preferences set out for the corresponding substituents of compounds of formula (I) except that R³ cannot be hydrogen.

In another embodiment the invention provides a method of controlling plants which comprises applying to the plants or to the locus thereof a herbicidally effective amount of a compound of formula (Ic)

wherein R¹, R² and R⁴ are as defined for compounds of formula (I) and R³ is C₁-C₁₀alkyl, C₂-C₁₀alkenyl, C₂-C₁₀alkynyl, C₃-C₁₀cycloalkyl, C₃-C₁₀cycloalkyl-C₁-C₆alkyl-, C₁-C₁₀alkoxy-C₁-C₆alkyl-, C₁-C₁₀cyanoalkyl-, C₁-C₁₀alkoxycarbonyl-C₁-C₆alkyl-, N—C₁-C₃alkyl-aminocarbonyl-C₁-C₆alkyl-, N,N-di-(C₁-C₃alkyl)-aminocarbonyl-C₁-C₆alkyl-, aryl-C₁-C₆alkyl- or aryl-C₁-C₆alkyl- wherein the aryl moiety is substituted by one to three R⁷, which may be the same or different, or heterocyclyl-C₁-C₆alkyl- or heterocyclyl-C₁-C₆alkyl- wherein the heterocyclyl moiety is substituted by one to three R⁷, which may be the same or different; and R⁵ is R⁹-oxy-, R¹⁰-carbonyloxy-, tri-R¹¹ silyloxy- or R¹²-sulfonyloxy-; or salts or N-oxides thereof. The preferences for R¹, R², R⁴, R⁶, R⁷, R⁸, R⁹, R¹⁰, R¹¹, R², R¹³ and R¹⁴ are the same as the preferences set out for the corresponding substituents of compounds of the formula (I). The preferences for R³ are the same as the preferences set out for the corresponding substituents of compounds of formula (I) except that R³ cannot be hydrogen. The preferences for R⁵ are the same as the preferences set out for the corresponding substituents of compounds of formula (I) except that R⁵ cannot be hydroxy.

In another embodiment the invention provides a method of controlling plants which comprises applying to the plants or to the locus thereof a herbicidally effective amount of a compound of formula (Id)

wherein R¹, R² and R⁴ are as defined for compounds of formula (I) and R³ is C₁-C₁₀alkyl, C₂-C₁₀alkenyl, C₂-C₁₀alkynyl, C₃-C₁₀cycloalkyl, C₃-C₁₀cycloalkyl-C₁-C₆alkyl-, C₁-C₁₀alkoxy-C₁-C₆alkyl-, C₁-C₁₀cyanoalkyl-, C₁-C₁₀alkoxycarbonyl-C₁-C₆alkyl-, N—C₁-C₃alkyl-aminocarbonyl-C₁-C₆alkyl-, N,N-di-(C₁-C₃alkyl)-aminocarbonyl-C₁-C₆alkyl-, aryl-C₁-C₆alkyl- or aryl-C₁-C₆alkyl- wherein the aryl moiety is substituted by one to three R⁷, which may be the same or different, or heterocyclyl-C₁-C₆alkyl- or heterocyclyl-C₁-C₆alkyl- wherein the heterocyclyl moiety is substituted by one to three R⁷, which may be the same or different; or salts or N-oxides thereof. The preferences for R¹, R², R⁴, R⁶, R⁷, R⁸ and R¹³ are the same as the preferences set out for the corresponding substituents of compounds of the formula (I). The preferences for R³ are the same as the preferences set out for the corresponding substituents of compounds of formula (I) except that R³ cannot be hydrogen.

Certain compounds of formula (I) are novel and as such form a further aspect of the invention. One group of novel compounds are compounds of formula (Ia)

wherein R¹, R² and R⁴ are as defined for compounds of formula (I); or salts or N-oxides thereof, provided that if R¹ and R² are hydrogen, R⁴ is not 4-bromo-2,6-difluoro-phenyl, 2-bromo-phenyl, 2-chloro-4-fluoro-phenyl, 2-chloro-6-fluoro-phenyl, 4-chloro-2-fluoro-phenyl, 4-chloro-2-methyl-phenyl, 2-chloro-phenyl, 5-chloro-2-trifluoromethyl-phenyl, 4-cyano-2,6-difluoro-phenyl, 2,4-dichloro-phenyl, 2,6-dichloro-phenyl, 2,6-difluoro-4-methoxycarbonyl-phenyl, 2,6-difluoro-4-methoxy-phenyl, 2,6-difluoro-4-methyl-phenyl, 2,3-difluoro-phenyl, 2,4-difluoro-phenyl, 2,5-difluoro-phenyl, 2,6-difluoro-phenyl, 2,4-dimethyl-phenyl, 2,6-dimethyl-phenyl, 6-fluoro-2-methoxy-phenyl, 2-fluoro-4-methyl-phenyl, 6-fluoro-2-methyl-phenyl, 4-fluoro-2-methyl-phenyl, 2-fluoro-phenyl, 4-fluoro-2-trifluoromethyl-phenyl, 5-fluoro-2-trifluoromethyl-phenyl, 2,3,4,5,6-pentafluoro-phenyl, 2,3,5,6-tetrafluoro-phenyl, 2,3,4-trifluoro-phenyl, 2,4,6-trifluoro-phenyl, 2,5,6-trifluoro-phenyl or 2,4,6-trimethyl-phenyl. The preferences for R¹, R², R⁴, R⁶, R⁸ and R¹³ are the same as the preferences set out for the corresponding substituents of compounds of the formula (I). Some of these compounds exhibit good herbicidal activity. Additionally, these compounds can be used as intermediates for the synthesis of compounds of the formula (Ib), (Ic) and (Id).

Another group of novel compounds are compounds of formula (Ia)

wherein R¹, R² and R⁴ are as defined for compounds of formula (I); or salts or N-oxides thereof, provided that if R¹ and R² are hydrogen, R⁴ is not 2-bromo-4,6-difluoro-phenyl, 4-bromo-2,6-difluoro-phenyl, 2-bromo-6-fluoro-phenyl, 2-bromo-phenyl, 2-chloro-4,6-difluoro-phenyl, 2-chloro-4-fluoro-phenyl, 2-chloro-6-fluoro-phenyl, 4-chloro-2-fluoro-phenyl, 6-chloro-2-methyl-phenyl, 4-chloro-2-methyl-phenyl, 2-chloro-phenyl, 6-chloro-2-trifluoromethyl-phenyl, 5-chloro-2-trifluoromethyl-phenyl, 4-cyano-2,6-difluoro-phenyl, 2,4-dichloro-6-fluoro-phenyl, 2,6-dichloro-4-fluoro-phenyl, 2,4-dichloro-phenyl, 2,6-dichloro-phenyl, 2,6-difluoro-4-methoxycarbonyl-phenyl, 4,6-difluoro-2-methoxy-phenyl, 2,6-difluoro-4-methoxy-phenyl, 4,6-difluoro-2-methyl-phenyl, 2,6-difluoro-4-methyl-phenyl, 2,3-difluoro-phenyl, 2,4-difluoro-phenyl, 2,5-difluoro-phenyl, 2,6-difluoro-phenyl, 4,6-difluoro-2-trifluoromethyl-phenyl, 2,6-dimethoxy-phenyl, 2,4-dimethyl-phenyl, 2,6-dimethyl-phenyl, 2,6-di(trifluoromethyl)-phenyl, 6-fluoro-2-methoxy-phenyl, 2-fluoro-4-methyl-phenyl, 6-fluoro-2-methyl-phenyl, 4-fluoro-2-methyl-phenyl, 2-fluoro-phenyl, 6-fluoro-2-trifluoromethyl-phenyl, 4-fluoro-2-trifluoromethyl-phenyl, 5-fluoro-2-trifluoromethyl-phenyl, 2-methoxy-phenyl, 2,3,4,5,6-pentachloro-phenyl, 2,3,4,5,6-pentafluoro-phenyl, 2,3,5,6-tetrafluoro-phenyl, 2,3,6-trichlorophenyl, 2,4,6-trichlorophenyl, 2-trifluoromethyl-phenyl, 2,3,4-trifluoro-phenyl, 2,4,6-trifluoro-phenyl, 2, ,5,6-trifluoro-phenyl or 2,4,6-trimethyl-phenyl. The preferences for R¹, R², R⁴, R⁶, R⁸ and R¹³ are the same as the preferences set out for the corresponding substituents of compounds of the formula (I). Some of these compounds exhibit good herbicidal activity. Additionally, these compounds can be used as intermediates for the synthesis of compounds of the formula (Ib), (c) and (Id).

An other group of novel compounds are compounds of formula (Ib)

wherein R¹, R² and R⁴ are as defined for compounds of formula (I) and R⁵ is R⁹-oxy-, R¹⁰-carbonyloxy-, tri-R¹¹-silyloxy- or R¹²-sulfonyloxy-; or salts or N-oxides thereof. The preferences for R¹, R², R⁴, R⁶, R⁸, R⁹, R¹⁰, R¹¹, R¹², R¹³ and R¹⁴ are the same as the preferences set out for the corresponding substituents of compounds of the formula (I). The preferences for R⁵ are the same as the preferences set out for the corresponding substituents of compounds of formula (I) except that R⁵ cannot be hydroxy. Some of these compounds exhibit good herbicidal activity. Additionally, these compounds can be used as intermediates for the synthesis of compounds of the formula (Ia), (Ic) and (Id).

Another group of novel compounds are compounds of formula (Ic)

wherein R¹, R² and R⁴ are as defined for compounds of formula (I) and R³ is C₁-C₁₀alkyl, C₂-C₁₀alkenyl, C₂-C₁₀alkynyl, C₃-C₁₀cycloalkyl, C₃-C₁₀cycloalkyl-C₁-C₆alkyl-, C₁-C₁₀alkoxy-C₁-C₆alkyl-, C₁-C₁₀cyanoalkyl-, C₁-C₁₀alkoxycarbonyl-C₁-C₆alkyl-, N—C₁-C₃alkyl-aminocarbonyl-C₁-C₆alkyl-, N,N-di-(C₁-C₃alkyl)-aminocarbonyl-C₁-C₆alkyl-, aryl-C₁-C₆alkyl- or aryl-C₁-C₆alkyl- wherein the aryl moiety is substituted by one to three R⁷, which may be the same or different, or heterocyclyl-C₁-C₆alkyl- or heterocyclyl-C₁-C₆alkyl- wherein the heterocyclyl moiety is substituted by one to three R⁷, which may be the same or different; and R⁵ is R⁹-oxy-, R¹⁰-carbonyloxy-, tri-R¹¹-silyloxy- or R¹²-sulfonyloxy-; or salts or N-oxides thereof. The preferences for R¹, R², R⁴, R⁶, R⁷, R⁸, R⁹, R¹⁰, R¹¹, R¹², R¹³ and R¹⁴ are the same as the preferences set out for the corresponding substituents of compounds of the formula (I). The preferences for R³ are the same as the preferences set out for the corresponding substituents of compounds of formula (I) except that R³ cannot be hydrogen. The preferences for R⁵ are the same as the preferences set out for the corresponding substituents of compounds of formula (I) except that R⁵ cannot be hydroxy. Most of these compounds exhibit excellent herbicidal activity. Additionally, these compounds can be used as intermediates for the synthesis of compounds of the formula (Ia), (Ib) and (Id).

A further group of novel compounds are compounds of formula (Id)

wherein R¹, R² and R⁴ are as defined for compounds of formula (I) and R³ is C₁-C₁alkyl, C₂-C₁₀alkenyl, C₂-C₁₀alkynyl, C₃-C₁₀cycloalkyl, C₃-C₁₀cycloalkyl-C₁-C₆alkyl-, C₁-C₁₀alkoxy-C₁-C₆alkyl-, C₁-C₁₀cyanoalkyl-, C₁-C₁₀alkoxycarbonyl-C₁-C₆alkyl-, N—C₁-C₃alkyl-aminocarbonyl-C₁-C₆alkyl-, N,N-di-(C₁-C₃alkyl)-aminocarbonyl-C₁-C₆alkyl-, aryl-C₁-C₆alkyl- or aryl-C₁-C₆alkyl- wherein the aryl moiety is substituted by one to three R⁷, which may be the same or different, or heterocyclyl-C₁-C₆alkyl- or heterocyclyl-C₁-C₆alkyl- wherein the heterocyclyl moiety is substituted by one to three R⁷, which may be the same or different; or salts or N-oxides thereof. The preferences for R¹, R², R⁴, R⁶, R⁷, R⁸ and R¹³ are the same as the preferences set out for the corresponding substituents of compounds of the formula (I). The preferences for R³ are the same as the preferences set out for the corresponding substituents of compounds of formula (I) except that R³ cannot be hydrogen. Most of these compounds exhibit good herbicidal activity. Additionally, these compounds can be used as intermediates for the synthesis of compounds of the formula (Ia), (Ib) and (Ic).

Certain intermediates are novel and as such form a further aspect of the invention. One group of novel intermediates are compounds of formula (5)

wherein R¹ and R² are as defined for compounds of formula (I) and R⁷ is C₁-C₆alkyl; or salts or N-oxides thereof. The preferences for R¹ and R² are the same as the preferences set out for the corresponding substituents of compounds of the formula (I). R¹⁷ is preferably C₁-C₄alkyl, more preferably methyl or ethyl, most preferably methyl.

Another group of novel intermediates are compounds of formula (6)

wherein R¹ and R² are as defined for compounds of formula (I); or salts or N-oxides thereof. The preferences for R¹ and R² are the same as the preferences set out for the corresponding substituents of compounds of the formula (I).

The compounds in Tables 1 to 28 below illustrate the compounds of the invention.

TABLE 1 Table 1 provides 140 compounds of formula (I), where R¹ and R² are both hydrogen, R⁴ is 2-chloro-3,6-difluoro-phenyl and R³ and R⁵ have the values listed in Table 1. (I)

Compound number R³ R⁵ 1.001 H —OH 1.002 H —OCH₃ 1.003 H —OCOCH₃ 1.004 H —OCOCH₂CH₃ 1.005 H —OCOCH(CH₃)₂ 1.006 H —OCOC(CH₃)₃ 1.007 H —OCO-cyclo-C₃H₅ 1.008 H —OCO—C₆H₅ 1.009 H —OCOCH₂C₆H₅ 1.010 H —OCOCH₂Cl 1.011 H —OCOCF₃ 1.012 H —OCOCH₂OCH₃ 1.013 H —OCON(CH₃CH₂)₂ 1.014 H —O(CO)OCH₂CH₃ 1.015 —CH₃ —OH 1.016 —CH₃ —OCH₃ 1.017 —CH₃ —OCOCH₃ 1.018 —CH₃ —OCOCH₂CH₃ 1.019 —CH₃ —OCOCH(CH₃)₂ 1.020 —CH₃ —OCOC(CH₃)₃ 1.021 —CH₃ —OCO-cyclo-C₃H₅ 1.022 —CH₃ —OCO—C₆H₅ 1.023 —CH₃ —OCOCH₂C₆H₅ 1.024 —CH₃ —OCOCH₂Cl 1.025 —CH₃ —OCOCF₃ 1.026 —CH₃ —OCOCH₂OCH₃ 1.027 —CH₃ —OCON(CH₃CH₂)₂ 1.028 —CH₃ —O(CO)OCH₂CH₃ 1.029 —CH₂CH₃ —OH 1.030 —CH₂CH₃ —OCH₃ 1.031 —CH₂CH₃ —OCOCH₃ 1.032 —CH₂CH₃ —OCOCH₂CH₃ 1.033 —CH₂CH₃ —OCOCH(CH₃)₂ 1.034 —CH₂CH₃ —OCOC(CH₃)₃ 1.035 —CH₂CH₃ —OCO-cyclo-C₃H₅ 1.036 —CH₂CH₃ —OCO—C₆H₅ 1.037 —CH₂CH₃ —OCOCH₂C₆H₅ 1.038 —CH₂CH₃ —OCOCH₂Cl 1.039 —CH₂CH₃ —OCOCF₃ 1.040 —CH₂CH₃ —OCOCH₂OCH₃ 1.041 —CH₂CH₃ —OCON(CH₃CH₂)₂ 1.042 —CH₂CH₃ —O(CO)OCH₂CH₃ 1.043 —CH₂CH₂CH₃ —OH 1.044 —CH₂CH₂CH₃ —OCH₃ 1.045 —CH₂CH₂CH₃ —OCOCH₃ 1.046 —CH₂CH₂CH₃ —OCOCH₂CH₃ 1.047 —CH₂CH₂CH₃ —OCOCH(CH₃)₂ 1.048 —CH₂CH₂CH₃ —OCOC(CH₃)₃ 1.049 —CH₂CH₂CH₃ —OCO-cyclo-C₃H₅ 1.050 —CH₂CH₂CH₃ —OCO-C₆H₅ 1.051 —CH₂CH₂CH₃ —OCOCH₂C₆H₅ 1.052 —CH₂CH₂CH₃ —OCOCH₂Cl 1.053 —CH₂CH₂CH₃ —OCOCF₃ 1.054 —CH₂CH₂CH₃ —OCOCH₂OCH₃ 1.055 —CH₂CH₂CH₃ —OCON(CH₃CH₂)₂ 1.056 —CH₂CH₂CH₃ —O(CO)OCH₂CH₃ 1.057 —CH(CH₃)₂ —OH 1.058 —CH(CH₃)₂ —OCH₃ 1.059 —CH(CH₃)₂ —OCOCH₃ 1.060 —CH(CH₃)₂ —OCOCH₂CH₃ 1.061 —CH(CH₃)₂ —OCOCH(CH₃)₂ 1.062 —CH(CH₃)₂ —OCOC(CH₃)₃ 1.063 —CH(CH₃)₂ —OCO-cyclo-C₃H₅ 1.064 —CH(CH₃)₂ —OCO-C₆H₅ 1.065 —CH(CH₃)₂ —OCOCH₂C₆H₅ 1.066 —CH(CH₃)₂ —OCOCH₂Cl 1.067 —CH(CH₃)₂ —OCOCF₃ 1.068 —CH(CH₃)₂ —OCOCH₂OCH₃ 1.069 —CH(CH₃)₂ —OCON(CH₃CH₂)₂ 1.070 —CH(CH₃)₂ —O(CO)OCH₂CH₃ 1.071 —CH₂CH₂CH₂CH₃ —OH 1.072 —CH₂CH₂CH₂CH₃ —OCH₃ 1.073 —CH₂CH₂CH₂CH₃ —OCOCH₃ 1.074 —CH₂CH₂CH₂CH₃ —OCOCH₂CH₃ 1.075 —CH₂CH₂CH₂CH₃ —OCOCH(CH₃)₂ 1.076 —CH₂CH₂CH₂CH₃ —OCOC(CH₃)₃ 1.077 —CH₂CH₂CH₂CH₃ —OCO-cyclo-C₃H₅ 1.078 —CH₂CH₂CH₂CH₃ —OCO-C₆H₅ 1.079 —CH₂CH₂CH₂CH₃ —OCOCH₂C₆H₅ 1.080 —CH₂CH₂CH₂CH₃ —OCOCH₂Cl 1.081 —CH₂CH₂CH₂CH₃ —OCOCF₃ 1.082 —CH₂CH₂CH₂CH₃ —OCOCH₂OCH₃ 1.083 —CH₂CH₂CH₂CH₃ —OCON(CH₃CH₂)₂ 1.084 —CH₂CH₂CH₂CH₃ —O(CO)OCH₂CH₃ 1.085 —CH₂CH═CH₂ —OH 1.086 —CH₂CH═CH₂ —OCH₃ 1.087 —CH₂CH═CH₂ —OCOCH₃ 1.088 —CH₂CH═CH₂ —OCOCH₂CH₃ 1.089 —CH₂CH═CH₂ —OCOCH(CH₃)₂ 1.090 —CH₂CH═CH₂ —OCOC(CH₃)₃ 1.091 —CH₂CH═CH₂ —OCO-cyclo-C₃H₅ 1.092 —CH₂CH═CH₂ —OCO-C₆H₅ 1.093 —CH₂CH═CH₂ —OCOCH₂C₆H₅ 1.094 —CH₂CH═CH₂ —OCOCH₂Cl 1.095 —CH₂CH═CH₂ —OCOCF₃ 1.096 —CH₂CH═CH₂ —OCOCH₂OCH₃ 1.097 —CH₂CH═CH₂ —OCON(CH₃CH₂)₂ 1.098 —CH₂CH═CH₂ —O(CO)OCH₂CH₃ 1.099 —CH₂C≡CH —OH 1.100 —CH₂C≡CH —OCH₃ 1.101 —CH₂C≡CH —OCOCH₃ 1.102 —CH₂C≡CH —OCOCH₂CH₃ 1.103 —CH₂C≡CH —OCOCH(CH₃)₂ 1.104 —CH₂C≡CH —OCOC(CH₃)₃ 1.105 —CH₂C≡CH —OCO-cyclo-C₃H₅ 1.106 —CH₂C≡CH —OCO—C₆H₅ 1.107 —CH₂C≡CH —OCOCH₂C₆H₅ 1.108 —CH₂C≡CH —OCOCH₂Cl 1.109 —CH₂C≡CH —OCOCF₃ 1.110 —CH₂C≡CH —OCOCH₂OCH₃ 1.111 —CH₂C≡CH —OCON(CH₃CH₂)₂ 1.112 —CH₂C≡CH —O(CO)OCH₂CH₃ 1.113 —CH₂CN —OH 1.114 —CH₂CN —OCH₃ 1.115 —CH₂CN —OCOCH₃ 1.116 —CH₂CN —OCOCH₂CH₃ 1.117 —CH₂CN —OCOCH(CH₃)₂ 1.118 —CH₂CN —OCOC(CH₃)₃ 1.119 —CH₂CN —OCO-cyclo-C₃H₅ 1.120 —CH₂CN —OCO—C₆H₅ 1.121 —CH₂CN —OCOCH₂C₆H₅ 1.122 —CH₂CN —OCOCH₂Cl 1.123 —CH₂CN —OCOCF₃ 1.124 —CH₂CN —OCOCH₂OCH₃ 1.125 —CH₂CN —OCON(CH₃CH₂)₂ 1.126 —CH₂CN —O(CO)OCH₂CH₃ 1.127 —CH₂C₆H₅ —OH 1.128 —CH₂C₆H₅ —OCH₃ 1.129 —CH₂C₆H₅ —OCOCH₃ 1.130 —CH₂C₆H₅ —OCOCH₂CH₃ 1.131 —CH₂C₆H₅ —OCOCH(CH₃)₂ 1.132 —CH₂C₆H₅ —OCOC(CH₃)₃ 1.133 —CH₂C₆H₅ —OCO-cyclo-C₃H₅ 1.134 —CH₂C₆H₅ —OCO—C₆H₅ 1.135 —CH₂C₆H₅ —OCOCH₂C₆H₅ 1.136 —CH₂C₆H₅ —OCOCH₂Cl 1.137 —CH₂C₆H₅ —OCOCF₃ 1.138 —CH₂C₆H₅ —OCOCH₂OCH₃ 1.139 —CH₂C₆H₅ —OCON(CH₃CH₂)₂ 1.140 —CH₂C₆H₅ —O(CO)OCH₂CH₃

Table 2:

Table 2 provides 140 compounds of formula (I), where R¹ and R² are both hydrogen, R⁴ is 2-chloro-4-fluoro-phenyl and R³ and R⁵ have the values listed in Table 1.

Table 3:

Table 3 provides 140 compounds of formula (I), where R¹ and R² are both hydrogen, R⁴ is 2-chloro-phenyl and R³ and R⁵ have the values listed in Table 1.

Table 4:

Table 4 provides 140 compounds of formula (I), where R¹ and R² are both hydrogen, R⁴ is 3,5-dichloro-2-methoxy-phenyl and R³ and R⁵ have the values listed in Table 1.

Table 5:

Table 5 provides 140 compounds of formula (I), where R¹ and R² are both hydrogen, R⁴ is 2,3-dichloro-phenyl and R³ and R⁵ have the values listed in Table 1.

Table 6:

Table 6 provides 140 compounds of formula (I), where R¹ and R² are both hydrogen, R⁴ is 2,4-dichloro-phenyl and R³ and R⁵ have the values listed in Table 1.

Table 7:

Table 7 provides 140 compounds of formula (I), where R¹ and R² are both hydrogen, R⁴ is 2,5-dichloro-phenyl and R³ and R⁵ have the values listed in Table 1.

Table 8:

Table 8 provides 140 compounds of formula (I), where R¹ and R² are both hydrogen, R⁴ is 2,6-dichloro-phenyl and R³ and R⁵ have the values listed in Table 1.

Table 9:

Table 9 provides 140 compounds of formula (I), where R¹ and R² are both hydrogen, R⁴ is 2,6-dichloro-4-trifluoromethyl-phenyl and R³ and R⁵ have the values listed in Table 1.

Table 10:

Table 10 provides 140 compounds of formula (I), where R¹ and R² are both hydrogen, R⁴ is 2,6-diethyl-4-methyl-phenyl and R³ and R⁵ have the values listed in Table 1.

Table 11:

Table 11 provides 140 compounds of formula (I), where R¹ and R² are both hydrogen, R⁴ is 2-fluoro-phenyl and R³ and R⁵ have the values listed in Table 1.

Table 12:

Table 12 provides 140 compounds of formula (I), where R¹ and R² are both hydrogen, R⁴ is 2-methoxy-phenyl and R³ and R⁵ have the values listed in Table 1.

Table 13:

Table 13 provides 140 compounds of formula (I), where R¹ and R² are both hydrogen, R⁴ is 2-methyl-phenyl and R³ and R⁵ have the values listed in Table 1.

Table 14:

Table 14 provides 140 compounds of formula (I), where R¹ and R² are both hydrogen, R⁴ is 2-trifluoromethoxy-phenyl and R³ and R⁵ have the values listed in Table 1.

Table 15:

Table 15 provides 140 compounds of formula (I), where R¹ and R² are both hydrogen, R⁴ is 2-trifluoromethyl-phenyl and R³ and R⁵ have the values listed in Table 1.

Table 16:

Table 16 provides 140 compounds of formula (I), where R¹ and R² are both hydrogen, R⁴ is 3-bromo-2-chloro-6-fluoro-phenyl and R³ and R⁵ have the values listed in Table 1.

Table 17:

Table 17 provides 140 compounds of formula (I), where R¹ and R² are both hydrogen, R⁴ is 2,3-dichloro-6-fluoro-phenyl and R³ and R⁵ have the values listed in Table 1.

Table 18:

Table 18 provides 140 compounds of formula (I), where R¹ and R² are both hydrogen, R⁴ is 2-chloro-6-fluoro-3-methyl-phenyl and R³ and R⁵ have the values listed in Table 1.

Table 19:

Table 19 provides 140 compounds of formula (I), where R¹ and R² are both hydrogen, R⁴ is 2,6-dichloro-4-trifluoromethoxy-phenyl and R³ and R⁵ have the values listed in Table 1.

Table 20:

Table 20 provides 140 compounds of formula (I), where R¹ and R² are both hydrogen, R⁴ is 6-chloro-2-trifluoromethyl-phenyl and R³ and R⁵ have the values listed in Table 1.

Table 21:

Table 21 provides 140 compounds of formula (I), where R¹ and R² are both hydrogen, R⁴ is 2-chloro-5-trifluoromethyl-phenyl and R³ and R⁵ have the values listed in Table 1.

Table 22:

Table 22 provides 140 compounds of formula (I), where R¹ and R² are both hydrogen, R⁴ is 2-chloro-5-fluoro-phenyl and R³ and R⁵ have the values listed in Table 1.

Table 23:

Table 23 provides 140 compounds of formula (I), where R¹ and R² are both hydrogen, R⁴ is 2,4-dichloro-5-fluoro-phenyl and R³ and R⁵ have the values listed in Table 1.

Table 24:

Table 24 provides 140 compounds of formula (I), where R¹ and R² are both hydrogen, R⁴ is 2-methoxy-5-trifluoromethoxy-phenyl and R³ and R⁵ have the values listed in Table 1.

Table 25:

Table 25 provides 140 compounds of formula (I), where R¹ and R² are both hydrogen, R⁴ is 2,3-dimethoxy-phenyl and R³ and R⁵ have the values listed in Table 1.

Table 26:

Table 26 provides 140 compounds of formula (I), where R¹ and R² are both hydrogen, R⁴ is 2-chloro-3-trifluoromethyl-phenyl and R³ and R⁵ have the values listed in Table 1.

Table 27:

Table 27 provides 140 compounds of formula (I), where R¹ and R² are both hydrogen, R⁴ is 2-chloro-6-fluoro-5-methyl-phenyl and R³ and R⁵ have the values listed in Table 1.

Table 28:

Table 28 provides 140 compounds of formula (I), where R¹ and R² are both hydrogen, R⁴ is 2,4,6-trimethyl-phenyl and R³ and R⁵ have the values listed in Table 1.

The compounds of the invention may be made by a variety of methods, for example by the methods described in Schemes 1 to 12.

1) Compounds of formula (4) wherein R¹, R² and R⁴ are as defined for compounds of formula (I) and R¹⁶ is C₁-C₆alkyl can be made by reaction of an amino-pyrazine ester of formula (2) wherein R¹ and R² are as defined for compounds of formula (I) and R¹⁶ is C₁-C₆alkyl with an acid derivative of formula (3) wherein R⁴ is as defined for compounds of formula (I) and X is halogen or hydroxy, as shown in Scheme 1. For example, if (3) is an acid chloride (i.e. where X is chlorine) the reaction can conveniently be carried out optionally in the presence of a base, such as triethylamine or pyridine, in a suitable solvent, such as acetonitrile or dichloromethane, optionally using microwave heating. Alternatively, if (3) is a carboxylic acid (i.e. where X is hydroxy) the reaction can conveniently be carried out using an amide coupling method, for example by reaction with a coupling agent, such as bis(2-oxo-3-oxazolidinyl)phosphinic chloride, in the presence of a base, such as triethylamine, in a suitable solvent, such as dichloromethane, or other amide coupling methods which have been reviewed in Tetrahedron (2005), 61(46), 10827-10852.

2) Compounds of formula (Ia), i.e. a compound of formula (I) wherein R³ is hydrogen and R⁵ is hydroxy, can be prepared by treating a compound of formula (4) as defined in 1) with a base, such as potassium carbonate in a suitable solvent, such as dimethylformamide, optionally using microwave heating, or lithium hexamethyl-disilazide in a suitable solvent, such as tetrahydrofuran.

3) Compounds of formula (Ij), i.e. a compound of formula (I) wherein R³ is hydrogen and R⁵ is —O—CO—R¹⁰, can be prepared by reaction of a compound of formula (Ia) as defined in 2) with an acid chloride of formula R¹⁰COCl or an acid anhydride of formula (R¹⁰CO)₂O wherein R¹⁰ is as defined for compounds of formula (I), optionally in the presence of a base, such as triethylamine, optionally in a suitable solvent, such as dichloromethane.

4) Compounds of formula (If), i.e. a compound of formula (I) wherein R³ is as defined for compound of formula (I) other than hydrogen and R⁵ is —O—CO—R¹⁰, can be prepared from a compound of formula (Ij) as defined in 3) by reaction with a compound of formula R³LG wherein R³ is as defined for compounds of formula (I) and LG is a leaving group such as a halide, for example bromide or iodide, or tosylate, mesylate or triflate, in the presence of a base, such as potassium carbonate, in a suitable solvent, such as acetonitrile or dimethylformamide, optionally using microwave heating, as shown in Scheme 2.

5) Compounds of formula (Id), i.e. a compound of formula (I) wherein R³ is as defined for compounds of formula (I) other than hydrogen and R⁵ is hydroxy, can be prepared by treating a compound of formula (If) as defined in 4) with a base, such as sodium hydroxide or potassium carbonate, in a suitable solvent, such as aqueous methanol.

6) Compounds of formula (Ie), i.e. compounds of formula (I) wherein R³ is as defined for compound of formula (I) other than hydrogen and R⁵ is —O—R⁹, can be prepared from a compound of formula (Id) as defined in 5) by reaction with a compound of formula R⁹LG wherein R⁹ is as defined for compounds of formula (I) and LG is a leaving group such as halide, for example bromide or iodide, or tosylate, mesylate or triflate, in the presence of a base, such as potassium carbonate, in a suitable solvent, such as dimethylformamide.

7) Where R³ and R⁹ happen to be identical, for example both are simple alkyl groups, compounds of formula (Ie) as defined in 6) can also be formed by reaction of a compound. of formula (Ia) as defined in 2) with at least two equivalents of a compound of formula R³LG as defined in 4), in the presence of a base, such as potassium carbonate, in a suitable solvent, such as dimethylformamide, as shown in Scheme 3.

8) Compounds of formula (If) as defined in 4) can additionally be prepared in a shortened route directly from a compound of formula (4) as defined in 1) by reaction with a compound of formula R³LG as defined in 4), in the presence of a base, such as sodium or potassium hexamethyldisilazide, in a suitable solvent, such as tetrahydrofuran, optionally using microwave heating, followed by reaction with an acid chloride of formula R¹⁰COCl or an acid anhydride of formula (R¹⁰CO)₂O as defined in 3), optionally in the presence of a base, such as triethylamine, in the same reaction pot, as shown in Scheme 4.

9) Alternatively compounds of formula (If) as defined in 4) can be made from compounds of formula (Id) as defined in 5), by reaction with an acid chloride of formula R¹⁰COCl or an acid anhydride of formula (R¹⁰CO)₂O as defined in 3), optionally in the presence of a base, such as triethylamine.

10) Compounds of formula (Id) as defined in 5) can be made by reaction of a compound of formula (4) as defined in 1) with a compound of formula R³LG as defined in 4), in the presence of a base, such as potassium hexamethyldisilazide, in a suitable solvent, such as tetrahydrofuran, optionally using microwave heating (Method 1).

11) Compounds of formula (Id) as defined in 5) can also be made from a compound of formula (Ia) as defined in 2) by reaction with a compound of formula R³LG as defined in 4), in the presence of a base, such as potassium hexamethyldisilazide, in a suitable solvent, such as tetrahydrofuran, optionally using microwave heating (Method 2). The synthesis of compounds of formula (Ia) was described under 2).

12) Silyl compounds of formula (Ig), i.e. a compound of formula (I) wherein R³ is as defined for compound of formula (I) other than hydrogen and R⁵ is —O—Si(R¹¹)₃, can be made from a compound of formula (Id) as defined in 5), by reaction with a trialkylsilyl chloride of formula (R¹¹)₃SiCl, in a suitable solvent, such as tetrahydrofuran or acetonitrile, in the presence of a base, such as triethylamine, as shown in Scheme 5.

13) Sulfonyl compounds of formula.(Ik), i.e. a compound of formula (I) wherein R³ is hydrogen and R⁵ is —O—SO₂—R¹², can be made from a compound of formula (Ia) as defined in 2) by reaction with a compound of formula R¹²SO₂Cl wherein R¹² is as defined for compounds of formula (I), in the presence of a base, such as triethylamine, in a suitable solvent, such as tetrahydrofuran or dichloromethane, as shown in Scheme 6.

14) Sulfonyl compounds of formula (Ih), i.e. a compound of formula (I) wherein R³ is as defined for compounds of formula (I) other than hydrogen and R⁵ is —O—SO₂—R¹², can be made by reaction of a compound of formula (Ik) as defined in 13), with a compound of formula R³LG as defined in 4), in the presence of a base, such as sodium or potassium hexamethyldisilazide, in a suitable solvent, such as tetrahydrofuran, optionally using microwave heating.

15) Alternatively, compounds of formula (Ih) as defined in 14) can be made by reaction of a compound of formula (Id) as defined in 5) with a compound of formula R₁₂SO₂Cl as defined in 13), in the presence of a base, such as triethylamine, in a suitable solvent, such as tetrahydrofuran or dichloromethane.

16) A mixture of N-oxides of formula (Im), i.e. compounds of formula (I) wherein the 5-nitrogen is oxidised, R³ is as defined for compounds of formula (I) other than hydrogen and R⁵ is —O—CO—R¹⁰, and N-oxides of formula (In), i.e. compounds of formula (I) wherein the 5-nitrogen is oxidised, R³ is as defined for compounds of formula (I) other than hydrogen and R⁵ is hydroxy, can be made by reaction of a compound of formula (If) as defined in 4), with a per-acid, such as per-trifluoroacetic acid, generated in situ for example by trifluoroacetic anhydride and hydrogen peroxide on urea pellets, in a suitable solvent, such as dichloromethane, as shown in Scheme 7.

17) Compounds of formula (5) wherein R¹ and R² are as defined for compounds of formula (I) and R¹⁷ is C₁-C₆alkyl can be made by reaction of an aminopyrazine ester of formula (2) as defined under I) with a dialkyl malonate of formula CH₂(CO₂R¹⁷)₂ wherein R¹⁷ is C₁-C₆alkyl, in the presence of a base, such as sodium methoxide, in a suitable solvent, such as methanol, at a temperature of 25° C. to reflux, preferably at reflux, as shown in Scheme 8.

18) Compounds of formula (6) wherein R¹ and R² are as defined for compounds of formula (I) can be made by hydrolysis and decarboxylation of a compound of formula (5) as defined in 17) by treatment with strong aqueous acid, for example concentrated hydrochloric acid, or alternatively by treatment with dilute aqueous acid, for example aqueous hydrochloric acid, in a suitable solvent, such as ethanol, optionally in a microwave reactor.

19) Compounds of formula (8) wherein R¹, R² and R⁸ are as defined for compounds of formula (I) can be made by reaction of a compound of formula (6) as defined in 18) with a lead compound of formula (7) wherein R⁸ is as defined for compounds of formula (I), in the presence of a base, such as 4-dimethylaminopyridine, and in a suitable solvent, such as dimethyl sulfoxide. Lead compounds (7) are known in the literature and can be made by the methods of J. T. Pinhey, B. A. Rowe, Aust. J. Chem., 1979, 32, 1561-6; J. Morgan, J. T. Pinhey, J. Chem. Soc. Perkin Trans. 1; 1990, 3, 715-20).

20) Nitro compounds of formula (12) wherein R¹, R², R³, R⁸ and R¹⁰ are as defined for compounds of formula (I), can be made by nitration of a compound of formula (11) wherein R¹, R², R³, R⁸ and R¹⁰ are as defined for compounds of formula (I), with a nitration mixture, for example fuming nitric acid and concentrated sulfuric acid, as shown in Scheme 9.

21) Amino compounds of formula (13) wherein R¹, R², R³, R⁸ and R¹⁰ are as defined for compounds of formula (I), can be made by reduction of a compound of formula (12) as defined in 20), using standard reducing conditions, for example, iron filings in aqueous hydrochloric acid.

22) Acylated compounds of formula (14) wherein R¹, R², R³, R⁸ and R¹⁰ are as defined for compounds of formula (I) and R¹⁷ is as defined in 17), can be made by acylation of a compound of formula (13) as defined in 21), for example by reaction with an acid chloride of formula R¹⁷COCl or an acid anhydride (R¹⁷CO)₂O wherein R¹⁷ is as defined in 21), in the presence of a base, such as triethylamine, in a suitable solvent, such as dichloromethane.

23) Alkylated compounds of formula (15) wherein R¹, R², R³, R⁸ and R¹⁰ are as defined for compounds of formula (I) and R¹⁴ is C₁-C₆alkyl, can be made by alkylation of a compound of formula (13) as defined in 21), for example by reaction with a compound of formula R¹⁴LG, wherein R¹⁴ is C₁-C₆alkyl and LG is a leaving group such as bromide or mesylate, optionally in the presence of a base, such as potassium carbonate, in a suitable solvent, such as ethanol or toluene.

24) Compounds of formula (16) wherein R¹, R², R³, R⁸ and R¹⁰ are as defined for compounds of formula (I) and R¹⁹ is cyano, C₁-C₄alkylthio, halo, or hydroxy, can be made by reaction of a compound of formula (13) as defined in 21), by diazotisation, for example by reaction with an alkyl nitrite, in the presence of a suitable nucleophile, for example potassium cyanide, in the presence of a copper salt, for example cuprous cyanide, in a suitable solvent such as acetonitrile.

25) Haloalkyl compounds of formula (18) wherein R¹, R², R³, R⁸ and R¹⁰ are as defined for compounds of formula (I), X is a halogen and n+m=3, can be made by reaction of a compounds of formula (17) with a halogenation agent, such as the halogen of formula X₂ wherein X is chlorine or bromine, in the presence of light, or a N-halosuccinimide of formula

wherein X is chlorine, bromine or iodine, in the presence of a radical initiator, such as benzoyl peroxide, in a suitable solvent, such as carbon tetrachloride, and optionally in the presence of a light source, such as a 500 watt tungsten halogen lamp, at reflux, as shown in Scheme 10.

26) Compounds of formula (19) wherein R¹, R², R³, R⁸ and R¹⁰ are as defined for compounds of formula (I) and R²⁰ is C₁-C₈alkoxy, C₁-C₈thioalkoxy, optionally substituted phenoxy, optionally substituted thiophenoxy, cyano, hydroxy, C₁-C₄alkyl-amino or di-(C₁-C₄alkyl)amino, can be made by reaction of a compound of formula (18) as defined in 25) wherein n=2 and m=1, with a compound of formula R²⁰H wherein R²⁰ is C₁-C₈alkoxy, C₁-C₈thioalkoxy, optionally substituted phenoxy, optionally substituted thiophenoxy, a mono-(C₁-C₄alkyl)amine or a di-(C₁-C₄alkyl)amine, in the presence of a base, such as potassium carbonate or sodium hydride, in a suitable solvent such as ethanol or dimethylformamide, or with a compound of formula R²⁰M wherein R²⁰ is cyano and M is a metal, such as sodium cyanide, or wherein R²⁰ is hydroxy and M is a metal, such as sodium hydroxide in a suitable solvent such as ethanol or dimethyl-formamide.

27) Compounds of formula (20) wherein R¹, R², R³, R⁸ and R¹⁰ are as defined for compounds of formula (I) can be made from a compound of formula (18) as defined in 25) wherein n=1 and m=2, by hydrolysis with an acid for example aqueous sulfuric acid, or from compounds of formula (20) where n=2 and m=1, by reaction with dimethyl-sulfoxide in the presence of a base, such as potassium carbonate.

28) Compounds of formula (21) wherein R¹, R², R³, R⁸ and R¹⁰ are as defined for compounds of formula (I) and R¹⁷ is as defined in 17), can be made from a compound of formula (18) as defined in 25) where n=0 and m=3, by hydrolysis with an alcohol of formula R¹⁷OH wherein R¹⁷ is as defined in 17), optionally in the presence of a silver salt, such as silver nitrate.

29) In certain cases where aryl acetic acids are not commercially available it is necessary to make them. A typical synthesis is shown in Scheme 11. Benzyl halides of formula (23) wherein R⁸ is as defined for compounds of formula (I) and X is halogen, can be made from a substituted toluene of formula (22) wherein R⁸ is as defined for compounds of formula (I), with a halogenation agent, such as the halogen of formula X₂ wherein X is chlorine or bromine, in the presence of light, or a N-halosuccinimide of formula

wherein X is chlorine, bromine or iodine, in the presence of a radical initiator, such as benzoyl peroxide, in a suitable solvent, such as carbon tetrachloride, and optionally in the presence of a light source, such as a 500 watt tungsten halogen lamp , at reflux.

30) Benzyl cyanides of formula (24) wherein R⁸ is as defined for compounds of formula (I) can be made by reaction of a compound of formula (23) as defined in 29) with a metal cyanide, such as potassium cyanide, in a suitable solvent, such as ethanol, at reflux.

31) Phenyl acetic acids of formula (25) wherein R⁸ is as defined for compounds of formula (I) can be made by reaction of a compound of formula (24) as defined in 30) by hydrolysis using aqueous acid or alkali, but preferably aqueous acid, such as aqueous sulfuric acid, at reflux.

The compounds of formula (I) according to the invention can be used as herbicides in unmodified form, as obtained in the synthesis, but they are generally formulated into herbicidal compositions in various ways using formulation adjuvants, such as carriers, solvents and surface-active substances. The formulations can be in various physical forms, e.g. in the form of dusting powders, gels, wettable powders, water-dispersible granules, water-dispersible tablets, effervescent pellets, emulsifiable concentrates, microemulsifiable concentrates, oil-in-water emulsions, oil-flowables, aqueous dispersions, oily dispersions, suspo-emulsions, capsule suspensions, emulsifiable granules, soluble liquids, water-soluble concentrates (with water or a water-miscible organic solvent as carrier), impregnated polymer films or in other forms known e.g. from the Manual on Development and Use of FAO Specifications for Plant Protection Products, 5th Edition, 1999. Such formulations can either be used directly or they are diluted prior to use. The dilutions can be made, for example, with water, liquid fertilisers, micronutrients, biological organisms, oil or solvents.

The formulations can be prepared e.g. by mixing the active ingredient with the formulation adjuvants in order to obtain compositions in the form of finely divided solids, granules, solutions, dispersions or emulsions. The active ingredients can also be formulated with other adjuvants, such as finely divided solids, mineral oils, oils of vegetable or animal origin, modified oils of vegetable or animal origin, organic solvents, water, surface-active substances or combinations thereof. The active ingredients can also be contained in very fine microcapsules consisting of a polymer. Microcapsules contain the active ingredients in a porous carrier. This enables the active ingredients to be released into the environment in controlled amounts (e.g. slow-release). Microcapsules usually have a diameter of from 0.1 to 500 microns. They contain active ingredients in an amount of about from 25 to 95% by weight of the capsule weight. The active ingredients can be in the form of a monolithic solid, in the form of fine particles in solid or liquid dispersion or in the form of a suitable solution. The encapsulating membranes comprise, for example, natural or synthetic rubbers, cellulose, styrene/butadiene copolymers, polyacrylonitrile, polyacrylate, polyesters, polyamides, polyureas, polyurethane or chemically modified polymers and starch xanthates or other polymers that are known to the person skilled in the art in this connection. Alternatively, very fine microcapsules can be formed in which the active ingredient is contained in the form of finely divided particles in a solid matrix of base substance, but the microcapsules are not themselves encapsulated.

The formulation adjuvants that are suitable for the preparation of the compositions according to the invention are known per se. As liquid carriers there may be used: water, toluene, xylene, petroleum ether, vegetable oils, acetone, methyl ethyl ketone, cyclohexanone, acid anhydrides, acetonitrile, acetophenone, amyl acetate, 2-butanone, butylene carbonate, chlorobenzene, cyclohexane, cyclohexanol, alkyl esters of acetic acid, diacetone alcohol, 1,2-dichloropropane, diethanolamine, p-diethylbenzene, diethylene glycol, diethylene glycol abietate, diethylene glycol butyl ether, diethylene glycol ethyl ether, diethylene glycol methyl ether, N,v-dimethylformamide, dimethyl sulfoxide, 1,4-dioxane, dipropylene glycol, dipropylene glycol methyl ether, dipropylene glycol dibenzoate, diproxitol, alkylpyrrolidone, ethyl acetate, 2-ethylhexanol, ethylene carbonate, 1,1,1-trichloroethane, 2-heptanone, alpha-pinene, d-limonene, ethyl lactate, ethylene glycol, ethylene glycol butyl ether, ethylene glycol methyl ether, gamma-butyrolactone, glycerol, glycerol acetate, glycerol diacetate, glycerol triacetate, hexadecane, hexylene glycol, isoamyl acetate, isobornyl acetate, isooctane, isophorone, isopropylbenzene, isopropyl myristate, lactic acid, laurylamine, mesityl oxide, methoxy-propanol, methyl isoamyl ketone, methyl isobutyl ketone, methyl laurate, methyl octanoate, methyl oleate, methylene chloride, m-xylene, n-hexane, n-octylamine, octa-decanoic acid, octylamine acetate, oleic acid, oleylamine, o-xylene, phenol, polyethylene glycol (PEG400), propionic acid, propyl lactate, propylene carbonate, propylene glycol, propylene glycol methyl ether, p-xylene, toluene, triethyl phosphate, triethylene glycol, xylenesulfonic acid, paraffin, mineral oil, trichloroethylene, perchloroethylene, ethyl acetate, amyl acetate, butyl acetate, propylene glycol methyl ether, diethylene glycol methyl ether, methanol, ethanol, isopropanol, and alcohols of higher molecular weight, such as amyl alcohol, tetrahydrofurfuryl alcohol, hexanol, octanol, ethylene glycol, propylene glycol, glycerol, N-methyl-2-pyrrolidone and the like. Water is generally the carrier of choice for diluting the concentrates. Suitable solid carriers are, for example, talc, titanium dioxide, pyrophyllite clay, silica, attapulgite clay, kieselguhr, limestone, calcium carbonate, bentonite, calcium montmorillonite, cottonseed husks, wheat flour, soybean flour, pumice, wood flour, ground walnut shells, lignin and similar substances, as described, for example, in CFR 180.1001. (c) & (d).

A large number of surface-active substances can advantageously be used in both solid and liquid formulations, especially in those formulations which can be diluted with a carrier prior to use. Surface-active substances may be anionic, cationic, non-ionic or polymeric and they can be used as emulsifiers, wetting agents or suspending agents or for other purposes. Typical surface-active substances include, for example, salts of alkyl sulfates, such as diethanolammonium lauryl sulfate; salts of alkylarylsulfonates, such as calcium dodecylbenzenesulfonate; alkylphenol/alkylene oxide addition products, such as nonylphenol ethoxylate; alcohol/alkylene oxide addition products, such as tridecylalcohol ethoxylate; soaps, such as sodium stearate; salts of alkylnaphthalenesulfonates, such as sodium dibutylnaphthalenesulfonate; dialkyl esters of sulfosuccinate salts, such as sodium di(2-ethylhexyl)sulfosuccinate; sorbitol esters, such as sorbitol oleate; quaternary amines, such as lauryltrimethylammonium chloride, polyethylene glycol esters of fatty acids, such as polyethylene glycol stearate; block copolymers of ethylene oxide and propylene oxide; and salts of mono- and di-alkylphosphate esters; and also further substances described e.g. in “McCutcheon's Detergents and Emulsifiers Annual” MC Publishing Corp., Ridgewood New Jersey, 1981.

Further adjuvants that can usually be used in pesticidal formulations include crystallisation inhibitors, viscosity modifiers, suspending agents, dyes, anti-oxidants, foaming agents, light absorbers, mixing auxiliaries, antifoams, complexing agents, neutralising or pH-modifying substances and buffers, corrosion inhibitors, fragrances, wetting agents, take-up enhancers, micronutrients, plasticisers, glidants, lubricants, dispersants, thickeners, antifreezes, microbicides, and also liquid and solid fertilisers.

The compositions according to the invention can additionally include an additive comprising an oil of vegetable or animal origin, a mineral oil, alkyl esters of such oils or mixtures of such oils and oil derivatives. The amount of oil additive in the composition according to the invention is generally from 0.01 to 10%, based on the spray mixture. For example, the oil additive can be added to the spray tank in the desired concentration after the spray mixture has been prepared. Preferred oil additives comprise mineral oils or an oil of vegetable origin, for example rapeseed oil, olive oil or sunflower oil, emulsified vegetable oil, such as AMIGO® (Rhône-Poulenc Canada Inc.), alkyl esters of oils of vegetable origin, for example the methyl derivatives, or an oil of animal origin, such as fish oil or beef tallow. A preferred additive contains, for example, as active components essentially 80% by weight alkyl esters of fish oils and 15% by weight methylated rapeseed oil, and also 5% by weight of customary emulsifiers and pH modifiers. Especially preferred oil additives comprise alkyl esters of C₈-C₂₂ fatty acids, especially the methyl derivatives of C₁₂-C₁₈ fatty acids, for example the methyl esters of lauric acid, palmitic acid and oleic acid, being of importance. Those esters are known as methyl laurate (CAS-111-82-0), methyl palmitate (CAS-112-39-0) and methyl oleate (CAS-112-62-9). A preferred fatty acid methyl ester derivative is Emery® 2230 and 2231 (Cognis GmbH). Those and other oil derivatives are also known from the Compendium of Herbicide Adjuvants, 5th Edition, Southern Illinois University, 2000.

The application and action of the oil additives can be further improved by combination with surface-active substances, such as non-ionic, anionic or cationic surfactants. Examples of suitable anionic, non-ionic and cationic surfactants are listed on pages 7 and 8 of WO 97/34485. Preferred surface-active substances are anionic surfactants of the dodecylbenzylsulfonate type, especially the calcium salts thereof, and also non-ionic surfactants of the fatty alcohol ethoxylate type. Special preference is given to ethoxylated C₁₂-C₂₂ fatty alcohols having a degree of ethoxylation of from 5 to 40. Examples of commercially available surfactants are the Genapol types (Clariant AG). Also preferred are silicone surfactants, especially polyalkyl-oxide-modified heptamethyltriloxanes which are commercially available e.g. as Silwet L-77®, and also perfluorinated surfactants. The concentration of the surface-active substances in relation to the total additive is generally from 1 to 30% by weight. Examples of oil additives consisting of mixtures of oil or mineral oils or derivatives thereof with surfactants are Edenor ME SU®, Turbocharge® (Syngenta AG, CH) or ActipronC (BP Oil UK Limited, GB).

If desired, it is also possible for the mentioned surface-active substances to be used in the formulations on their own, that is to say without oil additives.

Furthermore, the addition of an organic solvent to the oil additive/surfactant mixture may contribute to an additional enhancement of action. Suitable solvents are, for example, Solvesso® (ESSO) or Aromatic Solvent® (Exxon Corporation). The concentration of such solvents can be from 10 to 80% by weight of the total weight. Oil additives that are present in admixture with solvents are described, for example, in US-A-4,834,908. A commercially available oil additive disclosed therein is known by the name MERGE® (BASF Corporation). A further oil additive that is preferred according to the invention is SCORE® (Syngenta Crop Protection Canada).

In addition to the oil additives listed above, for the purpose of enhancing the action of the compositions according to the invention it is also possible for formulations of alkylpyrrolidones (e.g. Agrimax®) to be added to the spray mixture. Formulations of synthetic lattices, e.g. polyacrylamide, polyvinyl compounds or poly-1-p-menthene (e.g. Bond®, Courier® or Emerald®) may also be used. It is also possible for solutions that contain propionic acid, for example Eurogkem Pen-e-trate®, to be added to the spray mixture as action-enhancing agent.

The herbicidal compositions generally comprise from 0.1 to 99% by weight; especially from 0.1 to 95% by weight, compounds of formula (I) and from 1 to 99.9% by weight of a formulation adjuvant which preferably includes from 0 to 25% by weight of a surface-active substance. Whereas commercial products will preferably be formulated as concentrates, the end user will normally employ dilute formulations.

The rates of application of compounds of formula (I) may vary within wide limits and depend on the nature of the soil, the method of application (pre- or post-emergence; seed dressing; application to the seed furrow; no tillage application etc.), the crop plant, the grass or weed to be controlled, the prevailing climatic conditions, and other factors governed by the method of application, the time of application and the target crop. The compounds of formula (I) according to the invention are generally applied at a rate of from 10 to 2000 g/ha, especially from 50 to 1000 g/ha.

Preferred formulations have especially the following compositions (%=percent by weight):

Emulsifiable Concentrates:

active ingredient: 1 to 95%, preferably 60 to 90% surface-active agent: 1 to 30%, preferably 5 to 20% liquid carrier: 1 to 80%, preferably 1 to 35%

Dusts:

active ingredient:  0.1 to 10%, preferably 0.1 to 5% solid carrier: 99.9 to 90%, preferably 99.9 to 99%

Suspension Concentrates:

active ingredient:  5 to 75%, preferably 10 to 50% water: 94 to 24%, preferably 88 to 30% surface-active agent:  1 to 40%, preferably 2 to 30%

Wettable Powders:

active ingredient: 0.5 to 90%, preferably 1 to 80% surface-active agent: 0.5 to 20%, preferably 1 to 15% solid carrier: 5 to 95%, preferably 15 to 90%

Granules:

active ingredient:  0.1 to 30%, preferably 0.1 to 15% solid carrier: 99.5 to 70%, preferably 97 to 85%

The following Examples further illustrate, but do not limit, the invention.

Formulation Examples for Herbicides of Formula (I) (%=% by Weight)

F1. Emulsifiable concentrates a) b) c) d) active ingredient 5% 10%  25% 50% calcium dodecylbenzenesulfonate 6% 8%  6% 8% castor oil polyglycol ether 4% —  4% 4% (36 mol of ethylene oxide) octylphenol polyglycol ether — 4% — 2% (7-8 mol of ethylene oxide) NMP — — 10% 20% arom. hydrocarbon mixture 85%  78%  55% 16% C₉-C₁₂ Emulsions of any desired concentration can be obtained from such concentrates by dilution with water.

F2. Solutions a) b) c) d) active ingredient  5% 10% 50% 90% 1-methoxy-3-(3-methoxy- — 20% 20% — propoxy)-propane polyethylene glycol MW 400 20% 10% — — NMP — — 30% 10% arom. hydrocarbon mixture 75% 60% — — C₉-C₁₂ The solutions are suitable for use in the form of microdrops.

F3. Wettable powders a) b) c) d) active ingredient 5% 25%  50%  80%  sodium lignosulfonate 4% — 3% — sodium lauryl sulfate 2% 3% — 4% sodium diisobutylnaphthalene- — 6% 5% 6% sulfonate octylphenol polyglycol ether — 1% 2% — (7-8 mol of ethylene oxide) highly dispersed silicic acid 1% 3% 5% 10%  kaolin 88%  62%  35%  — The active ingredient is mixed thoroughly with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording wettable powders which can be diluted with water to give suspensions of any desired concentration.

F4. Coated granules a) b) c) active ingredient 0.1% 5% 15% highly dispersed silicic acid 0.9% 2% 2% inorganic carrier 99.0% 93% 83% (diameter 0.1-1 mm) e.g. CaCO₃ or SiO₂ The active ingredient is dissolved in methylene chloride and applied to the carrier by spraying, and the solvent is then evaporated off in vacuo.

F5. Coated granules a) b) c) active ingredient 0.1% 5% 15% polyethylene glycol MW 200 1.0% 2% 3% highly dispersed silicic acid 0.9% 1% 2% inorganic carrier 98.0% 92% 80% (diameter 0.1-1 mm) e.g. CaCO₃ or SiO₂ The finely ground active ingredient is uniformly applied, in a mixer, to the carrier moistened with polyethylene glycol. Non-dusty coated granules are obtained in this manner.

F6. Extruder granules a) b) c) d) active ingredient 0.1% 3% 5% 15% sodium lignosulfonate 1.5% 2% 3% 4% carboxymethylcellulose 1.4% 2% 2% 2% kaolin 97.0% 93% 90% 79% The active ingredient is mixed and ground with the adjuvants, and the mixture is moistened with water. The mixture is extruded and then dried in a stream of air.

F7. Dusts a) b) c) active ingredient 0.1% 1% 5% talcum 39.9% 49% 35% kaolin 60.0% 50% 60% Ready-to-use dusts are obtained by mixing the active ingredient with the carriers and grinding the mixture in a suitable mill.

F8. Suspension concentrates a) b) c) d) active ingredient 3% 10%  25%  50%  ethylene glycol 5% 5% 5% 5% nonylphenol polyglycol ether — 1% 2% — (15 mol of ethylene oxide) sodium lignosulfonate 3% 3% 4% 5% carboxymethylcellulose 1% 1% 1% 1% 37% aqueous formaldehyde 0.2%   0.2%   0.2%   0.2%   solution silicone oil emulsion 0.8%   0.8%   0.8%   0.8%   water 87%  79%  62%  38%  The finely ground active ingredient is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired concentration can be obtained by dilution with water.

The invention also relates to a method of inhibiting plant growth which comprises applying to the plants or to the locus thereof a herbicidally effective amount of a compound of formula (I).

The invention also relates to a method of selectively controlling grasses and weeds in crops of useful plants which comprises applying to the useful plants or locus thereof or to the area of cultivation a herbicidally effective amount of a compound of formula (I).

Crops of useful plants in which the composition according to the invention can be used include perennial crops, such as citrus fruit, grapevines, nuts, oil palms, olives, pome fruit, stone fruit and rubber, and annual arable crops, such as cereals, for example barley and wheat, cotton, oilseed rape, maize, rice, soy beans, sugar beet, sugar cane, sunflowers, ornamentals and vegetables, especially cereals and maize.

The grasses and weeds to be controlled may be both monocotyledonous species, for example Agrostis, Alopecurus, Avena, Bromus, Cyperus, Digitaria, Echinochloa, Lolium, Monochoria, Rottboellia, Sagittaria, Scirpus, Setaria, Sida and Sorghum, and dicotyledonous species, for example Abutilon, Amaranthus, Chenopodium, Chrysanthemum, Galium, Ipomoea, Nasturtium, Sinapis, Solanum, Stellaria, Veronica, Viola and Xanthium.

Crops are to be understood as also including those crops which have been rendered tolerant to herbicides or classes of herbicides (e.g. ALS-, GS-, EPSPS-, PPO- and HPPD-inhibitors) by conventional methods of breeding or by genetic engineering. An example of a crop that has been rendered tolerant to imidazolinones, e.g. imazamox, by conventional methods of breeding is Clearfield® summer rape (canola). Examples of crops that have been rendered tolerant to herbicides by genetic engineering methods include e.g. glyphosate- and glufosinate-resistant maize varieties commercially available under the trade names RoundupReady® and LibertyLink®.

Crops are also to be understood as being those which have been rendered resistant to harmful insects by genetic engineering methods, for example Bt maize (resistant to European corn borer), Bt cotton (resistant to cotton boll weevil) and also Bt potatoes (resistant to Colorado beetle). Examples of Bt maize are the Bt 176 maize hybrids of NK® (Syngenta Seeds). The Bt toxin is a protein that is formed naturally by Bacillus thuringiensis soil bacteria. Examples of toxins, or transgenic plants able to synthesise such toxins, are described in EP-A-451 878, EP-A-374 753, WO 93/07278, WO 95/34656, WO 03/052073 and EP-A-427 529. Examples of transgenic plants comprising one or more genes that code for an insecticidal resistance and express one or more toxins are KnockOut® (maize), Yield Gard® (maize), NuCOTIN33B® (cotton), Bollgard® (cotton), NewLeaf® (potatoes), NatureGard® and Protexcta®. Plant crops or seed material thereof can be both resistant to herbicides and, at the same time, resistant to insect feeding (“stacked” transgenic events). For example, seed can have the ability to express an insecticidal Cry3 protein while at the same time being tolerant to glyphosate.

Crops are also to be understood as being those which are obtained by conventional methods of breeding or genetic engineering and contain so-called output traits (e.g. improved storage stability, higher nutritional value and improved flavour).

Areas under cultivation include land on which the crop plants are already growing and land intended for cultivation with those crop plants.

The compounds of formula I according to the invention can also be used in combination with one or more further herbicides. In particular, the following mixtures of the compound of formula I are important:

Mixtures of a compound of formula I with a synthetic auxin (e.g. compound of formula I+clopyralid (162), compound of formula I+2,4-D (211), compound of formula I+dicamba (228), compound of formula I+MCPA (499), compound of formula I+quinclorac (712), or compound of formula I+aminopyralid (CAS RN 150114-71-9)).

Mixtures of a compound of formula I with diflufenzopyr (252).

Mixtures of a compound of formula I with an acetanilide (e.g. compound of formula I+acetochlor (5), compound of formula I+dimethenamid (260), compound of formula I+metolachlor (548), compound of formula I+S-metolachlor (549), or compound of formula I+pretilachlor (656)).

Mixtures of a compound of formula I with flamprop-M (355).

Mixtures of a compound of formula I with flufenacet (BAY FOE 5043) (369).

Mixtures of a compound of formula I with pyroxasulfone (CAS RN 447399-55-5).

Mixtures of a compound of formula I with a triazine (e.g. compound of formula I+atrazine (37), or compound of formula I+terbuthylazine (775)).

Mixtures of a compound of formula I with an HPPD inhibitor (e.g. compound of formula I+isoxaflutole (479), compound of formula I+mesotrione (515), compound of formula I+pyrasulfotole (CAS RN 365400-11-9), compound of formula I+sulcotrione (747), compound of formula I+tembotrione (CAS RN 335104-84-2), compound of formula I+topramezone (CAS RN 210631-68-8), compound of formula I+4-hydroxy-3-[[2-[(2-methoxyethoxy)methyl]-6-(trifluoromethyl)-3-pyridinyl]carbonyl]-bicyclo[3.2.1]oct-3-en-2-one (CAS RN 352010-68-5), or compound of formula I+4-hydroxy-3-[[2-(3-methoxypropyl)-6-(difluoromethyl)-3-pyridinyl]carbonyl]-bicyclo[3.2.1]oct-3-en-2-one).

Mixtures of a compound of formula I with an HPPD inhibitor and a triazine.

Mixtures of a compound of formula I with glyphosate (419).

Mixtures of a compound of formula I with glyphosate and an HPPD inhibitor (e.g. compound of formula I+glyphosate+isoxaflutole, compound of formula I+glyphosate+mesotrione, compound of formula I+glyphosate+pyrasulfotole (CAS RN 365400-11-9), compound of formula I+glyphosate+sulcotrione, compound of formula I+glyphosate+tembotrione, compound of formula I+glyphosate+topramezone, compound of formula I+glyphosate+4-hydroxy-3-[[2-[(2-methoxyethoxy)methyl]-6-(trifluoromethyl)-3-pyridinyl]carbonyl]-bicyclo[3.2.1]oct-3-en-2-one, or compound of formula I+glyphosate+4-hydroxy-3-[[2-(3-methoxypropyl)-6-(difluoromethyl)-3-pyridinyl]carbonyl]-bicyclo[3.2.1]oct-3-en-2-one).

Mixtures of a compound of formula I with glufosinate-ammonium (418).

Mixtures of a compound of formula I with glufosinate-ammonium and an HPPD inhibitor (e.g. compound of formula I+glufosinate-ammonium+isoxaflutole, compound of formula I+glufosinate-ammonium+mesotrione, compound of formula I+glufosinate-ammonium+pyrasulfotole (CAS RN 365400-11-9), compound of formula I+glufosinate-ammonium+sulcotrione, compound of formula I+glufosinate-ammonium+tembotrione, compound of formula I+glufosinate-ammonium+topramezone, compound of formula I+glufosinate-ammonium+4-hydroxy-3-[[2-[(2-methoxyethoxy)methyl]-6-(trifluoromethyl)-3-pyridinyl]carbonyl]-bicyclo[3.2.1]oct-3-en-2-one, or compound of formula I+glufosinate-ammonium+4-hydroxy-3-[[2-(3-methoxypropyl)-6-(difluoromethyl)-3-pyridinyl]carbonyl]-bicyclo[3.2.1]oct-3-en-2-one).

Mixtures of a compound of formula I with an ALS or an AHAS inhibitor (e.g. compound of formula I+bensulfuron-methyl (64), compound of formula I+chlorimuron-ethyl (135), compound of formula I+cloransulam-methyl (164), compound of formula I+florasulam (359), compound of formula I+flucarbazone-sodium (364), compound of formula I+imazamox (451), compound of formula I+imazapyr (453), compound of formula I+imazethapyr (455), compound of formula I+iodosulfuron-methyl-sodium (466), compound of formula I+mesosulfuron-methyl (514), compound of formula I+nicosulfuron (577), compound of formula I+penoxsulam (622), compound of formula I+pyroxsulam (triflosulam) (CAS RN 422556-08-9), compound of formula I+thifensulfuron-methyl (thiameturon-methyl) (795), compound of formula I+triasulfuron (817), compound of formula I+tribenuron-methyl (822), compound of formula I+trifloxysulfuron-sodium (833), compound of formula I+thiencarbazone (4-[(4,5-dihydro-3-methoxy-4-methyl-5-oxo-1H-1,2,4-triazol-1-yl)carbonylsulfamoyl]-5-methylthiophene-3-carboxylic acid, BAY636)), or compound of formula I+thiencarbazone-methyl (methyl 4-[(4,5-dihydro-3-methoxy-4-methyl-5-oxo-1H-1,2,4-triazol-1-yl)carbonylsulfamoyl]-5-methylthiophene-3-carboxylate, CAS RN 317815-83-1, BAY636-methyl)).

Mixtures of a compound of formula I with a PPO inhibitor (e.g. compound of formula I+butafenacil (101), compound of formula I+carfentrazone-ethyl (121), compound of formula I+cinidon-ethyl (152), compound of formula I+flumioxazin (376), compound of formula I+fomesafen (401), or compound of formula I+[3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridyloxy]acetic acid ethyl ester) (CAS RN 353292-31-6).

Mixtures of a compound of formula I with an ACCase inhibitor (e.g. compound of formula I+butroxydim (106), compound of formula I+clethodim (155), compound of formula I+clodinafop-propargyl (156), compound of formula I+cycloxydim (190), compound of formula I+cyhalofop-butyl (195), compound of formula I+diclofop-methyl (238), compound of formula I+fenoxaprop-P-ethyl (339), compound of formula I+fluazifop-butyl (361), compound of formula I+fluazifop-P-butyl (362), compound of formula I+haloxyfop (427), compound of formula I+haloxyfop-P (428), compound of formula I+propaquizafop (670), compound of formula I+quizalofop (717), compound of formula I+quizalofop-P (718), compound of formula I+sethoxydim (726), compound of formula I+tepraloxydim (771), compound of formula I+tralkoxydim (811)), or compound of formula I+pinoxaden (CAS RN 243973-20-8).

Mixtures of a compound of formula I with prosulfocarb (683), or a compound of formula I with tri-allate (816).

Mixtures of a compound of formula I with bromoxynil (95), a compound of formula I with chloridazon (134), a compound of formula I with chlorotoluron (143), a compound of formula I with diuron (281), or a compound of formula I with metribuzin (554).

Mixtures of a compound of formula I with clomazone (159), a compound of formula I with diflufenican (251), a compound of formula I with fluorochloridone (389), or a compound of formula I with flurtamone (392).

Mixtures of a compound of formula I with pendimethalin (621) or a compound of formula I with trifluralin (836).

Mixtures of a compound of formula I with difenzoquat metilsulfate (248).

Mixtures of a compound of formula I with diquat dibromide (276).

Mixtures of a compound of formula I with paraquat dichloride (614).

The mixing partners of the compound of formula I may also be in the form of esters or salts, as mentioned e.g. in The Pesticide Manual, 13^(th) Edition (BCPC), 2003. The reference to glufosinate-ammonium also applies to glufosinate, the reference to cloransulam-methyl also applies to cloransulam, the reference to dimethenamid also applies to dimethenamid-P, the reference to flamprop-M also applies to flamprop, and the reference to pyrithiobac-sodium also applies to pyrithiobac, etc.

The mixing ratio of the compound of formula I to the mixing partner is preferably from 1:100 to 1000:1.

The mixtures can advantageously be used in the above-mentioned formulations (in which case “active ingredient” relates to the respective mixture of compound of formula I with the mixing partner).

Additionally, one or more of the following herbicides can be used in combination with a compound of formula I according to the invention or in combination with a mixture as described above: acifluorfen-sodium (7), aclonifen (8), acrolein (10), alachlor (14), alloxydim (18), ametryn (20), amicarbazone (21), amidosulfuron (22), amitrole (aminotriazole) (25), ammonium sulfamate (26), anilofos (31), asulam (36), aviglycine (39), azafenidin (CAS RN 68049-83-2), azimsulfuron (43), BAS 800H(CAS RN 372137-35-4), beflubutamid (55), benazolin (57), bencarbazone (CAS RN 173980-17-1), benfluralin (59), benfuresate (61), bensulide (65), bentazone (67), benzfendizone (CAS RN 158755-95-4), benzobicyclon (69), benzofenap (70), bilanafos (bialaphos) (77), bispyribac-sodium (82), borax (86), bromacil (90), bromobutide (93), bromofenoxim (CAS RN 13181-17-4), butachlor (100), butamifos (102), butralin (105), butylate (108), cafenstrole (110), carbetamide (117), chlorbromuron (CAS RN 13360-45-7), chloroflurenol-methyl (133), chloroacetic acid (138), chlorpropham (144), chlorsulfuron (147), chlorthal-dimethyl (148), cinmethylin (153), cinosulfuron (154), clomeprop (160), cumyluron (180), cyanamide (182), cyanazine (183), cyclanilide (186), cycloate (187), cyclosulfamuron (189), daimuron (213), dalapon (214), dazomet (216), desmedipham (225), desmetryn (CAS RN 1014-69-3), dichlobenil (229), dichlorprop (234), dichlorprop-P (235), diclosulam (241), dimefuron (256), dimepiperate (257), dimethachlor (258), dimethametryn (259), dimethipin (261), dimethylarsinic acid (264), dinitramine (268), dinoterb (272), diphenamid (274), dipropetryn (CAS RN 4147-51-7), dithiopyr (280), DNOC (282), DSMA (CAS RN 144-21-8), endothal (295), EPTC (299), esprocarb (303), ethalfluralin (305), ethametsulfuron-methyl (306), ethephon (307), ethofumesate (311), ethoxyfen (CAS RN 188634-90-4), ethoxyfen-ethyl (CAS RN 131086-42-5), ethoxysulfuron (314), etobenzanid (318), fentrazamide (348), ferrous sulfate (353), flazasulfuron (356), fluazolate (isopropazol) (CAS RN 174514-07-9), flucetosulfuron (CAS RN 412928-75-7), fluchloralin (365), flufenpyr-ethyl (371), flumetralin (373), flumetsulam (374), flumiclorac-pentyl (375), flumipropyn (flumipropin) (CAS RN 84478-52-4), fluometuron (378), fluoroglycofen-ethyl (380), flupoxam (CAS RN 119126-15-7), flupropacil (CAS RN 120890-70-2), flupropanate (383), flupyrsulfuron-methyl-sodium (384), flurenol (387), fluridone (388), fluoroxypyr (390), fluthiacet-methyl (395), foramsulfuron (402), fosamine (406), halosulfuron-methyl (426), HC-252 (429), hexazinone (440), imazamethabenz-methyl (450), imazapic (452), imazaquin (454), imazosulfuron (456), indanofan (462), ioxynil (467), isoproturon (475), isouron (476), isoxaben (477), isoxachlortole (CAS RN 141112-06-3), isoxapyrifop (CAS RN 87757-18-4), karbutilate (482), lactofen (486), lenacil (487), linuron (489), MCPA-thioethyl (500), MCPB (501), mecoprop (503), mecoprop-P (504), mefenacet (505), mefluidide (507), metam (519), metamifop (mefluoxafop) (520), metamitron (521), metazachlor (524), methabenzthiazuron (526), methazole (CAS RN 20354-26-1), methylarsonic acid (536), methyldymron (539), methyl isothiocyanate (543), metobenzuron (547), metobromuron (CAS RN 3060-89-7), metosulam (552), metoxuron (553), metsulfuron-methyl (555), MK-616 (559), molinate (560), monolinuron (562), MSMA (CAS RN 2163-80-6), naproanilide (571), napropamide (572), naptalam (573), neburon (574), nipyraclofen (CAS RN 99662-11-0), n-methyl-glyphosate, nonanoic acid (583), norflurazon (584), oleic acid (fatty acids) (593), orbencarb (595), orthosulfamuron (CAS RN 213464-77-8), oryzalin (597), oxadiargyl (599), oxadiazon (600), oxasulfuron (603), oxaziclomefone (604), oxyfluorfen (610), pebulate (617), pentachlorophenol (623), pentanochlor (624), pentoxazone (625), pethoxamid (627), petrolium oils (628), phenmedipham (629), picloram (645), picolinafen (646), piperophos (650), primisulfuron-methyl (657), prodiamine (661), profluazol (CAS RN 190314-43-3), profoxydim (663), prohexadione calcium (664), prometon (665), prometryn (666), propachlor (667), propanil (669), propazine (672), propham (674), propisochlor (667), propoxycarbazone-sodium (procarbazone-sodium) (679), propyzamide (681), prosulfuron (684), pyraclonil (pyrazogyl) (CAS RN 158353-15-2), pyraflufen-ethyl (691), pyrazolynate (692), pyrazosulfuron-ethyl (694), pyrazoxyfen (695), pyribenzoxim (697), pyributicarb (698), pyridafol (CAS RN 40020-01-7), pyridate (702), pyriftalid (704), pyriminobac-methyl (707), pyrimisulfan (CAS RN 221205-90-9), pyrithiobac-sodium (709), quinmerac (713), quinoclamine (714), rimsulfuron (721), sequestrene, siduron (727), simazine (730), simetryn (732), sodium chlorate (734), sulfentrazone (749), sulfometuron-methyl (751), sulfosate (CAS RN 81591-81-3), sulfosulfuron (752), sulfuric acid (755), tar oils (758), TCA-sodium (760), tebutam (CAS RN 35256-85-0), tebuthiuron (765), tefuryltrione (CAS RN 473278-76-1), terbacil (772), terbumeton (774), terbutryn (776), thenylchlor (789), thidiazimin (CAS RN 123249-43-4), thiazafluoron (CAS RN 25366-23-8), thiazopyr (793), thiobencarb (797), tiocarbazil (807), triaziflam (819), triclopyr (827), trietazine (831), triflusulfuron-methyl (837), trihydroxytriazine (CAS RN 108-80-5), trinexapac-ethyl (CAS RN 95266-40-3) and tritosulfuron (843).

The mixing partners of the compound of formula I may also be in the form of esters or salts, as mentioned e.g. in The Pesticide Manual, 13 h Edition (BCPC), 2003. The reference to acifluorfen-sodium also applies to acifluorfen, and the reference to bensulfuron-methyl also applies to bensulfuron, etc.

The mixing ratio of the compound of formula I to the mixing partner is preferably from 1:100 to 1000:1.

The mixtures can advantageously be used in the above-mentioned formulations (in which case “active ingredient” relates to the respective mixture of compound of formula I with the mixing partner).

The compounds of formula I according to the invention can also be used in combination with one or more safeners. Likewise, mixtures of a compound of formula I according to the invention with one or more further herbicides can also be used in combination with one or more safeners. The safeners can be benoxacor (63), cloquintocet-mexyl (163), cyometrinil (CAS RN 78370-21-5), cyprosulfamide (CAS RN 221667-31-8), dichlormid (231), dicyclonon (CAS RN 79260-71-2), fenchlorazole-ethyl (331), fenclorim (332), flurazole (386), fluxofenim (399), furilazole (413) and the corresponding R isomer, isoxadifen-ethyl (478), mefenpyr-diethyl (506), naphthalic anhydride (CAS RN 81-84-5), and oxabetrinil (598). Particularly preferred are mixtures of a compound of formula I with benoxacor and a compound of formula I with cloquintocet-mexyl.

The safeners of the compound of formula I may also be in the form of esters or salts, as mentioned e.g. in The Pesticide Manual, 13^(th) Edition (BCPC), 2003. The reference to cloquintocet-mexyl also applies to cloquintocet, and the reference to fenchlorazole-ethyl also applies to fenchlorazole, etc.

Preferably the mixing ratio of compound of formula I to safener is from 100:1 to 1:10, especially from 20:1 to 1:1.

The mixtures can advantageously be used in the above-mentioned formulations (in which case “active ingredient” relates to the respective mixture of compound of formula I with the safener). It is possible that the safener and a compound of formula I and one or more additional herbicide(s), if any, are applied simultaneously. For example, the safener, a compound of formula I and one or more additional herbicide(s), if any, might be applied to the locus pre-emergence or might be applied to the crop post-emergence. It is also possible that the safener and a compound of formula I and one or more additional herbicide(s), if any, are applied sequentially. For example, the safener might be applied before sowing the seeds as a seed treatment and a compound of formula I and one or more additional herbicides, if any, might be applied to the locus pre-emergence or might be applied to the crop post-emergence.

Preferred mixtures of a compound of formula I with further herbicides and safeners include:

Mixtures of a compound of formula I with a triazine and a safener.

Mixtures of a compound of formula I with glyphosate and a safener.

Mixtures of a compound of formula I with glufosinate and a safener.

Mixtures of a compound of formula I with isoxaflutole and a safener.

Mixtures of a compound of formula I with isoxaflutole and a triazine and a safener.

Mixtures of a compound of formula I with isoxaflutole and glyphosate and a safener.

Mixtures of a compound of formula I with isoxaflutole and glufosinate and a safener.

Mixtures of a compound of formula I with mesotrione and a safener.

Mixtures of a compound of formula I with mesotrione and a triazine and a safener.

Mixtures of a compound of formula I with mesotrione and glyphosate and a safener.

Mixtures of a compound of formula I with mesotrione and glufosinate and a safener.

Mixtures of a compound of formula I with sulcotrione and a safener.

Mixtures of a compound of formula I with sulcotrione and a triazine and a safener.

Mixtures of a compound of formula I with sulcotrione and glyphosate and a safener.

Mixtures of a compound of formula I with sulcotrione and glufosinate and a safener.

The following Examples further illustrate, but do not limit, the invention.

PREPARATION EXAMPLES 1. Reactions which are covered by Scheme I Example 1.1 Preparation of 7-(2-chloro-3 6-difluorophenyl)-8-hydroxy-5H-pyrido[2,3-b]pyrazin-6-one (Compound A11 of Table A) Step 1

Oxalyl chloride (1.30 mL) was added dropwise to a solution of (2-chloro-3,6-difluoro-phenyl)-acetic acid (3.151 g) in dichloromethane (20 mL) at ambient temperature. A drop of dimethylformamide was added to initiate the reaction. The reaction mixture was stirred at ambient temperature for 1 hour. The reaction mixture was concentrated to give a colourless oil which was dissolved in acetonitrile (30 mL). The mixture was divided into three portions and each portion was added to a slurry of 3-amino-pyrazine-2-carboxylic acid methyl ester (0.76 g) in acetonitrile (15 mL). The reaction mixture was heated in the microwave to 130° C. for 40 minutes. The reaction mixture was allowed to cool to ambient temperature and stored at ambient temperature for 16 hours. The samples were combined and concentrated to produce 3-[2-(2-chloro-3,6-difluorophenyl)methylcarbonylamino]-pyrazine-2-carboxylic acid methyl ester as a dark orange solid (4.15 g).

¹H NMR (CDCl₃): 4.02 (s, 3H), 4.22 (s, 2H), 7.02-7.10 (m, 1H), 7.11-7.17 (m, 1H), 8.41 (d, 1H), 8.61 (d, 1H), 10.8 (s, 1H) ppm.

Step 2

A mixture of the product of Step 1 (4.15 g) and potassium carbonate (1.67 g) in dimethylformamide (50 mL) was heated to 110° C. for 2 hours. The reaction mixture was allowed to cool to ambient temperature and then stored at ambient temperature for 16 hours. Water was added to the reaction mixture and the mixture acidified with concentrated hydrochloric acid (36% by weight in water). The precipitate was isolated and washed successively with water and hexane to give Compound A11 of Table A as a brown solid (2.88 g).

Compounds A1-A10, A12-A43, A45-A49 of Table A were made using analogous procedures.

Example 1.2 Preparation of acetic acid 7-(2-chloro-3,6-difluorophenyl)-6-oxo-5,6-dihydro-pyrido[2,3-b]pyrazin-8-yl ester (Compound B5 of Table B)

Compound A11 of Table A (0.62 g) in acetic anhydride (10 mL) was heated to 140° C. for 3 hours. The reaction mixture was allowed to cool to ambient temperature and then stored at ambient temperature for 16 hours. The reaction mixture was poured onto water at 0° C. and extracted with ethyl acetate. The organic extract was concentrated to produce a brown solid which was triturated with hexane to give Compound B5 of Table B as a brown solid (0.56 g).

Compounds B1, B8-B10, B15, B25-B27, B29 and B33 of Table B were made using analogous procedures.

Example 1.3 Preparation of isobutyric acid 7-(2-chloro-3,6-difluorophenyl)-6-oxo-5,6-dihydro-pyrido[2,3-b]pyrazin-8-yl ester (Compound B4 of Table B)

Compound A11 of Table A (1.0 g), isobutyryl chloride (0.4 mL) and pyridine (0.31 mL) were stirred in dichloromethane (30 mL) at ambient temperature for 2 hours and stored at ambient temperature for 16 hours. The reaction mixture was filtered. The filtrate was diluted with dichloromethane and washed with water and aqueous sodium hydrogencarbonate (1M), dried over magnesium sulfate and concentrated to give Compound B4 of Table B as a yellow solid (0.65 g). Compounds B2-B3 and B6-B7, B11-B14, B16-B17, B19-B24, B28, B30-B32 and B35-B62 of Table B were made using analogous procedures.

2. Reactions which are Covered by Scheme 2 Example 2.1 Preparation of acetic acid 7-(2-chloro-3,6-difluorophenyl)-5-methyl-6-oxo-5,6-dihydro-pyrido[2,3-b]pyrazin-8-yl ester (Compound C16 of Table C)

A mixture of Compound B5 of Table B (0.146 g), potassium carbonate (0.060 g) and methyl iodide (0.03 mL) in acetonitrile (5 mL) were heated to 100° C. in the microwave for 10 minutes. The reaction mixture was allowed to cool to ambient temperature and stored at ambient temperature for 16 hours. The solution was decanted from the insoluble material, absorbed onto silica gel and purified by column chromatography on silica gel (eluent: ethyl acetate/hexane 1:1) to produce Compound C16 of Table C as a yellow solid (0.122 g).

Compounds C₁-C₁₅, C17, C19-C41, C43-C70, C72-C110, C112-C172, C173-C177, C179-C181, C183, C185 of Table C were made using analogous procedures.

Example 2.2 Preparation of 7-(2-chloro-3,6-difluorophenyl)-8-hydroxy-5-methyl-5H-pyrido[2,3-b]pyrazin-6-one (Compound D1 of Table D)

A mixture of Compound C16 of Table C (0.10 g) and potassium carbonate (0.037 g) in methanol (3 mL) and water (1 mL) was heated to reflux for 1 hour. The reaction mixture was allowed to cool to ambient temperature and stored at ambient temperature for 16 hours. The solvent was concentrated to give a yellow solid which was suspended in diethyl ether and aqueous hydrochloric acid (2M). The phases were separated and the organic phase was concentrated to produce Compound D1 of Table D as a pale yellow solid (0.086 g).

Compounds D2-D5 and D7-D15 of Table D were made using analogous procedures.

3. Reactions which are Covered by Scheme 3 Example 3.1 Preparation of 7-(2-chloro-3,6-difluoro-phenyl)-8-methoxy-5-methyl-5H-pyrido[2,3-b]pyrazin-6-one (Compound C18 of Table C)

A mixture of Compound A11 of Table A (0.098 g), potassium carbonate (0.074 g) and methyl iodide (0.04 mL) in dimethylformamide (5 mL) were heated at 100° C. in a microwave for 10 minutes. The reaction mixture was allowed to cool to ambient temperature and stored at ambient temperature for 16 hours. Water was added to the reaction mixture and the mixture extracted with ethyl acetate. The organic extract was washed with water and concentrated. The residue was purified by column chromatography on silica gel (eluent: ethyl acetate/hexane 1:1) to give Compound C18 of Table C (0.032 g).

Compound C42 of Table C was made using an analogous procedure.

4. Reactions which are Covered by Scheme 4 Example 4.1 Alternative preparation of 7-(2-chloro-3,6-difluorophenyl)-8-hydroxy-5-methyl-5H-pyrido[2,3-b]pyrazin-6-one (Compound D1 of Table D) by Method 1

Sodium hexamethyldisilazide (1.0 mL) (1M in THF) was added dropwise to a solution of 3-[2-(2-chloro-3,6-difluorophenyl)methylcarbonylamino]-pyrazine-2-carboxylic acid methyl ester (0.33 g) in tetrahydrofuran (12 mL) under a nitrogen atmosphere at 0° C. Methyl iodide (0.60 mL) was added at 0° C. and the reaction mixture then heated to reflux for 45 minutes. The reaction mixture was allowed to cool to ambient temperature and further sodium hexamethyldisilazide (1.5 mL) (1M in THF) was added. The reaction mixture was then heated to reflux for a further 3 hours. The reaction mixture was allowed to cool and treated with concentrated hydrochloric acid (36% by weight in water). The suspension was filtered and the filtrate evaporated. The residue was dissolved in ethyl acetate, washed with water and aqueous hydrochloric acid (2M), dried over magnesium sulfate and concentrated. The residue was triturated with diethyl ether to give Compound D1 of Table D as a red solid (0.189 g).

Example 4.2 Alternative preparation of 7-(2-chloro-3,6-difluorophenyl)-8-hydroxy-5-methyl-5H-pyrido[2,3-b]pyrazin-6-one (Compound D1 of Table D) by Method 2

Compound A11 of Table A (0.155 g) and methyl iodide (0.60 mL) were stirred in tetrahydrofuran (10 mL) under a nitrogen atmosphere at ambient temperature, and sodium hexamethyldisilazide (0.5 mL) (1M in THF) was added dropwise. The reaction mixture was heated to reflux for 1 hour and then allowed to cool to ambient temperature. More sodium hexamethyldisilazide (0.5 mL) (1M in THF) and methyl iodide (0.60 mL) were added and the reaction mixture heated to reflux for 2 hours. The reaction mixture was allowed to cool and diluted with water. Aqueous hydrochloric acid (2M) was added and the mixture extracted with ethyl acetate. The organic extract was washed with water, dried over magnesium sulfate and concentrated to give Compound D1 of Table D as a red crystalline solid (0.115 g).

Example 4.3 Alternative preparation of 2,2-dimethyl-propionic acid 7-(2-chloro-3,6-difluoro-phenyl)-5-methyl-6-oxo-5,6-dihydropyrido[2,3-b]pyrazin-8-yl ester (Compound C20 of Table C)

Compound D1 of Table D (0.050 g) was stirred in dichloromethane (5 mL) with pyridine (0.5 mL) at ambient temperature for 20 minutes. A solution of 2,2-dimethylpropionic acid chloride (0.039 g) in dichloromethane (1 mL) was added, and the reaction was stirred at ambient temperature for 24 hours. More dichloromethane (5 mL) was added and the mixture was washed successively with hydrochloric acid (2M), aqueous sodium hydrogencarbonate (1M) and water. The organic layer was concentrated to give Compound C20 of Table C as a solid (0.039 g).

Example 4.4 Alternative preparation of cyclopropane carboxylic acid 7-(2-chloro-3,6-difluoro-phenyl)-5-methyl-6-oxo-5,6-dihydropyrido[2,3-b]pyrazin-8-yl ester (Compound C54 of Table C)

Sodium hexamethyldisilazide (3.0 mL) (1M in THF) was added dropwise to a solution of 3-[2-(2-chloro-3,6-difluorophenyl)methylcarbonylamino]-pyrazine-2-carboxylic acid methyl ester (0.33 g) in tetrahydrofuran (10 mL) under a nitrogen atmosphere at ambient temperature. Methyl iodide (0.60 mL) was added at ambient temperature and the reaction mixture heated to reflux for 3 hours. The reaction mixture was allowed to cool to ambient temperature and a solution of cyclopropyl carbonyl chloride (0.201 g) in tetrahydrofuran (4 mL) was added. The reaction mixture was heated to reflux for a further 15 minutes and then allowed to cool. The reaction mixture was diluted with ethyl acetate and washed successively with aqueous hydrochloric acid (2M), aqueous sodium hydrogencarbonate (1M) and water. The organic layer was concentrated and the residue was purified by column chromatography on silica gel (eluent: diethyl ether/hexane 1:1) to give Compound C54 of Table C as a solid (0.127 g).

5. Reactions which are Covered by Scheme 5 Example 5.1 Preparation of 8-(tert-butyl-dimethylsilanyloxy)-7-(2-chloro-3,6-difluorophenyl)-5-methyl-5H-pyrido[2,3-b]pyrazin-6-one (Compound C 184 of Table C)

A mixture of t-butyldimethylsilyl chloride (0.094 g), Compound D1 of Table D (0.10 g) and triethylamine (0.5 mL) in dichloromethane (8 mL) was stirred at ambient temperature for 16 hours. The reaction was diluted with more dichloromethane and washed with water. The organic layer was dried over magnesium sulfate and concentrated to give an oil which was purified by column chromatography on silica gel (eluent:diethyl ether/hexane 1:1) to give Compound C184 of Table C as a colourless solid.

6. Reactions which are Covered by Scheme 6 Example 6.1 Preparation of propane-2-sulfonic acid 7-(2-chloro-3,6-difluorophenyl)-5-methyl-6-oxo-5,6-dihydropyrido[2,3-b]pyrazin-8-yl ester (Compound B34 of Table B)

A mixture of isopropyl sulfonyl chloride (0.218 mL), Compound A 11 of Table A (0.50 g) and pyridine (2 mL) in dichloromethane (10 mL) was heated to reflux for 7 hours. The reaction mixture was allowed to cool to ambient temperature and diluted with water. The phases were separated. The organic layer was washed with aqueous sodium hydrogencarbonate (1M), dried over magnesium sulfate and concentrated to give an oil which was purified by column chromatography on silica gel (eluent: diethyl ether /hexane 1:1) to give Compound B34 of Table B (0.048 g).

Compound B 18 of Table B was made using an analogous procedure.

Example 6.2 Preparation of propane-2-sulfonic acid 7-(2-chloro-3,6-difluorophenyl)-5-methyl-6-oxo-5,6-dihydropyrido[2,3-b]pyrazin-8-yl ester (Compound C111 of Table C)

A mixture of Compound B34 of Table B (0.045 g), acetonitrile (4 mL), potassium carbonate (0.046 g) and methyl iodide (0.015 mL) was heated to 150° C. in a microwave for 10 minutes. The reaction mixture was allowed to cool to ambient temperature and was filtered. The filtrate was concentrated to give Compound C111 of Table C (0.054 g).

7. Reactions which are Covered by Scheme 7 Example 7.1 Preparation of 7-(2-chloro-3,6-difluorophenyl)-8-hydroxy-5-methyl- 1-oxy-5H-pyrido[2,3-b]pyrazin-6-one (Compound D6 of Table D) and isobutyric acid 7-(2-chloro-3,6-difluorophenyl)-5-methyl-6-oxo-1-oxy-5,6-dihydropyrido[2,3-]pyrazin-8-yl ester (Compound C71 of Table C)

Compound C12 of Table C (0.30 g) and freshly ground urea hydrogen peroxide (0.107 g) were stirred in dichloromethane (10 mL) and trifluoroacetic anhydride (TFAA) (0.238 g) was added dropwise at ambient temperature. The reaction was stirred at ambient temperature for 5 hours and then stored at ambient temperature for 16 hours. The reaction mixture was quenched by addition of aqueous sodium metabisulfite (1M). The phases were separated. The organic phase was washed with aqueous sodium hydrogencarbonate (1M), dried over magnesium sulfate and concentrated to give a yellow oil which was purified by column chromatography on silica gel (eluent: ethyl acetate/hexane 1:1) to give Compound C71 of Table C (0.054 g) and Compound D6 of Table D (0.024 g).

8. Reactions which are Covered by Scheme 8 Example 8.1 Alternative preparation of acetic acid 7-(3,4-dichlorophenyl)-6-oxo-5,6-dihydro-pyrido[2,3-b]pyrazin-8-yl ester (Compound B29 of Table B) Step 1

Sodium methoxide (6.5 mL) (30% by weight in methanol) was dissolved in methanol (75 mL) at room temperature. Dimethyl malonate (3.7 mL) was added dropwise at ambient temperature over a period of 20 minutes and the reaction stirred at ambient temperature for 1 hour. Methyl 3-aminopyrazine-2-carboxylate (5.0 g) was added in portions at ambient temperature over a period of 40 minutes. The reaction mixture was heated to reflux for 3 days, and then allowed to cool. The solvent was concentrated. The residue was dissolved in water and acidified with concentrated hydrochloric acid (36% by weight in water). The precipitate was isolated, washed with water, methanol and ethyl acetate, and dried under high vacuum to give 6,8-dihydroxypyrido[2,3-b]pyrazine-7-carboxylic acid methyl ester as a beige solid (4.16 g). ¹H NMR (d₆-DMSO): 3.80 (s, 3H), 8.59 (s, 1H), 8.70 (s, 1H) ppm.

Step 2

To a solution of 6,8-dihydroxypyrido[2,3-b]pyrazine-7-carboxylic acid methyl ester (5.0 g) in concentrated hydrochloric acid (36% by weight in water) was added a few drops of concentrated sulfuric acid at ambient temperature. The reaction mixture was then heated to 100° C. for four hours. The reaction mixture was allowed to cool to ambient temperature and stored at ambient temperature for 16 hours. Then the reaction mixture was concentrated and dried under high vacuum to give 8-hydroxy-5H-pyrido[2,3-b]pyrazin-6-one as a brown solid (3.02 g).

¹H NMR (d₆-DMSO): 8.53 (s, 1H), 8.63 (s, 1H) ppm.

Step 3

A mixture of 3,4-dichlorophenyl lead triacetate (1.63 g), 8-hydroxy-5H-pyrido[2,3-b]pyrazin-6-one (0.254 g) and 4-dimethylaminopyridine (DMAP) (0.549 g) in anhydrous dimethylsulfoxide (10 mL) under a nitrogen atmosphere was heated to 60° C. for four hours. The reaction mixture was then allowed to cool to ambient temperature and stored at ambient temperature for 16 hours. The reaction mixture was diluted with ethyl acetate. The mixture was washed with aqueous hydrochloric acid (1M) and water, and the organic layer concentrated to give 7-(3,4-dichlorophenyl)-8-hydroxy-5H-pyrido[2,3-b]pyrazin-6-one (0.13 g) which was used without further purification.

Step 4

Crude 7-(3,4-dichlorophenyl)-8-hydroxy-5H-pyrido[2,3-b]pyrazin-6-one (0.13 g) was heated in acetic anhydride (10 mL) for 3 hours and then allowed to cool and stored at ambient temperature for 16 hours. The reaction mixture was poured onto ice and water, stirred vigorously and extracted with ethyl acetate. The organic extract was washed with water and concentrated. The residue was purified by column chromatography on silica gel (eluent: ethyl acetate/hexane 1:1) to give Compound B29 of Table B as a yellow solid (0.077 g).

9. Reactions which are Covered by Scheme 9 Example 9.1 Preparation of 2,2-dimethyl-propionic acid 7-(2-chloro-3,6-difluoro-5-nitro-phenyl)-5-methyl-6-oxo-5,6-dihydro-pyrido[2,3-b]pyrazin-8-yl ester (Compound A44 of Table A)

to Compound B6 of Table B (1.0 g) was added to concentrated sulfuric acid (10 mL) (50% by weight in water) at 0° C. Nitric acid (0.7 mL) (79% by weight in water) was added at 0° C. followed by fuming nitric acid (0.7 mL) at 0° C. The reaction mixture was allowed to warm to ambient temperature and stirred at ambient temperature for 5 hours. The reaction mixture was quenched by pouring onto ice. The precipitate formed was isolated to give Compound A44 of Table A (0.78 g).

10. Reactions which are Covered by Scheme 10 Example 10.1 Preparation of 2,2-dimethyl-propionic acid 7-(2-chloro-3-dibromomethyl-6-fluorophenyl)-5-methyl-6-oxo-5,6-dihydropyrido[2,3-b]pyrazin-8-yl ester (Compound C182 of Table C)

Compound C126 of Table C (0.016 g), N-bromosuccinimide (NBS) (0.014 g) and benzoyl peroxide (catalytic amount) were heated to reflux in carbon tetrachloride (5 mL). A 500 watt tungsten halogen lamp was used to initiate the reaction. The reaction mixture was heated to reflux and irradiated until all the starting material had been consumed. The reaction mixture was allowed to cool and then filtered. The filtrate was concentrated to give a colourless oil which was purified by column chromatography on silica gel (eluent: ethyl acetate/hexane 1:4) to give Compound C182 of Table C as a white solid (0.018 g).

11. Reactions which are covered by Scheme 11 Example 11.1 Preparation of (3-bromo-2-chloro-6-fluoro-phenyl)-acetic acid Step 1

3-Bromo-2-chloro-6-fluoro-toluene (8.0 g), N-bromosuccinimide (NBS) (6.42 g) and a catalytic amount of benzoyl peroxide in carbon tetrachloride (40 ml) were heated to reflux. A 500 watt tungsten halogen lamp was used to initiate the reaction. The reaction mixture was heated to reflux and irradiated for 30 minutes. The reaction mixture was allowed to cool and then filtered. The filtrate was concentrated to give a colourless oil which solidified on standing to give 1-bromo-3-bromomethyl-2-chloro-4-fluorobenzene as an off-white solid (10.7 g).

¹H NMR (CDCl₃): 4.64 (d, 2H), 6.94 (t, 1H), 7.58 (dd, 1H) ppm.

Step 2

A solution of 1-bromo-3-bromomethyl-2-chloro-4-fluorobenzene (9.945 g) in absolute ethanol (40 mL) was added dropwise to a solution of potassium cyanide (2.38 g) in water (2 ml) under heating over a period of 30 minutes. The reaction mixture was heated to reflux for 7 hours. The reaction mixture was then allowed to cool and stored at ambient temperature for 16 hours. The mixture was filtered and the filtrate concentrated. The residue was dissolved in ethyl. acetate, dried over magnesium sulfate and concentrated to give (3-bromo-2-chloro-6-fluoro-phenyl)-acetonitrile as a pale yellow oil (8.19 g).

¹H NMR (CDCl₃): 3.89 (d, 2H), 7.00 (t, 1H), 7.64 (dd, 1H) ppm.

Step 3

The (3-bromo-2-chloro-6-fluoro-phenyl)-acetonitrile (8.15 g) was dissolved in concentrated sulfuric acid (50% by weight in water) (90 ml). The reaction became very hot and was then heated to reflux for 3 hours. The reaction mixture was allowed to cool and was stored at ambient temperature for 16 hours. The mixture was extracted twice with dichloromethane. The organic phases were combined, dried over magnesium sulfate and concentrated to give (3-bromo-2-chloro-6-fluoro-phenyl)-acetic acid as an off-white solid (8.3 g).

¹H NMR (CDCl₃): 3.94 (d, 2H), 6.94 (t, 1H), 7.56 (dd, 1H) ppm.

12. Substituted Amino Pyrazine Esters

Although substituted 3-amino-5-pyrazinecarboxylate esters are known in the literature, particularly in the publications of E. J. Cragoe et al, for example J. Med. Chem., 10, 66, (1967), J. Med. Chem., 10, 899, (1967) and J. Med. Chem., 10, 598, (1967), it is sometimes necessary to make some of these compounds using shorter or more convenient syntheses.

Example 12.1 Preparation of 3-amino-5-chloropyrazine-2-carboxylic acid methyl ester and 3-amino-6-chloropyrazine-2-carboxylic acid methyl ester

3-Amino-4-oxy-pyrazine-2-carboxylic acid methyl ester (3.2 g) (prepared according to GB 1,248,146), was stirred as a suspension in dry dimethylformamide (32 mL). Phosphorous oxychloride (6.5 mL) was added a rate to keep the reaction mixture below reflux. After all the oxychloride had been added the reaction was stored at ambient temperature for 30 minutes and then poured onto ice. The mixture was stored at ambient temperature overnight. The precipitate was filtered and dried under vacuum to give 3-5 amino-5-chloro-pyrazine-2-carboxylic acid methyl ester and 3-amino-6-chloro-pyrazine-2-carboxylic acid methyl ester as a free flowing yellow solid (2.05 g) which formed an inseparable mixture. This mixture was used as the starting material for the preparation of Compound C82 and Compound C83 of Table C by the route described in Scheme 1 and Scheme 2. Compound C82 and Compound C83 of Table C were separated in the final step by column chromatography on silica gel (eluent: ethyl acetate/hexane).

¹H NMR (CDCl₃): 4.00 (s, 3H), 7.95 (s, 0.66H, 6-chloro isomer), 8.23 (s, 033H, 5-chloro-isomer) ppm.

Example 12.2 Preparation of 3-amino-6-methylpyrazine-2-carboxylic acid methyl ester

3-Amino-6-bromopyrazine-2-carboxylic acid methyl ester (1.0 g), palladium acetate (0.101 g), and S-Phos (2′-dicyclohexylphosphino-2,6-dimethoxy-1,1′-biphenyl) were placed in a flask, with toluene (15 mL) and water (3 drops). Methyl boronic acid (0.394 g) and potassium phosphate (1.71 g) were added and the reaction mixture was refluxed for 24 hours. After allowing the reaction mixture to cool, the mixture was diluted with aqueous hydrochloric acid (1M) and extracted with ethyl acetate. The solvent was evaporated and the residue was purified by column chromatography on silica gel (eluent: diethyl ether) to give 3-amino-6-methylpyrazine-2-carboxylic acid methyl ester as a yellow solid (0.114 g).

¹H NMR (CDCl₃): 2.40 (s, 3H), 3.92 (s, 3H), 6.21 (bs, 2H), 8.03 (s, 1H) ppm.

The compounds mentioned in the following Tables A to D can be prepared in an analogous manner.

TABLE A Compounds of formula (Ia), i.e. compounds of formula (I) wherein R³ is hydrogen and R⁵is hydroxy. (1a)

Comp ¹H NMR (CDCl₃ except where No. R¹ R² R⁴ indicated; chemical shifts in ppm) A1 H H 2,4-di-Cl- (d₆-DMSO): 7.37 (d, 1H), 7.49 phenyl- (dd, 1H), 7.79 (d, 1H), 8.58 (d, 1H), 8.68 (d, 1H), 11.6 (s, 1H), 12.3 (s, 1H). A2 H H 2-Cl-phenyl- 7.38-7.42 (m, 3H), 7.52-7.57 (m, 1H), 8.02 (bs, 1H), 8.49 (d, 1H), 8.62 (d, 1H). A3 H H 2,5-di-Cl- (CDCl₃ + d₆-DMSO): 7.31 (dd, phenyl- 1H), 7.39 (d, 1H), 7.44 (d, 1H), 8.46 (d, 1H), 8.61 (d, 1H). A4 H H 2,3-di-Cl- (CDCl₃ + d₆-DMSO): 7.29-7.35 phenyl- (m, 2H), 7.54 (dd, 1H), 8.49 (d, 1H), 8.73 (d, 1H). A5 H H 2,6-di-Cl- (d₆-DMSO): 7.38 (t, 1H), 7.49 (d, phenyl- 2H), 8.52 (d, 1H), 8.64 (d, 1H), 11.7 (s, 1H), 12.3 (s, 1H). A6 H H 2-Me- (d₆-DMSO): 2.12 (s, 3H), 7.10- phenyl- 7.14 (m, 1H), 7.19-7.28 (m, 3H), 8.55 (d, 1H), 8.66 (d, 1H), 11.1 (s, 1H), 12.2 (s, 1H). A7 H H 2-MeO- (d₆-DMSO): 3.62 (s, 3H), 6.90 (t, phenyl- 1 H), 6.99 (d, 1H), 7.08 (dd, 1H), 7.28 (t, 1H), 8.47 (d, 1H), 8.56 (d, 1H), 10.8 (s, 1H), 12.0 (s, 1H). A8 H H 2-F₃C- 7.39 (d, 1H), 7.58 (t, 1H), 7.68 (t, phenyl- 1H), 7.83 (d, 1H), 8.48 (d, 1H), 8.62 (d, 1H). A9 H H 3,5-di-Cl-2- (d₆-DMSO): 3.60 (s, 3H), 7.27 (s, MeO- 1H), 7.68 (s, 1H), 8.57 (s, 1H), phenyl- 8.68 (s, 1H), 11.59 (s, 1H), 12.3 (s, 1H). A10 H H 2-Cl-4-F- (d₆-DMSO): 7.28 (dt, 1H), 7.39 phenyl- (dt, 1H), 7.53 (dd, 1H), 8.57 (d, 1H), 8.68 (d, 1H), 11.5 (s, 1H), 12.3 (s, IR). A11 H H 2-Cl-3,6-di- (d₆-DMSO): 7.34-7.42 (m, 1H), F-phenyl- 7.51-7.59 (m, 1H), 8.59 (d, 1H), 8.72 (d, 1H), 12.0 (bs, 1H), 12.4 (s, 1H). A12 H H 2,6-di-Et-4- 1.11 (t, 6H), 2.38 (s, 3H), 2.39- Me-phenyl- 2.51 (m, 4H), 7.05 (s, 1H), 8.51 (d, 1H), 8.67 (4, 1H). A13 H H 2-F₃CO- 7.39-7.44 (m, 2H), 7.49 (t, 2H), phenyl- 8.10 (bs, 1H), 8.49 (d, 1H), 8.65 (d, 1H), 9.77 (bs, 1H). A14 H H 2,6-di-Cl-4- (d₆-DMSO): 8.04 (s, 2H), 8.61 (s, F₃C-phenyl- 1H), 8.73 (s, 1H), 12.0 (s, 1H), 12.42 (s, 1H). A15 H H 2-F-phenyl- — A16 H H 6-F-2-F₃C- — phenyl A17 H H 4-F-2-F₃C- — phenyl A18 H H 2-Br-4-F- — phenyl A19 H H 5-Cl-2-F₃C- — phenyl A20 H H 2,4-di-MeO- — phenyl- A21 H H 2,3,6-tri-Cl- — phenyl- A22 H H phenyl- 7.25 (d, 1H), 7.37 (t, 2H), 7.50 (d, 2H), 8.50 (d, 1H), 8.61 (d, 1H). A23 H H 2-Cl-6-F- (CD₃OH): 7.15 (t, 1H), 7.40-7.50 phenyl- (m, 2H), 8.58 (d, 1H), 8.60 (d, 1H). A24 H H 2-Br-phenyl- (CD₃OH): 7.21-7.35 (m, 2H), 7.40 (m, 1H), 7.71 (dd, 1H), 8.58 (d, 1H), 8.62 (d, 1H). A25 H H naphth-3-yl- — A26 Br H 2,6-di-Cl- (d₆-DMSO): 7.45 (t, 1H), 7.55 (d, phenyl- 2H), 9.78 (s, 1H), 11.9 (bs, 1H), 12.6 (s, 1H). A27 Cl H 2,6-di-Cl- (d₆-DMSO): 7.45 (t, 1H), 7.55 (d, phenyl- 2H), 9.81 (s, 1H), 11.9 (bs, 1H), 12.6 (s, 1H). A28 H H 2,3,5-tri-Cl- (d₆-DMSO): 7.40 (s, 1H), 7.80 (s, phenyl- 1H), 8.55 (d, 1H), 8.65 (d, 1H). A29 H H naphth-2-yl 7.50 (m, 5H), 7.95 (m, 2H), 8.55 (d, 1H), 8.70 (d, 1H), 11.1 (s, 1H), 12.3 (s, 1H). A30 H H 2,4,6-tri-Me- (d₆-DMSO): 2.30 (s, 3H), 2.33 (s, phenyl- 6H), 6.98 (s, 2H), 8.48 (d, 1H), 8.61 (d, 1H), 10.56 (s, 1H). A31 H H 6-Cl-2-F₃C- 7.51 (t, 1H), 7.73 (d, 2H), 8.49 (d, phenyl- 1H), 8.64 (d, 1H), 10.75 (s, 1H). A32 H H 2-Cl-3-F₃C- 7.55 (t, 1H), 7.60 (d, 1H), 7.80 (d, phenyl- 1H), 8.56 (d, 1H), 8.64 (d, 1H). A33 H H 2-Cl-6-F-5- (d₆-DMSO): 2.24 (d, 3H), 7.30 Me-phenyl- (m, 2H), 8.54 (d, 1H), 8.65 (d, 1H), 11.70 (s, 1H), 12.16 (s, 1H). A34 H H 2-Cl-5-F₃C- (d₆-DMSO): 7.72 (s, 1H), 7.78 (m, phenyl- 2H), 8.58 (d, 1H), 8.69 (d, 1H), 11.72 (s, 1H), 12.35 (s, 1H). A35 H H 2-Cl-6-F-3- (d₆-DMSO): 2.30 (s, 3H), 7.15 (t, Me-phenyl- 1H), 7.40 (t, 1H), 8.50 (d, 1H), 8.65 (d, 1H), 11.7 (s, 1H), 12.3 (s, 1H). A36 H H 2,6-di-Cl-4- (CD₃OH): 7.47 (d, 1H), 7.66 (d, F₃CO- 1H), 8.60 (d, 1H), 8.68 (d, 1H). phenyl- A37 H H 2,5-di-Me- (d₆-DMSO): 2.05 (s, 3H), 2.30 (s, phenyl- 3H), 6.95 (s, 1H), 7.05 (d, 1H), 7.15 (d, 1H), 8.55 (d, 1H), 8.65 (d, 1H), 11.0 (s, 1H), 12.2 (s, 1H). A38 H H 2-Cl-5-F- (d₆-DMSO): 7.25 (m, 2H), 7.57 phenyl- (dd, 1H), 8.56 (d, 1H), 8.67 (d, 1H), 11.60 (s, 1H), 12.29 (s, 1H). A39 H H 2,4-di-Cl-5- (d₆-DMSO): 7.50 (d, 1H), 7.91 (d, F-phenyl- 1H), 8.59 (d, 1H), 8.70 (d, 1H), 11.75 (s, 1H), 12.36 (s, 1H). A40 H H 3-Br-2-Cl-6- (d₆-DMSO): 7.50 (t, 1H), 7.88 F-phenyl- (dd, 1H), 8.59 (d, 1H), 8.70 (d, 1H), 12.00 (s, 1H), 12.41 (s, 1H). A41 H H 2,3-di-MeO- 3.83 (s, 3H), 3.90 (s, 3H), 6.95 phenyl- (dd, 1H), 7.00 (dd, 1H), 7.17 (t, 1H), 8.04 (bs, 1H), 8.47 (d, 1H), 8.59 (d, 1H), 9.93 (bs, 1H). A42 H H 2-MeO-5- 3.87 (s, 3H), 7.10 (d, 1H), 7.62 (d, F₃CO- 1H), 7.67 (dd, 1H), 8.00 (bs, 1H), phenyl- 8.48 (d, 1H), 8.61 (d, 1H), 9.44 (bs, 1H). A43 H H 2-Br-4-F₃C- 7.50-7.52 (d, 1H), 7.68-7.70 (d, phenyl- 1H), 7.99 (d, 1H), 8.56 (d, 1H), 8.57 (d, 1H), 8.11 (bs, 1H), 9.50 (bs, 1H). A44 H H 2-Cl-3,6-di- (CD₃OH): 8.03 (t, 1H), 8.48 (d, F-5-O₂N- 1H), 8.51 (d, 1H), 10.03 (bs, 1H). phenyl- A45 H H 2-F₂HCO- (CD₃OH): 6.63 (t, 1H), 7.26 (d, phenyl- 1H), 7.31 (t, 1H), 7.38-7.47 (m, 2H), 8.54 (d, 1H), 8.61 (d, 1H). A46 H H 2-Cl-4,5-di- (CD₃OH): 7.32 (dd, 1H), 7.48 (dd, F-phenyl- 1H), 8.55 (d, 1H), 8.62 (d, 1H). A47 H H 2,3-di-Cl-6- (CD₃OH): 7.18 (t, 1H), 7.62 (dd, F-phenyl- 1H), 8.55 (d, 1H), 8.62 (d, 1H). A48 H Me 2-Cl-3,6-di- (d₆-DMSO): 2.60 (s, 3H), 7.35 (m, F-phenyl- 1H), 7.55 (m, 1H), 8.50 (s, 1H), 11.8 (s, 1H), 12.3 (s, 1H). A49 Me H 2-Cl-3,6-di- 2.65 (s, 3H), 7.35 (m, 1H), 7.55 F-phenyl- (m, 1H), 8.60 (s, 1H), 12.2 (s, 1H). Key: s = singlet; d = doublet; t = triplet; bs = broad singlet; dd = double doublet; dt = double triplet; m = multiplet.

TABLE B Compounds of formula (Ib), i.e. compounds of formula (I) wherein R³ is hydrogen and R⁵ is as defined for compounds of formula (I) other than hydroxy. (Ib)

¹H NMR (CDCl₃ except Comp where indicated; No. R¹ R² R⁴ R⁵ chemical shifts in ppm) B1 H H 2,4-di-Cl- Me(CO)O— 2.28 (s, 3H), 7.23 (d, phenyl- 1H), 7.36 (dd, 1H), 7.56 (d, 1H), 8.53-8.59 (m, 2H), 9.98 (bs, 1H). B2 H H 2-Cl-4-F- i-Pr-(CO)O— 1.11 (d, 3H), 1.17 (d, phenyl- 3H), 2.79 (sept, 1H), 7.09 (dt, 1H), 7.25-7.31 (m, 2H), 8.52-8.60 (m, 2H), 9.87 (bs, 1H). B3 H H 2-Cl-4-F- Et(CO)O— 1.14 (t, 3H), 2.50-2.61 phenyl- (m, 2H), 7.09 (dt, 1H), 7.25-7.32 (m, 2H), 8.45 (bs, 1H), 8.58 (bs, 1H), 10.1 (s, 1H). B4 H H 2-Cl-3,6- i-Pr-(CO)O— 1.17 (dd, 6H), 2.81 di-F- (sept, 1H), 7.08-7.13 phenyl- (m, 1H), 7.21-7.27 (m, 1H), 8.56 (bs, 1H), 8.59 (bs, 1H), 9.91 (bs, 1H). B5 H H 2-Cl-3,6- Me(CO)O— 2.30 (s, 3H), 7.09-7.15 di-F- (m, 1H), 7.22-7.30 (m, phenyl- 1H), 8.56 (d, 1H), 8.59 (d, 1H), 9.56 (bs, 1H). B6 H H 2-Cl-3,6- t-Bu(CO)O— 1.21 (s, 9H), 7.08-7.13 di-F- (m, 1H), 7.21-7.27 (m, phenyl- 1H), 8.55-8.57 (m, 2H), 9.51 (bs, 1H). B7 H H 2-F₃CO- Et(CO)O— 1.13 (t, 3H), 2.49-2.63 phenyl- (m, 2H), 7.37-7.43 (m, 3H), 7.47-7.53 (m, 1H), 8.53 (d, 1H), 8.56 (d, 1H), 9.69 (s, 1H). B8 H H 2-F₃CO- Me(CO)O— 2.28 (t, 3H), 7.37-7.43 phenyl- (m, 3H), 7.48-7.53 (m, 1H), 8.54 (d, 1H), 8.58 (d, 1H), 10.1 (bs, 1H). B9 H H 2,6-di-Et- Me(CO)O— 1.12 (t, 6H), 2.19 (s, 4-Me- 3H), 2.38 (s, 3H), 2.40- phenyl- 2.48 (m, 4H), 7.00 (s, 2H), 8.51 (s, 2H), 9.25 (bs, 1H). B10 H H 2,6-di-Cl- Me(CO)O— 2.27 (s, 3H), 7.32-7.38 phenyl- (m, 1H), 7.45 (d, 2H), 8.53-8.58 (m, 2H), 9.49 (bs, 1H). B11 H H 2,6-di-Cl- Et(CO)O— 1.11 (t, 3H), 2.56 (q, phenyl- 2H), 7.34 (t, 1H), 7.46 (d, 2H), 8.56 (d, 1H), 8.59 (d, 1H), 9.95 (bs, 1H). B12 H H 2,6-di-Cl- EtO(CO)O— (d₆-DMSO): 1.18 (t, phenyl- 3H), 4.19 (q, 2H), 7.53 (t, 1H), 7.63 (d, 2H), 8.63 (d, 1H), 8.76 (d, 1H). B13 H H 2,6-di-Cl- t-Bu(CO)O— (d₆-DMSO): 1.06 (s, phenyl- 9H), 7.51 (t, 1H), 7.62 (d, 2H), 8.63 (d, 1H), 8.73 (d, 1H), 13.19 (s, 1H). B14 H H 2,6-di-Cl- n-Pr(CO)O— (d₆-DMSO): 0.69 (t, phenyl- 3H), 1.40-1.49 (m, 2H), 2.47 (t, 2H), 7.51 (t, 1H), 7.62 (d, 2H), 8.62 (d, 1H), 8.74 (d, 1H), 13.1 (s, 1H). B15 H H 2,6-di-Cl- Me(CO)O— 2.31 (s, 3H), 7.72 (s, 4-F₃C- 2H), 8.59 (d, 1H), 8.67 phenyl- (d, 1H), 11.02 (bs, 1H). B16 H H 2,6-di-Cl- c-Pr(CO)O— 1.12-0.99 (m, 4H), 4-F₃C- 1.83-1.77 (m, 1H), 7.72 phenyl- (s, 2H), 8.60 (d, 1H), 8.64 (d, 1H), 10.68 (bs, 1H). B17 H H 2-F₃CO- t-Bu(CO)O— 1.18 (s, 9H), 7.35-7.41 phenyl- (m, 3H), 7.46-7.52 (m, 1H), 8.52 (s, 2H), 9.39 (bs, 1H). B18 H H 2-Cl-3,6- MeS(O)₂O— (CD₃OH): 3.56 (s, 3H), di-F- 7.20-7.70 (m, 1H), phenyl- 7.38-7.44 (m, 1H), 8.67 (s, 1H), 8.72 (s, 1H). B19 Br H 2,6-di-Cl- i-Pr(CO)O— 1.11 (d, 3H), 1.17 (d, phenyl- 3H), 2.83 (sept, 1H), 7.30-7.35 (m, 2H), 7.43-7.46 (m, 1H), 8.59 (s, 1H). B20 Cl H 2,6-di-Cl- i-Pr(CO)O— 1.11 (d, 3H), 1.17 (d, phenyl- 3H), 2.83 (sept, 1H), 7.30-7.35 (m, 2H), 7.43-7.46 (m, 1H), 8.67 (s, 1H). B21 H H 2,3-di-Cl- i-Pr(CO)O— 1.05 (d, 3H), 1.15 (d, phenyl- 3H), 2.75 (m, 1H), 7.20 (d, 1H), 7.30 (t, 1H), 7.55 (d, 1H), 8.50 (d, 1H), 8.55 (d, 1H), 9.50 (s, 1H). B22 H H 2-Cl- t-Bu(CO)O— 1.15 (s, 9H), 7.25 (m, phenyl- 3H), 7.50 (d, 1H), 8.50 (m, 2H), 10.0 (s, 1H). B23 H H 2,3,6-tri-F- t-Bu(CO)O— 1.25 (s, 9H), 6.95 (m, phenyl- 1H) 7.25 (m, 1H), 8.55 (d, 1H), 8.60 (d, 1H), 10.2 (s, 1H). B24 H H 2,3,6-tri-F- i-Pr(CO)O— 1.20 (d, 6H), 2.85 (m, phenyl- 1H), 6.95 (m, 1H) 7.25 (m, 1H), 8.55 (d, 1H), 8.60 (d, 1H), 10.4 (s, 1H). B25 H H 2-Cl- Me(CO)O— 2.23 (s, 3H), 7.28-7.31 phenyl- (m, 1H), 7.34-7.43 (m, 2H), 7.53 (dd, 1H), 8.54 (dd, 2H), 9.69 (bs, 1H). B26 H H 3-Cl- Me(CO)O— 2.32 (s, 3H), 7.36-7.39 phenyl- (m, 1H), 7.40-7.43 (m, 2H), 7.48 (s, 1H), 8.54 (s, 2H), 9.7 (bs, 1H). B27 H H 4-Cl- Me(CO)O— 2.31 (s, 3H), 7.41-7.48 phenyl- (m, 4H), 8.53 (s, 2H), 9.67 (bs, 1H). B28 H H 2-Cl-3,6- Me—C≡C—CH₂O(CO)O— 1.90 (t, 3H), 4.80 (m, di-F- 1H), 4.98 (m, 1H), 7.03 phenyl- (m, 1H), 7.30 (m, 1H), 8.60 (m, 1H), 8.80 (m, 1H). B29 H H 3,4-di-Cl- Me(CO)O— 2.34 (s, 3H), 7.34 (dd, phenyl- 1H), 7.56 (d, 1H), 7.60 (d, 1H), 8.55 (bs, 2H) 9.70 (bs, 1H). B30 H H 2,4,6-tri- i-Pr(CO)O— 1.01 (d, 6H), 2.12 (s, Me- 2.30 (s, 3H), 2.70 phenyl- (sept, 1H), 6.93 (bs, 2H), 8.54 (m, 2H), 9.84 (bs, 1H). B31 H H 6-Cl-2- i-Pr(CO)O— 1.03 (d, 3H), 1.06 (d, F₃C- 3H), 2.72 (sept, 1H), phenyl- 7.52 (t, 1H), 7.12 (d, 2H), 8.54 (d, 1H), 8.60 (d, 1H), 10.32 (bs, 1H). B32 H H 2-Cl-3- i-Pr(CO)O— 1.04 (d, 3H), 1.10 (d, F₃C- 3H), 2.74 (m, 1H), 7.43 phenyl- (m, 2H), 7.82 (dd, 1H), 8.62 (d, 1H) 8.64 (d, 1H), 9.89 (bs, 1H). B33 H H 2,4,6-tri- Me(CO)O— 2.13 (s, 6H), 2.19 (s, Me- 3H), 2.32 (s, 3H), 6.94 phenyl- (s, 2H), 8.53 (s, 2H), 9.45 (bs, 1H). B34 H H 2-Cl-3,6- i-PrS(O)₂O— 1.50 (d, 6H), 3.82 (m, di-F- 1H), 7.20 (m, 1H), 7.32 phenyl- (m, 1H), 8.50 (d, 1H), 8.65 (m, 1H). B35 H H 2-Cl-3,6- t-BuO—(CO)O— 1.45 (s, 9H), 7.09 (m, di-F- 1H), 7.23 (m, 1H), 8.58 phenyl- (d, 1H), 8.65 (d, 1H), 11.07 (bs, 1H). B36 H H 2-Cl-6-F- i-Pr(CO)O— 1.11 (d, 3H), 1.12 (d, 5-Me- 3H), 2.78 (sept, 1H), phenyl- 7.20 (m, 2H), 8.53 (d, 1H), 8.56 (d, 1H), 9.83 (bs, 1H). B37 H H 2-Cl-6-F- t-Bu(CO)O— 1.17 (s, 9H), 2.28 (d, 5-Me- 3H), 7.23 (dd, 2H), 8.54 phenyl- (d, 1H), 8.58 (d, 1H), 10.34 (bs, 1H). B38 H H 2-Cl-5- i-Pr(CO)O— 1.07 (d, 3H), 1.14 (d, F₃C- 3H), 2.76 (sept, 1H), phenyl- 7.65 (s, 1H), 7.65 (s, 2H), 8.56 (d, 1H), 8.62 (d, 1H), 10.69 (bs, 1H). B39 H H 2-Cl-5- t-Bu(CO)O— 1.15 (s, 9H), 7.57 (s, F₃C- 1H), 7.64 (s, 2H), 8.56 phenyl- (d, 1H), 8.61 (d, 1H), 10.96 (bs, 1H). B40 H H 2-Cl-3,6- 4-O₂N—C₆H₄—(CO)O 7.05 (m, 1H), 7.22 (m, di-F- 1H), 8.20-8.40 (m, 4H), phenyl- 8.50 (d, 1H), 8.65 (d, 1H). B41 H H 2,6-di-Cl- t-Bu(CO)O— 1.16 (s, 9H), 7.80 (s, 4-F₃C- 2H), 8.55 (d, 1H), 8.60 phenyl- (d, 1H), 10.1 (bs, 1H). B42 H H 2,6-di-Cl- t-Bu(CO)O— 1.18 (s, 9H), 7.22 (d, 4-F₃CO- 1H), 7.50 (d, 1H), 8.52 phenyl- (d, 1H), 8.60 (d, 1H), 10.2 (bs, 1H). B43 H H phenyl- t-Bu(CO)O— 1.22 (s, 9H), 7.40 (m, 5H), 8.50 (s, 2H), 9.72 (bs, 1H). B44 H H 2-O₂N-4- t-Bu(CO)O— 1.22 (s, 9H), 7.62 (d, F₃C- 1H), 7.92 (d, 1H), 8.50 phenyl- (s, 1H), 8.55 (d, 1H), 8.60 (d, 1H). B45 H H 2-Cl-5-F- i-Pr(CO)O— 1.10 (d, 3H), 1.16 (d, phenyl- 3H), 2.78 (sept, 1H), 7.04 (dd, 1H), 7.10 (m, 1H), 7.48 (dd, 1H), 8.55 (d, 1H), 8.60 (d, 1H), 10.48 (bs, 1H). B46 H H 2-Cl-5-F- t-Bu(CO)O— 1.18 (s, 9H), 7.04 (dd, phenyl- 1H), 7.10 (m, 1H), 7.47 (dd, 1H), 8.54 (d, 1H), 8.56 (d, 1H), 9.95 (bs, 1H). B47 H H 2,4-di-Cl- i-Pr(CO)O— 1.15 (d, 3H), 1.20 (d, 5-F- 3H), 2.80 (sept, 1H), phenyl- 7.12 (d, 1H), 7.58 (d, 1H), 8.54 (d, 1H), 8.57 (d, 1H), 9.92 (d, 1H). B48 H H 2,4-di-Cl- t-Bu(CO)O— 1.21 (s, 9H), 7.12 (d, 5-F- 1H), 7.58 (d, 1H), 8.54 phenyl- (d, 1H), 8.57 (d, 1H), 9.95 (bs, 1H). B49 H H 3-Br-2-Cl- t-Bu(CO)O— 1.19 (s, 9H), 7.03 (t, 6-F- 1H), 7.70 (dd, 1H), 8.54 phenyl- (d, 1H), 8.56 (d, 1H), 9.81 (bs, 1H). B50 H H 3-Br-2-Cl- i-Pr(CO)O— 1.13 (d, 3H), 1.14 (d, 6-F- 3H), 2.79 (sept, 1H), phenyl- 7.03 (t, 1H), 7.70 (dd, 1H), 8.54 (d, 1H), 8.56 (d, 1H), 9.69 (bs, 1H). B51 H H 2-Br- t-Bu(CO)O— 1.14 (s, 9H), 7.29 (m, phenyl- 2H), 7.40 (m, 1H), 7.69 (dd, 1H), 8.54 (d, 1H), 8.56 (d, 1H). B52 H H 2,3-di- i-Pr(CO)O— 1.08 (d, 3H), 1.14 (d, MeO- 3H), 2.74 (sept, 1H), phenyl- 3.81 (s, 3H), 3.89 (s, 3H), 6.79 (d, 1H), 6.99 (dd, 1H), 7.09 (t, 1H), 8.49 (m, 2H), 9.71 (bs, 1H). B53 H H 2,3-di- t-Bu(CO)O— 1.16 (s, 9H), 3.80 (s, MeO- 3H), 3.89 (s, 3H), 6.79 phenyl- (d, 1H), 6.98 (dd, 1H), 7.09 (t, 1H), 8.48 (m, 2H), 9.42 (bs, 1H). B54 H H 2-Br-4- t-Bu(CO)O— 1.16 (s, 9H), 7.41-7.43 F₃C- (d, 1H), 7.65-7.67 (d, phenyl- 1H), 7.98 (d, 1H), 8.56 (d, 1H), 8.57 (d, 1H), 9.76 (bs, 1H). B55 H H 2-MeO-5- i-Pr(CO)O— 1.11 (d, 3H), 1.16 (d, F₃CO- 3H), 2.77 (sept, 1H), phenyl- 3.86 (s, 3H), 7.08 (d, 1H), 7.49 (s, 1H), 7.69 (dd, 1H), 8.53 (m, 2H), 9.69 (bs, 1H). B56 H H 2-MeO-5- t-Bu(CO)O— 1.18 (s, 9H), 3.86 (s, F₃CO- 3H), 7.07 (d, 1H), 7.49 phenyl- (s, 1H), 7.68 (dd, 1H), 8.51 (m, 2H), 9.45 (bs, 1H). B57 H H 2-Cl-3,6- t-Bu(CO)O— 1.21 (s, 9H), 8.01 (dd, di-F-5- 1H), 8.58 (d, 1H), 8.62 O₂N- (d, 1H), 10.1 (bs, 1H). phenyl- B58 H H 2-F₂HCO- i-Pr(CO)O— 1.12 (d, 3H), 1.16 (d, phenyl- 3H), 2.77 (sept, 1H), 6.50 (dd, 1H), 7.31 (m, 3H), 7.46 (m, 1H), 8.52 (d, 1H), 8.54 (d, 1H), 10.15 (bs, 1H). B59 H H 2-F₂HCO- t-Bu(CO)O— 1.18 (s, 9H), 6.50 (dd, phenyl- 1H), 7.30 (m, 3H), 7.45 (m, 1H), 8.52 (d, 1H), 8.53 (d, 1H), 10.13 (bs, 1H). B60 H H 2,3-di-Cl- t-Bu(CO)O— 1.21 (s, 9H), 7.03 (t, 6-F- 1H), 7.55 (dd, 1H), 8.52 phenyl- (d, 1H), 8.54 (d, 1H). B61 H H 2-Cl-4,5- t-Bu(CO)O— 1.18 (s, 9H), 7.12 (dd, di-F- 1H), 7.34 (dd, 1H), 8.56 phenyl- (dd, 2H), 9.77 (bs, 1H). B62 H H 2-Cl-6-F- t-Bu(CO)O— 1.21 (s, 9H), 7.12 (dd, phenyl- 1H), 7.39-7.42 (m, 2H), 8.62 (d, 1H), 8.70 (d, 1H). Key: s = singlet; d = doublet; t = triplet; q = quartet; bs = broad singlet; dd = double doublet; dt = double triplet; sept = septet; m = multiplet.

TABLE C Compounds of formula (Ic), i.e. a compound of formula (I) wherein R³ is as defined for compounds of formula (I) other than hydrogen and R⁵ is as defined for compounds of formula (I) other than hydroxy. (Ic)

¹H NMR (CDCl₃ except Comp where indicated; No. R¹ R² R³ R⁴ R⁵ N-oxide chemical shifts in ppm) C1 H H Et 2-Cl-4- Et(CO)O— — 1.12 (t, 3H), 1.39 (t, F- 3H), 2.48-2.63 (m, phenyl- 2H), 4.59 (q, 2H), 7.08 (dt, 1H), 7.26- 7.30 (m, 2H), 8.49 (d, 1H), 8.60 (d, 1H). C3 H H Et 2-Cl-4- i-Pr(CO)O— — 1.10 (d, 3H), 1.17 (d, F- 3H), 1.39 (t, 3H), phenyl- 2.79 (sept, 1H), 4.59 (q, 2H), 7.08 (dt, 1H), 7.24-7.30 (m, 2H), 8.49 (d, 1H), 8.59 (d, 1H). C5 H H Me 2-Cl-4- i-Pr(CO)O— — 1.09 (d, 3H), 1.17 (d, F- 3H), 2.79 (sept, 1H), phenyl- 3.88 (s, 3H), 7.08 (dt, 1H), 7.23-7.30 (m, 2H), 8.50 (d, 1H), 8.60 (d, 1H). C6 H H Et 2,4-di- Me(CO)O— — 1.40 (t, 3H), 2.28 (s, Cl- 3H), 4.55 (q, 2H), phenyl- 7.22 (s, 1H), 7.35 (d, 1H), 7.55 (d, 1H), 8.50 (d, 1H), 8.63 (d, 1H). C7 H H i-Pr 2,4-di- Me(CO)O— — 1.65 (dd, 6H), 2.28 Cl- (s, 3H), 5.91 (sept, phenyl- 1H), 7.23 (d, 1H), 7.34 (dd, 1H), 7.53 (d, 1H), 8.48 (d, 1H), 8.59 (d, 1H). C9 H H MeO—CH₂CH₂— 2,4-di- Me(CO)O— — 2.28 (s, 3H), 3.39 (s, Cl- 3H), 3.79 (t, 2H), phenyl- 4.79 (t, 2H), 7.25 (d, 1H), 7.35 (dd, 1H), 7.56-7.58 (m, 1H), 8.52 (d, 1H), 8.63 (d, 1H). C11 H H Et 2-Cl- i-Pr(CO)O— — 1.17 (dd, 6H), 1.39 3,6-di- (t, 3H), 2.81 (sept, F- 1H), 4.59 (q, 2H), phenyl- 7.06-7.12 (m, 1H), 7.19-7.26 (m, 1H), 8.51 (d, 1H), 8.62 (d, 1H). C12 H H Me 2-Cl- 1-Pr(CO)O— — 1.13-1.19 (m, 6H), 3,6-di- 2.81 (sept, 1H), 3.89 F- (s, 3H), 7.07-7.12 phenyl- (m, 1H), 7.21-7.27 (m, 1H), 8.51 (d, 1H), 8.63 (d, 1H). C13 H H Et 2-Cl- Me(CO)O— — 1.39 (t, 3H), 2.29 (s, 3,6-di- 3H), 4.59 (q, 2H), F- 7.08-7.13 (m, 1H), phenyl- 7.21-7.27 (m, 1H), 8.51 (d, 1H), 8.63 (d, 1H). C14 H H allyl 2-Cl- Me(CO)O— — 2.29 (s, 3H), 5.15 (d, 3,6-di- 2H), 5.20-5.30 (m, F- 2H), 5.97-6.07 (m, phenyl- 1H), 7.07-7.13 (m, 1H), 7.2 1-7.26 (m, 1H), 8.52 (d, 1H), 8.62 (d, 1H). C15 H H MeO—CH₂CH₂— 2-Cl- i-Pr(CO)O— — 1.17 (dd, 6H), 2.78- 3,6-di- 2.86 (m, 1H), 3.38 F- (s, 3H), 3.79 (t, 2H), phenyl- 4.79 (t, 2H), 7.08- 7.13 (m, 1H), 7.21- 7.28 (m, 1H), 8.53 (d, 1H), 8.63 (d, 1H). C16 H H Me 2-Cl- Me(CO)— — 2.29 (s, 3H), 3.88 (s, 3,6-di- 3H), 7.09-7.15 (m, F- 1H), 7.22-7.28 (m, phenyl- 1H), 8.54 (d, 1H), 8.65 (d, 1H). C17 H H n-Bu 2-Cl- Me(CO)O— — 0.99 (t, 3H), 1.41- 3,6-di- 1.52 (m, 2H), 1.72- F- 1.81 (m, 2H), 2.30 (s, phenyl- 3H), 4.50-4.56 (m, 2H), 7.08-7.14 (m, 1H), 7.22-7.28 (m, 1H), 8.53 (d, 1H), 8.64 (d, 1H). C18 H H Me 2-Cl- MeO— — 3.83 (s, 3H), 4.09 (s, 3,6-di- 3H), 7.08-7.13 (m, F- 1H), 7.20-7.27 (m, phenyl- 1H), 8.57 (d, 1H), 8.63 (d, 1H). C19 H H i-Pr 2-Cl- t-Bu(CO)O— — 1.20 (s, 9H), 1.67 (d, 3,6-di- 6H), 5.93 (sept, 1H), F- 7.04-7.11 (m, 1H), phenyl- 7.19-7.24 (m, 1H), 8.48 (d, 1H), 8.58 (d, 1H). C20 H H Me 2-Cl- t-Bu(CO)O— — 1.20 (s, 9H), 3.89 (s, 3,6-di- 3H), 7.06-7.11 (m, F- 1H), 7.19-7.26 (m, phenyl- 1H), 8.51 (d, 1H), 8.62 (d, 1H). C21 H H Et 2-Cl- t-Bu(CO)O— — 1.20 (s, 9H), 1.39 (t, 3,6-di- 3H), 4.60 (q, 2H), F- 7.06-7.12 (m, 1H), phenyl- 7.19-7.26 (m, 1H), 8.50 (d, 1H), 8.61 (d, 1H). C22 H H CH₂═CH—CH₂CH₂— 2- Me(CO)O— — 2.25 (s, 3H), 2.54 (q, F₃CO- 2H), 4.59 (t, 2H), phenyl- 4.99-5.11 (m, 2H), 5.82-5.93 (m, 1H), 7.35-7.41 (m, 3H), 7.47-7.51 (m, 1H), 8.49 (d, 1H), 8.59 (d, 1H). C23 H H i-Pr 2- t-Bu(CO)O— — 1.18 (s, 9H), 1.66 (d, F₃CO- 6H), 5.92 (sept, 1H), phenyl- 7.32-7.39 (m, 3H), 7.43-7.48 (m, 1H), 8.45 (d, 1H), 8.53 (d, 1H). C24 H H Ph—CH₂— 2- Me(CO)O— — 2.25 (s, 3H), 5.67 (d, F₃CO- 1H), 5.80 (d, 1H), phenyl- 7.21-7.31 (m, 3H), 7.35-7.43 (m, 3H), 7.47-7.55 (m, 3H), 8.49 (d, 1H), 8.59 (d, 1H). C25 H H allyl 2- t-Bu(CO)O— — 1.19 (s, 9H), 5.14- F₃CO- 5.18 (m, 2H), 5.19- phenyl- 5.27 (m, 2H), 5.97- 6.08 (m, 1H), 7.32- 7.40 (m, 3H), 7.43- 7.49 (m, 1H), 8.49 (d, 1H), 8.57 (d, 1H). C26 H H Et 2- t-Bu(CO)O— — 1.18 (s, 9H), 1.37 (t, F₃CO- 3H), 4.59 (q, 2H), phenyl- 7.33-7.41 (m, 3H), 7.43-7.50 (m, 1H), 8.48 (d, 1H), 8.58 (d, 1H). C27 H H Et 2- Me(CO)O— — 1.38 (t, 3H), 2.27 (s, F₃CO- 3H), 4.59 (q, 2H), phenyl- 7.35-7.42 (m, 3H), 7.47-7.51 (m, 1H), 8.49 (d, 1H), 8.59 (d, 1H). C28 H H Me 2- Et(CO)O— — 1.12 (t, 3H), 2.47- F₃CO- 2.64 (m, 2H), 3.87 phenyl- (s, 3H), 7.35-7.42 (m, 3H), 7.46-7.52 (m, 1H), 8.49 (d, 1H), 8.59 (d, 1H). C29 H H Me 2- t-Bu(CO)O— — 1.18 (s, 9H), 3.88 (s, F₃CO- 3H), 7.32-7.40 (m, phenyl- 3H), 7.45-7.50 (m, 1H), 8.49 (d, 1H), 8.59 (d, 1H). C30 H H allyl 2,6-di- Et(CO)O— — 1.11 (t, 3H), 2.56 (q, Cl- 2H), 5.16-5.29 (m, phenyl- 4H), 5.99-6.09 (m, 1H), 7.31-7.36 (m, 1H), 7.44 (d, 2H), 8.53 (d, 1H), 8.62 (d, 1H). C31 H H Et 2,6-di- Et(CO)O— — 1.10 (t, 3H), 1.39 (t, Cl- 3H), 2.56 (q, 2H), phenyl- 4.61 (q, 2H), 7.31- 7.36 (m, 1H), 7.44 (d, 2H), 8.52 (d, 1H), 8.63 (d, 1H). C32 H H Me 2,6-di- Et(CO)O— — 1.10 (t, 3H), 2.56 (q, Cl- 2H), 3.89 (s, 3H), phenyl- 7.32-7.37 (m, 1H), 7.46 (d, 2H), 8.53 (d, 1H), 8.64 (d, 1H). C33 H H Me 2,6-di- Me(CO)O— — 2.27 (s, 3H), 3.89 (s, Cl- 3H), 7.31-7.35 (m, phenyl- 1H), 7.44 (d, 2H), 8.51 (d, 1H), 8.62 (d, 1H). C34 H H MeO—CH₂CH₂— 2,6-di- Et(CO)O— — 1.10 (t, 3H), 2.55 (q, Cl- 2H), 3.38 (s, 3H), phenyl- 3.79 (t, 2H), 4.80 (t, 2H), 7.30-7.35 (m, 1H), 7.43 (d, 2H), 8.52 (d, 1H), 8.63 (d, 1H). C35 H H Me 2,6-di- (E)-Me—CH═CH—(CO)O— — 1.92 (dd, 3H), 3.89 Cl- (s, 3H), 5.98 (dd, phenyl- 1H), 7.10-7.19 (m, 1H), 7.32 (t, 1H), 7.44 (d, 2H), 8.53 (d, 1H), 8.63 (d, 1H). C36 H H Me 2,6-di- EtO(CO)O— — 1.36 (t, 3H), 3.92 (s, Cl- 3H), 4.32 (q, 2H), phenyl- 7.38 (t, 1H), 7.48 (d, 2H), 8.59 (d, 1H), 8.69 (d, 1H). C37 H H Me 2,6-di- t-Bu(CO)O— — 1.21 (s, 9H), 3.94 (s, Cl- 3H), 7.35 (t, 1H), phenyl- 7.48 (d, 2H), 8.57 (d, 1H), 8.66 (d, 1H). C38 H H Me 2,6-di- n-Pr(CO)O— — 0.83 (t, 3H), 1.57- Cl- 1.65 (m, 2H), 2.50 (t, phenyl- 2H), 3.89 (s, 3H), 7.30-7.34 (m, 1H), 7.43 (d, 2H), 8.51 (d, 1H), 8.62 (d, 1H). C39 H H allyl 2,6-di- EtO(CO)O— — 1.31 (t, 3H), 4.29 (q, Cl- 2H), 5.17 (d, 2H), phenyl- 5.19-5.28 (m, 2H), 5.99-6.09 (m, 1H), 7.32 (t, 1H), 7.43 (d, 2H), 8.53 (d, 1H), 8.61 (d, 1H). C40 H H n-Bu 2,6-di- Me(CO)O— — 0.99 (t, 3H), 1.47 Cl- (sext, 2H), 1.73-1.80 phenyl- (m, 2H), 2.27 (s, 3H), 4.50-4.57 (m, 2H), 7.32 (t, 1H), 7.44 (d, 2H), 8.50 (d, 1H), 8.61 (d, 1H). C41 H H Et 2,6-di- t-Bu(CO)O— — 1.21 (s, 9H), 1.42 (t, Cl- 3H), 4.66 (q, 2H), phenyl- 7.34 (t, 1H), 7.47 (d, 2H), 8.54 (d, 1H), 8.64 (d, 1H). C42 H H Me 2,6-di- MeO— — 3.84 (s, 3H), 4.10 (s, Cl-4- 3H), 7.70 (s, 2H), F₃C- 8.57 (d, 1H), 8.64 (d, phenyl- 1H). C43 H H Me 2,4-di- Me(CO)O— — 2.28 (s, 3H), 3.87 (s, Cl- 3H), 7.21 (d, 1H), phenyl- 7.33 (dd, 1H), 7.55 (d, 1H), 8.51 (d, 1H), 8.61 (d, 1H). C44 H H Me 2-Cl-4- Et(CO)O— — 1.13 (t, 3H), 2.48- F- 2.63 (m, 2H), 3.87 phenyl- (s, 3H), 7.08 (dt, 1H), 7.24-7.30 (m, 2H), 8.50 (d, 1H), 8.61 (d, 1H). C45 H H Et 2,3-di- i-Pr-(CO)O— — 1.05 (d, 3H), 1.15 (d, Cl- 3H), 1.40 (t, 3H), phenyl- 2.80 (m, 1H), 4.60 (q, 2H), 7.20 (d, 1H), 7.30 (t, 1H), 7.55 (d, 1H), 8.50 (d, 1H), 8.60 (d, 1H). C46 H H i-Pr—CH₂— 2- t-Bu(CO)O— — 0.95 (t, 6H), 1.18 (s, F₃CO- 9H), 2.31 (sept, 1H), phenyl- 4.39 (d, 2H), 7.31- 7.39 (m, 3H), 7.42- 7.49 (m, 1H), 8.45 (d, 1H), 8.54 (d, 1H). C47 H H c-Pr—CH₂— 2- t-Bu(CO)O— — 0.48-0.60 (m, 4H), F₃CO- 1.21 (s, 9H), 1.50- phenyl- 1.59 (m, 1H), 4.47 (d, 2H), 7.35-7.46 (m, 3H), 7.47-7.53 (m, 1H), 8.49 (s, 1H), 8.59 (s, 1H). C48 H H i-Pr—CH₂— 2-Cl- t-Bu(CO)O— — 0.99 (dd, 6H), 1.20 3,6-di- (s, 9H), 2.31 (sept, F- 1H), 4.39 (d, 2H), phenyl- 7.04-7.11 (m, 1H), 7.19-7.24 (m, 1H), 8.49 (d, 1H), 8.59 (d, 1H). C49 H H c-Pr—CH₂— 2-Cl- t-Bu(CO)O— — 0.48-0.57 (m, 4H), 3,6-di- 1.20 (s, 9H), 1.37- F- 1.44 (m, 1H), 4.44 phenyl- (d, 2H), 7.06-7.11 (m, 1H), 7.19-7.26 (m, 1H), 8.50 (d, 1H), 8.60 (d, 1H). C50 H H Me 2-Cl- t-Bu(CO)O— — 1.15 (s, 9H), 3.90 (s, phenyl- 3H), 7.30 (m, 3H), 7.50 (d, 1H), 8.50 (d, 1H), 8.60 (d, 1H). C51 H H Me 2-Cl- 4-O₂N—Ph—(CO)O— — 3.92 (s, 3H), 7.02 3,6-di- (m, 1H), 7.17 (m, F- 1H), 8.25 (d, 2H), phenyl- 8.32 (d, 2H), 8.50 (d, 1H), 8.70 (d, 1H). C52 H H Me naphth- t-Bu(CO)O— — 0.85 (s, 9H), 3.85 (s, 2-yl 3H), 7.35-7.45 (m, 4H), 7.55 (d, 1H), 7.80 (t, 2H), 8.45 (d, 1H), 8.55 (d, 1H). C53 H H Me 2-Cl- t-Bu—CH₂—(CO)O— — 0.92 (s, 9H), 2.41 (s, 3,6-di- 2H), 3.88 (s, 3H), F- 7.05 (m, 1H), 7.27 phenyl- (m, 1H), 8.52 (d, 1H), 8.64 (d, 1H). C54 H H Me 2-Cl- c-Pr(CO)O— — 1.01 (m, 2H), 1.12 3,6-di- (m, 2H), 1.72 (m, F- 1H), 3.88 (s, 3H), phenyl- 7.10 (m, 1H), 7.21 (m, 1H), 8.50 (d, 1H), 8.60 (d, 1H). C55 H H Me 2,3,6- t-Bu(CO)O— — 1.30 (s, 9H), 3.95 (s, tri-F- 3H), 7.00 (m, 1H), phenyl- 7.30 (m, 1H), 8.55 (d, 1H), 8.65 (d, 1H). C56 H H Me 2,6-di- i-Pr(CO)— — 1.10 (d, 6H), 3.68 Cl- (m, 1H), 3.92 (s, phenyl- 3H), 7.33 (m, 1H), 7.48 (d, 2H), 8.55 (d, 1H), 8.65 (d, 1H). C57 H H Et 2,3,6- i-Pr(CO)O— — 1.25 (d, 6H), 1.45 (t, tri-F- 3H), 2.90 (m, 1H), phenyl- 4.65 (q, 2H), 7.00 (m, 1H), 7.30 (m, 1H), 8.55 (d, 1H), 8.65 (d, 1H). C58 H H Me 2,3,6- i-Pr(CO)O— — 1.25 (d, 6H), 2.90 tri-F- (m, 1H), 3.95 (s, phenyl- 3H), 7.00 (m, 1H), 7.30 (m, 1H), 8.55 (d, 1H), 8.65 (d, 1H). C59 H H Et 2,3,6- t-Bu(CO)O— — 1.30 (s, 9H), 1.45 (t, tri-F- 3H), 4.65 (q, 2H), phenyl- 7.00 (m, 1H), 7.30 (m, 1H), 8.55 (d, 1H), 8.65 (d, 1H). C60 H H c-Pr—CH₂— 2-Cl- i-Pr(CO)O— — 0.42 (m, 4H) 1.32 (d, 3,6-di- 6H), 1.44 (m, 1H), F- 2.62 (m, 1H), 4.48 phenyl- (d, 2H), 7.05 (m, 1H), 7.35 (m, 1H), 8.55 (d, 1H), 8.72 (d, 1H). C61 H H Me 2,4-di- t-Bu(CO)O— — 1.20 (s, 9H), 3.90 (s, Cl- 1H), 7.25 (d, 1H), phenyl- 7.35 (d, 1H), 7.55 (s, 1H), 8.50 (d, 1H), 8.60 (d, 1H). C62 H H Et 2,4-di- t-Bu(CO)O— — 1.20 (d, 9H), 1.35 (t, Cl- 3H), 4.60 (q, 2H), phenyl- 7.25 (d, 1H), 7.35 (d, 1H), 7.55 (s, 1H), 8.50 (d, 1H), 8.60 (d, 1H). C63 H H Me 2,4-di- i-Pr(CO)O— — 1.10 (d, 3H), 1.20 (d, Cl- 3H), 2.80 (m, 1H), phenyl- 3.85 (s, 3H), 7.20 (d, 1H), 7.35 (d, 1H) 7.55 (s, 1H), 8.50 (d, 1H), 8.60 (d, 1H). C64 H H Et 2,4-di- i-Pr(CO)O— — 1.10 (d, 3H), 1.20 (d, Cl- 3H), 1.40 (t, 3H), phenyl- 2.80 (m, 1H), 4.60 (q, 2H), 7.25 (d, 1H), 7.35 (d, 1H), 7.55 (s, 1H), 8.50 (d, 1H), 8.60 (d, 1H). C65 H H Me 2,6-di- i-Pr(CO)O— — 0.99 (d, 6H), 1.10 (t, Et-4- 6H), 2.34-2.46 (m, Me- 7H), 2.61-2.73 (m, phenyl- 1H), 3.87 (s, 3H), 6.98 (s, 2H), 8.48 (d, 1H), 8.58 (d, 1H). C66 H H Et 3-Cl- Me(CO)O— — 1.39 (t, 3H), 2.319 phenyl- (s, 3H), 4.59 (q, 2H), 7.34-7.38 (m, 1H), 7.39-7.42 (m, 2H), 7.48 (s, 1H), 8.49 (d, 1H), 8.59 (d, 1H). C67 H H Et 4-Cl- Me(CO)O— — 1.38 (t, 3H), 2.31 (s, phenyl- 3H), 4.58 (q, 2H), 7.42-7.47 (m, 4H), 8.49 (d, 1H), 8.59 (d, 1H). C68 H H Me 2,3,5- i-Pr(CO)O— — 1.15 (d, 3H), 1.20 (d, tri-Cl- 3H), 2.80 (m, 1H), phenyl- 3.85 (s, 3H), 7.20 (d, 1H), 7.55 (s, 1H), 8.55 (d, 1H), 8.65 (d, 1H). C69 H H Me 2-MeO- i-Pr(CO)O— — 1.10 (d, 3H), 1.15 (d, phenyl- 3H), 2.75 (m, 1H), 3.80 (s, 3H), 3.85 (s, 3H), 7.00 (m, 2H), 7.20 (d, 1H) 7.40 (t, 1H), 8.45 (d, 1H), 8.55 (d, 1H). C70 H H Et 2-MeO- i-Pr(CO)O— — 1.10 (d, 3H), 1.15 (d, phenyl- 3H), 1.40 (t, 3H), 2.75 (m, 1H), 3.78 (s, 3H), 4.60 (q, 2H), 7.01 (m, 2H), 7.24 (d, 1H), 7.42 (t, 1H), 8.45 (d, 1H), 8.55 (d, 1H). C71 H H Me 2-Cl- i-Pr(CO)O— 5-N- 1.10 (bs, 6H), 2.72 3,6-di- oxide (m, 1H), 3.88 (s, F- 3H), 7.02 (m, 1H), phenyl- 7.21 (d, 1H), 7.92 (m, 1H), 8.42 (d, 1H). C72 H H Et 3,4-di- Me(CO)O— — 1.38 (t, 3H), 2.33 (s, Cl- 3H), 4.59 (q, 2H), phenyl- 7.33 (dd, 1H), 7.53 (d, 1H), 7.60 (d, 1H), 8.49 (d, 1H), 8.59 (d, 1H). C73 H H Me 2-Cl- Me—C≡C—CH₂O(CO)O— — 1.82 (t, 3H), 3.88 (s, 3,6-di- 3H), 4.72 (q, 2H), F- 7.02 (m, 1H), 7.21 phenyl- (m, 1H), 8.50 (d, 1H), 8.62 (d, 1H). C74 H H c-Pr—CH₂— 2-Cl- Me—C≡C—CH₂O(CO)O— — 0.51 (s, 4H), 1.39 3,6-di- (m, 1H), 1.88 (t, 3H), F- 4.32 (d, 2H), 4.72 (q, phenyl- 2H), 7.05 (m, 1H), 7.21 (m, 1H), 8.53 (d, 1H), 8.62 (d, 1H). C75 H H Me 2,4,6- i-Pr(CO)O— — 0.99 (d, 6H), 2.08 (s, tri-Me- 6H), 2.28 (s, 3H), phenyl- 2.68 (sept, 1H), 3.86 (s, 3H), 6.90 (bs, 2H), 8.47 (1d, 1H), 8.57 (d, 1H). C76 H H Me 6-Cl-2- i-Pr(CO)O— — 1.02 (d, 3H), 1.07 (d, F₃C- 3H), 2.71 (sept, 1H), phenyl- 3.86 (s, 3H), 7.51 (t, 1H), 7.71 (d, 2H), 8.50 (d, 1H), 8.61 (d, 1H). C77 H H Me 2-Cl-3- i-Pr(CO)O— — 1.04 (d, 3H), 1.10 (d, F₃C- 3H), 2.73 (m, 1H), phenyl- 3.88 (s, 3H), 7.45 (m, 2H), 7.81 (m, 1H), 8.51 (d, 1H), 8.65 (d, 1H). C78 H H Et 2-Cl-3- i-Pr(CO)O— — 1.03 (d, 3H), 1.10 (d, F₃C- 3H), 1.37 (t, 3H), phenyl- 2.72 (m, 1H), 4.57 (q, 2H), 7.42 (m, 2H), 7.78 (dd, 1H), 8.50 (d, 1H), 8.62 (d, 1H). C79 H H Me 2,3,6- i-Pr(CO)O— — 1.25 (d, 6H), 2.80 tri-Cl- (m, 1H), 3.90 (s, phenyl- 3H), 7.40 (d, 1H), 7.50 (d, 1H), 8.50 (d, 1H), 8.60 (d, 1H). C80 H H Et 6-Cl-2- i-Pr(CO)O— — 1.02 (d, 3H), 1.07 (d, F₃C- 3H), 1.34 (t, 3H), phenyl- 2.71 (sept, 1H), 4.58 (q, 2H), 7.50 (t, 1H), 7.70 (d, 2H), 8.48 (d, 1H), 8.60 (d, 1H). C81 H H Et 2,4,6- Me(CO)O— — 1.37 (t, 3H), 2.09 (s, tri-Me- 6H), 2.18 (s, 3H), phenyl- 2.32 (s, 3H), 4.59 (q, 2H), 6.93 (s, 2H), 8.48 (d, 1H), 8.58 (d, 1H). C82 H Cl Me 2-Cl- i-Pr(CO)O— — 1.05 (m, 6H), 2.78 3,6-di- (m, 1H), 3.82 (s, F- 3H), 7.05 (m, 1H), phenyl- 7.20 (m, 1H), 8.42 (s, 1H). C83 Cl H Me 2-Cl- i-Pr(CO)O— — 1.17 (m, 6H), 2.80 3,6-di- (m, 1H), 3.82 (s, F- 3H), 7.05 (m, 1H), phenyl- 7.20 (m, 1H), 8.60 (s, 1H). C84 H H Me 2-Cl- Ph(CO)O— — 3.90 (s, 3H), 7.04 3,6-di- (m, 1H), 7.15 (m, F- 1H), 7.46 (t, 2H), phenyl- 7.62 (t, 1H), 8.07 (m, 2H), 8.47 (d, 1H), 8.62 (d, 1H). C85 H H Me 2-Cl- 3-MeO—Ph(CO)O— — 3.82 (s, 3H), 3.90 (s, 3,6-di- 3H), 7.04 (m, 1H), F- 7.15 (m, 2H), 7.36 (t, phenyl- 1H), 7.56 (m, 1H), 7.68 (m, 1H), 8.48 (d, 1H), 8.62 (d, 1H). C86 H H Me 2-Cl- furan-2-yl-(CO)O— — 3.88 (s, 3H), 6.56 3,6-di- (m, 1H), 7.05 (m, F- 1H), 7.17 (m, 1H), phenyl- 7.34 (m, 1H), 7.65 (m, 1H), 8.49 (d, 1H), 8.63 (d, 1H). C87 H H Me 2-Cl- but-2-yl-(CO)O— — 0.80 (m, 3H), 1.13 3,6-di- (dd, 3H), 1.45 (m, F- 1H), 1.65 (m, 1H), phenyl- 2.59 (m, 1H), 3.87 (s, 3H), 7.07 (m, 1H), 7.21 (m, 1H), 8.50 (d, 1H), 8.61 (d, 1H). C88 H H Me 2-Cl- octyl-(CO)O— — 0.88 (t, 3H), 1.23 (m, 3,6-di- 12H), 2.52 (t, 2H), F- 3.86 (s, 3H), 7.07 phenyl- (m, 1H), 7.21 (m, 1H), 8.50 (d, 1H) 8.62 (d, 1H). C89 H H Me 2-Cl- pent-3-yl-(CO)O— — 0.79 (t, 6H), 1.51 (m, 3,6-di- 2H), 1.63 (m, 2H), F- 2.40 (m, 1H), 3.86 phenyl- (s, 3H), 7.06 (m, 1H), 7.20 (m, 1H), 8.49 (d, 1H), 8.60 (d, 1H). C90 H H Me 2-Cl- Me₂C═CH—(CO)O— — 1.94 (s, 3H), 2.11 (s, 3,6-di- 3H), 3.86 (s, 3H), F- 5.86 (s, 1H), 7.06 phenyl- (m, 1H), 7.20 (m, 1H), 8.51 (d, 1H), 8.60 (d, 1H). C91 H H Me 2-Cl- thio-phen-2-yl-(CO)O— — 3.88 (s, 3H), 7.04 3,6-di- (m, 1H), 7.12 (dd, F- 1H), 7.16 (m, 1H), phenyl- 7.65 (dd, 1H), 7.90 (dd, 1H), 8.50 (d, 1H), 8.62 (d, 1H). C92 H H Me 2-Cl- hept-3-yl-(CO)O— — 0.82 (m, 6H), 1.18 3,6-di- (m, 4H), 1.54 (m, F- 4H), 2.45 (m, 1H), phenyl- 3.86 (s, 3H), 7.07 (m, 1H), 7.20 (m, 1H), 8.48 (d, 1H), 8.60 (d, 1H). C93 H H Me 2-Cl- i-Pr—CH₂—(CO)O— — 0.86 (d, 3H), 0.88 (d, 3,6-di- 3H), 2.07 (m, 1H), F- 2.41 (m, 1H), 3.88 phenyl- (s, 3H), 7.08 (m, 1H), 7.21 (m, 1H), 8.52 (d, 1H), 8.63 (d, 1H). C94 H H Me 2-Cl- 1-Ph-prop-1-yl-(CO)O— — 0.92 (m, 3H), 1.80 3,6-di- (m, 1H), 2.16 (m, F- 1H), 3.70 (m, 1H), phenyl- 3.86 (s, 3H), 6.80 (m, 1H), 6.98 (m, 1H), 7.12 (m, 2H), 7.21 (m, 3H), 8.48 (m, 1H), 8.62 (m, 1H). C95 H H Me 2-Cl- pent-2-yl-(CO)O— — 0.82 (t, 3H), 1.15- 3,6-di- 1.22 (m, 5H), 1.38 F- (m, 1H), 1.58-1.65 phenyl- (m, 1H), 2.67 (m, 1H), 3.88 (s, 3H), 7.08 (m, 1H), 7.22 (m, 1H), 8.52 (d, 1H), 8.62 (d, 1H). C96 H H Me 2-Cl- hept-4-yl-(CO)O— — 0.85-0.89 (m, 6H), 3,6-di- 1.24 (m, 4H), 1.47 F- (m, 3H), 1.65 (m, phenyl- 2H), 3.92 (s, 3H), 7.12 (m, 1H), 7.27 (m, 1H), 8.54 (d, 1H), 8.66 (d, 1H). C97 H H Me 2-Cl- c-Pe-CH₂—(CO)O— — 1.00-1.6 (m, 8H), 3,6-di- 2.17 (m, 1H), 2.53 F- (d, 2H), 3.87 (s, 3H), phenyl- 7.09 (m, 1H), 7.23 (m, 1H), 8.52 (d, 1H), 8.62 (d, 1H). C98 H H Me 2-Cl- 2,4,4-tri-methyl-pent-1-yl-(CO)O— — 0.81-0.92 (m, 10H), 3,6-di- 1.01-1.29 (m, 3H), F- 2.35 (m, 1H), 2.62 phenyl- (m, 1H), 3.88 (s, 3H), 7.10 (m, 1H), 7.23 (m, 1H), 8.52 (d, 1H), 8.63 (d, 1H). C99 H H Me 2-Cl-6- t-Bu—(CO)O— — 1.18 (s, 9H), 3.88 (s, F-3- 3H), 7.25 (m, 1H), O₂N- 8.00 (m, 1H), 8.50 phenyl- (d, 1H), 8.65 (d, 1H). C100 H H Me 2-Cl- 3,5-di-methyl-isoxa-zol-4-yl-(CO)O— — 2.37 (s, 3H), 2.62 (s, 3,6-di- 3H), 3.91 (s, 3H), F- 7.09 (m, 1H), 7.24 phenyl- (m, 1H), 8.52 (d, 1H), 8.66 (d, 1H). C101 H H Me 2-Cl- dec-9-en-1-yl-(CO)O— — 1.22 (m, 8H), 1.36 3,6-di- (m, 2H), 1.58 (m, F- 2H), 2.03 (m, 2H), phenyl- 2.52 (t, 2H), 3.86 (s, 3H), 4.95 (m, 2H), 5.80 (m, 1H), 7.08 (m, 1H), 7.22 (m, 1H), 8.50 (d, 1H), 8.62 (d, 1H). C102 H H Me 2-Cl- 2,5-di-methyl-furan-3-yl-(CO)O— — 2.28 (s, 3H), 2.52 (s, 3,6-di- 3H), 3.93 (s, 3H), F- 6.29 (s, 1H), 7.10 phenyl- (m, 1H), 7.22 (m, 1H), 8.55 (d, 1H), 8.66 (d, 1H). C103 H H Et 2,4,6- i-Pr(CO)O— — 0.99 (d, 6H), 1.35 (t, tri-Me- 3H), 2.07 (s, 6H), phenyl- 2.28 (s, 3H), 2.68 (sept, 1H), 4.58 (q, 2H), 6.90 (bs, 2H), 8.47 (d, 1H), 8.56 (d, 1H). C104 H H Et 3,5-di- Me(CO)O— — 1.49 (t, 3H), 2.32 (s, F₃C- 3H), 4.60 (q, 2H), phenyl- 7.94 (s, 1H), 8.00 (s, 2H), 8.52 (d, 1H), 8.64 (d, 1H). C105 H H Me 2-Cl- t-Bu(CO)O— — 1.45 (s, 9H), 3.86 (s, 3,6-di- 3H), 7.08 (m, 1H), F- 7.22 (m, 1H), 8.53 phenyl- (d, 1H), 8.63 (d, 1H). C106 H H Me 2-MeO- t-Bu(CO)O— — 1.20 (s, 9H), 3.80 (s, phenyl- 3H), 3.85 (s, 3H), 7.00 (m, 2H), 7.20 (d, 1H) 7.40 (m, 1H), 8.45 (d, 1H), 8.55 (d, 1H). C107 H H Et 2,3,6- i-Pr(CO)O— — 1.15 (d, 6H), 1.40 (t, tri-Cl- 3H), 2.80 (m, 1H), phenyl- 4.60 (q, 2H), 7.40 (d, 1H), 7.50 (d, 1H), 8.50 (d, 1H), 8.60 (d, 1H). C108 H H Me 2,3,6- t-Bu(CO)O— — 1.20 (s, 9H), 3.90 (s, tri-Cl- 3H), 7.40 (d, 1H), phenyl- 7.50 (d, 1H), 8.50 (d, 1H), 8.60 (d, 1H). C109 H H Me 2-F₃C- t-Bu(CO)O— — 1.15 (s, 9H), 3.90 (s, phenyl- 3H), 7.35 (d, 1H), 7.60 (t, 1H), 7.65 (t, 1H), 7.85 (d, 1H), 8.55 (d, 1H), 8.65 (d, 1H). C110 H H Me 2-F₃C- i-Pr(CO)O— — 0.95 (d, 3H), 1.10 (d, phenyl- 3H), 2.80 (m, 1H), 3.90 (s, 3H), 7.30 (d, 1H), 7.60 (t, 1H), 7.65 (t, 1H), 7.80 (d, 1H), 8.50 (d, 1H), 8.60 (d, 1H). C111 H H Me 2-Cl- i-PrS(O)₂O— — 1.45 (d, 6H), 3.71 3,6-di- (m, 1H), 3.88 (s, F- 3H), 7.05 (m, 1H), phenyl- 7.22 (m, 1H), 8.62 (d, 1H), 8.69 (d, 1H). C112 H H Et 2-Cl- t-Bu—CH₂—(CO)O— — 0.98 (bs, 9H), 1.40 3,6-di- (t, 3H), 1.48 (s, 2H), F- 4.65 (q, 2H), 7.10 phenyl- (m, 1H), 7.21 (m, 1H), 8.52 (d, 1H), 8.65 (d, 1H). C113 H H allyl 2-Cl- allyl-(CO)O— — 4.97 (m, 2H), 5.08- 3,6-di- 5.25 (m, 6H), 5.86 F- (m, 1H), 6.00 (m, phenyl- 1H), 7.07 (m, 1H), 7.19 (m, 1H), 8.54 (d, 1H), 8.60 (d, 1H). C114 H H Me 2-Cl-6- i-Pr(CO)— — 1.10 (d, 3H), 1.11 (d, F-5-Me- 3H), 2.27 (d, 3H), phenyl- 2.77 (sept, 1H), 3.86 (s, 3H), 7.19 (d, 2H), 8.49 (d, 1H), 8.59 (d, 1H). C115 H H Et 2-Cl-6- i-Pr(CO)O— — 1.10 (d, 3H), 1.11 (d, F-5-Me- 3H), 1.37 (t, 3H), phenyl- 2.27 (d, 3H), 2.77 (sept, 1H), 4.58 (q, 2H), 7.18 (m, 2H), 8.48 (d, 1H), 8.59 (d, 1H). C116 H H Me 2-Cl-6- t-Bu(CO)O— — 1.17 (s, 9H), 2.27 (d, F-5-Me- 3H), 3.87 (s, 3H), phenyl- 7.19 (m, 2H), 8.49 (d, 1H), 8.58 (d, 1H). C117 H H Et 2-Cl-6- t-Bu(CO)O— — 1.17 (s, 9H), 1.37 (t, F-5-Me- 3H), 2.27 (d, 3H), phenyl- 4.59 (q, 2H), 7.19 (m, 2H), 8.48 (d, 1H), 8.58 (d, 1H). C118 H H Me 2-Cl-5- i-Pr(CO)O— — 1.05 (d, 3H), 1.12 (d, F₃C- 3H), 2.75 (sept, 1H), phenyl- 3.87 (s, 3H), 7.54 (s, 1H), 7.63 (s, 2H), 8.51 (d, 1H), 8.61 (d, 1H). C119 H H Et 2-Cl-5- i-Pr(CO)O— — 1.06 (d, 3H), 1.13 (d, F₃C- 3H), 1.37 (t, 3H), phenyl- 2.75 (sept, 1H), 4.59 (q, 2H), 7.56 (s, 1H), 7.63 (s, 2H), 8.50 (d, 1H), 8.61 (d, 1H). C120 H H Me 2,6-di- t-Bu(CO)O— — 1.18 (s, 9H), 3.88 (s, Cl-4- 3H), 7.69 (s, 2H), F₃C- 8.50 (d, 1H), 8.62 (d, phenyl- 1H). C121 H H Me 2-Cl-5- t-Bu(CO)O— — 1.14 (s, 9H), 3.87 (s, F₃C- 3H), 7.54 (s, 1H), phenyl- 7.63 (m, 2H), 8.50 (d, 1H), 8.60 (d, 1H). C122 H H Et 2-Cl-5- t-Bu(CO)O— — 1.15 (s, 9H), 1.37 (t, F₃C- 3H), 4.59 (q, 2H), phenyl- 7.56 (s, 1H), 7.62 (s, 2H), 8.50 (d, 1H), 8.60 (d, 1H). C123 H H Me 2-Cl-3- t-Bu(CO)O— — 1.15 (s, 9H), 3.90 (s, F₃C- 3H), 7.50 (m, 2H), phenyl- 7.80 (m, 1H), 8.50 (d, 1H), 8.60 (d, 1H). C124 H H c-Pr—CH₂— 2-Cl-3- i-Pr(CO)O— — 0.50 (m, 4H), 1.05 F₃C- (d, 3H), 1.15 (d, 3H), phenyl- 1.40 (m, 1H), 2.80 (m, 1H), 4.45 (m, 2H), 7.50 (m, 2H), 7.80 (d, 1H), 8.50 (d, 1H), 8.60 (d, 1H). C125 H H allyl 2-Cl-3- i-Pr(CO)O— — 1.05 (d, 3H), 1.15 (d, F₃C- 3H), 2.80 (m, 1H), phenyl- 5.15 (d, 2H), 5.25- 5.30 (m, 2H), 6.00 (m, 1H), 7.50 (m, 2H), 7.80 (d, 1H), 8.50 (d, 1H), 8.60 (d, 1H). C126 H H Me 2-Cl-6- i-Pr(CO)O— — 1.10 (d, 6H), 2.40 (s, F-3-Me- 3H), 2.80 (m, 1H), phenyl- 3.90 (s, 3H), 7.00 (t, 1H), 7.30 (m, 1H), 8.50 (d, 1H), 8.60 (d, 1H). C127 H H Et 2-Cl-6- i-Pr(CO)O— — 1.15 (d, 6H), 1.45 (t, F-3-Me- 3H), 2.45 (s, 3H), phenyl- 2.80 (m, 1H), 4.60 (q, 2H), 7.05 (t, 1H), 7.30 (t, 1H), 8.55 (d, 1H), 8.65 (d, 1H). C128 H H Me 2-Cl-6- t-Bu(CO)O— — 1.15 (s, 9H), 2.40 (s, F-3-Me- 3H), 3.90 (s, 3H), phenyl- 7.00 (t, 1H), 7.30 (t, 1H), 8.50 (d, 1H), 8.60 (d, 1H). C129 H H Et 2,6-di- t-Bu(CO)O— — 1.16 (s, 9H), 1.38 (t, Cl-4- 3H), 4.62 (q, 2H), F₃C- 7.68 (s, 2H), 8.50 (d, phenyl- 1H), 8.62 (d, 1H). C130 H H c-Pr—CH₂— -2,6-di- t-Bu(CO)O— — 0.48 (m, 4H), 1.17 Cl-4- (s, 9H), 1.41 (m, F₃C- 1H), 4.47 (d, 2H), phenyl- 7.68 (s, 2H), 8.50 (d, 1H), 8.60 (d, 1H). C131 H H c-Bu—CH₂— 2-Cl- t-Bu(CO)O— — 1.22 (s, 9H), 1.82- 3,6-di- 2.12 (m, 6H), 2.94 F- (m, 1H), 4.17 (m, phenyl- 2H), 7.05 (m, 1H), 7.23 (m, 1H), 8.50 (d, 1H), 8.62 (d, 1H). C132 H H Et 2-Cl-3- t-Bu(CO)O— — 1.15 (s, 9H), 1.40 (t, F₃C- 3H), 4.60 (q, 2H), phenyl- 7.50 (m, 2H), 7.80 (d, 1H), 8.50 (d, 1H), 8.60 (d, 1H). C133 H H Me 2,5-di- i-Pr(CO)O— — 1.00 (d, 6H), 2.15 (s, Me- 3H), 2.30 (s, 3H), phenyl- 2.70 (m, 1H), 3.90 (s, 3H), 6.95 (s, 1H), 7.10 (d, 1H), 7.20 (d, 1H), 8.50 (d, 1H), 8.60 (d, 1H). C134 H H Me 2,5-di- t-Bu(CO)O— — 1.10 (s, 9H), 2.15 (s, Me- 3H), 2.30 (s, 3H), phenyl- 3.85 (s, 3H), 6.95 (s, 1H), 7.10 (d, 1H), 7.15 (t, 1H), 8.50 (d, 1H), 8.60 (d, 1H). C135 H H Et 2,5-di- t-Bu(CO)O— — 1.10 (s, 9H), 1.40 (t, Me- 3H), 2.15 (s, 3H), phenyl- 2.30 (s, 3H), 4.60 (q, 2H), 6.95 (s, 1H), 7.10 (d, 1H), 7.15 (d, 1H), 8.50 (d, 1H), 8.60 (d, 1H). C136 H H Me 2-I- t-Bu(CO)O— — 1.15 (s, 9H), 3.90 (s, phenyl- 3H), 7.10 (t, 1H), 7.20 (d, 1H), 7.40 (t, 1H), 7.95 (d, 1H), 8.50 (d, 1H), 8.60 (d, 1H). C137 H H Me phenyl- t-Bu(CO)O— — 1.21 (s, 9H), 3.88 (s, 3H), 7.40 (s, 5H), 8.46 (d, 1H), 8.52 (d, 1H). C138 H H Me 2,6-di- t-Bu(CO)O— — 1.18 (s, 9H), 3.87 (s, Cl-4- 3H), 7.31 (d, 1H), F₃CO- 7.48 (d, 1H), 8.50 (d, phenyl- 1H), 8.61 (d, 1H). C139 H H Et 2,6-di- t-Bu(CO)O— — 1.19 (s, 9H), 1.34 (t, Cl-4- 3H), 4.56 (q, 2H), F₃CO- 7.31 (d, 1H), 7.47 (d, phenyl- 1H), 8.49 (d, 1H), 8.61 (d, 1H). C140 H H Me 2-O₂N- t-Bu(CO)O— — 1.21 (s, 9H), 3.84 (s, 4-F₃C- 3H), 7.60 (d, 1H), phenyl- 7.92 (dd, 1H), 8.49 (d, 1H), 8.51 (d, 1H), 8.60 (d, 1H). C141 H H Et 2-O₂N- t-Bu(CO)O— — 1.21 (s, 9H), 1.31 (t, 4-F₃C- 3H), 4.55 (q, 2H), phenyl- 7.60 (d, 1H), 7.92 (dd, 1H), 8.46 (d, 1H), 8.50 d, 1H), 8.62 (d, 1H). C142 H H Me 2-Cl-5- i-Pr(CO)O— — 1.09 (d, 3H), 1.15 (d, F- 3H), 2.78 (sept, 1H), phenyl- 3.86 (s, 3H), 7.01 (dd, 1H), 7.09 (dt, 1H), 7.47 (dd, 1H), 8.50 (d, 1H), 8.60 (d, 1H). C143 H H Me 2-Cl-5- t-Bu(CO)O— — 1.17 (s, 9H), 3.86 (s, F- 3H), 7.02 (dd, 1H), phenyl- 7.08 (dt, 1H), 7.46 (dd, 1H), 8.50 (d, 1H), 8.59 (d, 1H). C144 H H Me 3-Br-2- i-Pr(CO)O— — 1.12 (d, 3H), 1.13 (d, Cl-6-F- 3H), 2.79 (sept, 1H), phenyl- 3.87 (s, 3H), 7.02 (t, 1H), 7.69 (dd, 1H), 8.51 (d, 1H), 8.61 (d, 1H). C145 H H Me 3-Br-2- t-Bu(CO)O— — 1.18 (s, 9H), 3.87 (s, Cl-6-F- 3H), 7.01 (t, 1H), phenyl- 7.68 (dd, 1H), 8.51 (d, 1H), 8.60 (d, 1H). C146 H H Me 2-Br- t-Bu(CO)O— — 1.18 (s, 9H), 3.92 (s, phenyl- 3H), 7.31 (m, 2H), 7.42 (m, 1H), 7.73 (dd, 1H), 8.54 (d, 1H), 8.62 (d, 1H). C147 H H Et 2-Br-4- t-Bu(CO)O— — 1.20 (s, 9H), 1.41- F₃C- 1.44 (t, 3H), 4.62- phenyl- 4.67 (q, 2H), 7.45- 7.47 (d, 1H), 7.68- 7.70 (d, 1H), 8.01 (s, 1H), 8.56 (d, 1H), 8.66 (d, 1H). C148 H H Me 2,4-di- i-Pr(CO)O— — 1.14 (d, 3H), 1.19 (d, Cl-5-F- 3H), 2.80 (sept, 1H), phenyl- 3.86 (s, 3H), 7.10 (d, 1H), 7.57 (d, 1H), 8.50 (d, 1H), 8.61 (d, 1H). C149 H H Me 2,4-di- t-Bu(CO)O— — 1.21 (s, 9H), 3.86 (s, Cl-5-F- 3H), 7.10 (d, 1H), phenyl- 7.57 (d, 1H), 8.50 (d, 1H), 8.60 (d, 1H). C150 H H Et 2-Cl-5- i-Pr(CO)O— — 1.09 (d, 3H), 1.15 (d, F- 3H), 1.36 (t, 3H), phenyl- 2.77 (sept, 1H), 4.57 (q, 2H), 7.02 (dd, 1H), 7.08 (m, 1H), 7.45 (dd, 1H), 8.48 (d, 1H), 8.59 (d, 1H). C151 H H Et 2-Cl-5- t-Bu(CO)O— — 1.18 (s, 9H), 1.37 (t, F- 3H), 4.58 (q, 2H), phenyl- 7.00-7.11 (m, 2H), 7.46 (dd, 1H), 8.49 (d, 1H), 8.59 (d, 1H). C152 H H Et 2,4-di- i-Pr(CO)O— — 1.14 (d, 3H), 1.19 (d, Cl-5-F- 3H), 1.36 (t, 3H), phenyl- 2.79 (sept, 1H), 4.57 (q, 2H), 7.11 (d, 1H), 7.56 (d, 1H), 8.49 (d, 1H), 8.60 (d, 1H). C153 H H Et 2,4-di- t-Bu(CO)O— — 1.21 (s, 9H), 1.36 (t, Cl-5-F- 3H), 4.57 (q, 2H), phenyl- 7.12 (d, 1H), 7.56 (d, 1H), 8.49 (d, 1H), 8.59 (d, 1H). C154 H H Et 3-Br-2- i-Pr(CO)O— — 1.12 (d, 3H), 1.13 (d, Cl-6-F- 3H), 1.37 (t, 3H), phenyl- 2.78 (sept, 1H), 4.58 (q, 2H), 7.02 (t, 1H), 7.68 (dd, 1H), 8.50 (d, 1H), 8.61 (d, 1H). C155 H H Et 3-Br-2- t-Bu(CO)O— — 1.18 (s, 9H), 1.36 (t, Cl-6-F- 3H), 4.58 (q, 2H), phenyl- 7.01 (t, 1H), 7.67 (dd, 1H), 8.49 (d, 1H), 8.59 (d, 1H). C156 H H Et 5-(4′- i-Pr(CO)O— — 0.96 (m, 6H), 1.39 (t, Cl-Ph)- 3H), 2.24 (s, 3H), 2-Me- 2.67-2.77 (sept, 1H), phenyl- 4.61 (q, 2H), 7.34- 7.40 (m, 4H), 7.48- 7.52 (m, 3H), 8.50 (d, 1H), 8.59 (d, 1H). C157 H H Me 2-Cl- t-Bu(CO)O— — 1.20 (s, 9H), 3.88 (s, 3,6-di- 3H), 8.01 (dd, 1H), F-5- 8.55 (d, 1H), 8.65 (d, O₂N- 1H). phenyl- C158 H H Et 2-Cl- t-Bu(CO)O— — 1.20 (s, 9H), 1.36 (t, 3,6-di- 3H), 4.58 (q, 2H), F-5- 8.02 (dd, 1H), 8.51 O₂N- (d, 1H), 8.65 (d, 1H). phenyl C159 H H Me 2-MeO- i-Pr(CO)O— — 1.08 (d, 3H), 1.13 (d, 5- 3H), 2.74 (sept, 1H), F₃CO- 3.82 (s, 3H), 3.84 (s, phenyl- 3H), 7.05 (d, 1H), 7.46 (s, 1H), 7.65 (dd, 1H), 8.47 (d, 1H), 8.56 (d, 1H). C160 H H Et 2-MeO- i-Pr(CO)O— — 1.08 (d, 3H), 1.14 (d, 5- 3H), 1.37 (t, 3H), F₃CO- 2.75 (sept, 1H), 3.83 phenyl- (s, 3H), 4.57 (m, 2H), 7.05 (d, 1H), 7.48 (s, 1H), 7.65 (dd, 1H), 8.46 (d, 1H), 8.56 (d, 1H). C161 H H Me 6-Me-2- t-Bu(CO)O— — 1.07 (s, 9H), 2.28 (s, O₂N- 3H), 3.91 (s, 3H), phenyl- 7.57-7.59 (d, 1H), 7.46-7.50, m, 1H), 7.96-7.98 (d, 1H), 8.48 (d, 1H), 8.59 (d, 1H). C162 H H Me 2-Cl- t-Bu(CO)O— — 1.21 (s, 9H), 3.83 (s, 4,5-di- 3H), 7.12 (dd, 1H), F- 7.37 (dd, 1H), 8.51 phenyl- (d, 1H) 8.62 (d, 1H). C163 H H Me 2,3-di- t-Bu(CO)O— — 1.19 (s, 9H), 3.88 (s, Cl-6-F- 3H), 7.03 (t, 1H), phenyl- 7.52 (dd, 1H), 8.50 (d, 1H), 8.62 (d, 1H). C164 H H Me 2- i-Pr(CO)O— — 1.10 (d, 3H), 1.15 (d, F₂HCO- 3H), 2.76 (sept, 1H), phenyl- 3.85 (s, 3H), 6.47 (dd, 1H), 7.29 (m, 3H), 7.44 (m, 1H), 8.48 (d, 1H), 8.58 (d, 1H). C165 H H Et 2- i-Pr(CO)O— — 1.11 (d, 3H), 1.16 (d, F₂HCO- 3H), 1.35 (t, 3H), phenyl- 2.77 (sept, 1H), 4.56 (q, 2H), 6.48 (dd, 1H), 7.29 (m, 3H), 7.44 (m, 1H), 8.47 (d, 1H), 8.57 (d, 1H). C166 H H Me 2-MeO- t-Bu(CO)O— — 1.16 (s, 9H), 3.83 (s, 5- 3H), 3.85 (s, 3H), F₃CO- 7.05 (d, 1H), 7.46 (s, phenyl- 1H), 7.66 (dd, 1H), 8.47 (d, 1H), 8.56 (d, 1H). C167 H H Et 2-MeO- t-Bu(CO)O— — 1.16 (s, 9H), 1.36 (t, 5- 3H), 3.82 (s, 3H), F₃CO- 4.57 (m, 2H), 7.04 phenyl- (d, 1H), 7.48 (s, 1H), 7.64 (dd, 1H), 8.45 (d, 1H), 8.55 (d, 1H). C168 H H Me 2- t-Bu(CO)O— — 1.17 (s, 9H), 3.84 (s, F₂HCO- 3H), 6.47 (dd, 1H), phenyl- 7.27 (m, 3H), 7.43 (m, 1H), 8.47 (d, 1H), 8.56 (d, 1H). C169 H H Et 2- t-Bu(CO)O— — 1.18 (s, 9H), 1.35 (t, F₂HCO- 3H), 4.57 (q, 2H), phenyl- 6.48 (dd, 1H), 7.27 (m, 3H), 7.43 (m, 1H), 8.47 (d, 1H), 8.56 (d, 1H). C170 H Me Me 2-Cl- t-Bu(CO)O— — 1.20 (s, 9H), 2.70 (s, 3,6-di- 3H), 3.90 (s, 3H), F- 7.10 (m, 1H), 7.20 phenyl- (m, 1H), 8.40 (s, 1H). C171 H H HO—CH₂CH₂— 2-Cl- i-Pr-(CO)O— — 1.14-1.16 (m, 6H), 3,6-di- 2.77-2.84 (m, 1H), F- 2.71 (m, 1H), 4.03- phenyl- 4.05 (m, 2H), 4.79- 4.82 (m, 2H), 7.07- 7.12 (m, 1H), 7.21- 7.27 (m, 1H), 8.55 (d, 1H), 8.60 (d, 1H). C172 H H Me 2-Cl-6- t-Bu-(CO)O— — 1.17 (s, 9H), 3.88 (s, F- 3H), 7.10 (dt, 1H), phenyl- 7.30-7.41 (m, 2H), 8.49 (d, 1H), 8.62 (d, 1H). C173 Me Me Me 2-Cl- t-Bu(CO)O— — 1.25 (s, 9H), 2.60 (s, 3,6-di- 3H), 2.70 (s, 3H), F- 3.90 (s, 3H), 7.10 phenyl- (m, 1H), 7.20 (m, 1H). C174 H H N≡C—CH₂— 2-Cl- t-Bu(CO)O— — 1.21 (s, 9H), 5.42 (s, 3,6-di- 2H), 7.08-7.14 (m, F- 1H), 7.23-7.29 (m, phenyl- 1H), 8.63 (d, 1H), 8.68 (d, 1H). C175 Me H Me 2-Cl- t-Bu—(CO)O— — 1.20 (s, 9H), 2.60 (s, 3,6-di- 3H), 3.85 (s, 3H), F- 7.10 (m, 1H), 7.20 phenyl- (m, 1H), 8.50 (s, 1H). C176 H H HC≡C—CH₂— 2-Cl- t-Bu—(CO)O— — 1.21 (s, 9H), 2.21 (t, 3,6-di- 1H), 5.30 (d, 2H), F- 7.06-7.11 (m, 1H), phenyl- 7.19-7.26 (m, 1H), 8.57 (d, 1H), 8.68 (d, 1H). C177 H H MeO—CH₂— 2-Cl- t-Bu(CO)O— — 1.20 (s, 9H), 3.53 (s, 3,6-di- 3H), 5.98 (s, 2H), F- 7.06-7.12 (m, 1H), phenyl- 7.20-7.26 (m, 1H), 8.55 (d, 1H), 8.64 (d, 1H). C178 H H Me 2,6-di- Me—C≡C—CH₂O(CO)O— — 1.88 (t, 3H), 3.90 (s, Cl- 3H), 4.72 (q, 2H), phenyl- 7.32 (t, 1H), 7.41 (dd, 2H), 8.50 (d, 1H), 8.65 (d, 1H). C179 H H (5-F₃C-furan-2-yl)-CH₂— 2-Cl- t-Bu(CO)O— — 1.22 (s, 9H), 5.82 (s, 3,6-di- 2H), 6.45 (d, 1H), F- 6.72 (d, 1H), 7.12 phenyl- (m, 1H), 7.28 (m, 1H), 8.55 (d, 1H), 8.60 (d, 1H). C180 H H c-Bu 2-Cl- t-Bu(CO)O— — 1.20 (s, 9H), 1.81- 3,6-di- 1.91 (m, 1H), 2.01- F- 2.07 (m, 1H), 2.39- phenyl- 2.45 (m, 1H), 3.10- 3.20 (m, 2H), 5.97 (quin, 1H), 7.04-7.10 (m, 1H), 7.18-7.24 (m, 1H), 8.48 (d, 1H), 8.58 (d, 1H). C181 H H HC≡C—CH₂— 2-Cl- i-Pr(CO)O— — 1.17 (d, 6H), 2.21 (t, 3,6-di- 1H), 2.80 (sept, 1H), F- 5.29 (d, 2H), 7.06- phenyl- 7.12 (m, 1H), 7.20- 7.26 (m, 1H), 8.56 (d, 1H), 8.67 (d, 1H). C182 H H Me 2-Cl-3- t-Bu(CO)O— — 1.15 (s, 9H), 3.87 (s, Br₂HC- 3H), 7.11 (s, 1H), 6-F- 7.22 (t, 1H), 8.11 phenyl- (dd, 1H), 8.51 (d, 1H), 8.61 (d, 1H). C183 H H EtO—CH₂— 2-Cl- t-Bu(CO)O— — 1.21 (s, 9H), 1.23 (t, 3,6-di- 3H), 3.79 (q, 2H), F- 6.02 (s, 2H), 7.07- phenyl- 7.12 (m, 1H), 7.19- 7.25 (m, 1H), 8.54 (d, 1H), 8.66 (d, 1H). C184 H H Me 2-Cl- t-Bu—Me₂Si—O— — 0.42 (s, 6H), 0.64 (s, 3,6-di- 9H), 3.82 (s, 3H), F- 7.02 (m, 1H), 7.14 phenyl- (m, 1H), 8.42 (d, 1H), 8.60 (d, 1H). C185 H H Et 2-Cl- Me(CO)O— — 1.38 (t, 3H), 2.23 (s, phenyl- 3H), 4.59 (q, 2H), 7.29 (dd, 1H), 7.32- 7.40 (m, 2H), 7.52 (dd, 1H), 8.49 (d, 1H), 8.60 (d, 1H). Key: s = singlet; d = doublet; t = triplet; q = quartet; bs = broad singlet; dd = double doublet; dt = double triplet; quin = quintet; sext = sextet; sept = septet; m = multiplet.

TABLE D Compound of formula (Id), i.e. compounds of formula (I) wherein R³ is as defined for compounds of formula (I) other than hydrogen and R⁵ is hydroxy. (Id)

¹H NMR (CDCl₃ except Comp where indicated; No. R¹ R² R³ R⁴ N-oxide chemical shifts in ppm) D1 H H Me 2-Cl- — 3.84 (s, 3H), 7.09-7.14 3,6-di- (m, 1H), 7.20-7.26 (m, F-phenyl- 1H), 8.16 (bs, 1H), 8.48 (d, 1H), 8.72 (d, 1H). D2 H H Et 2-Cl- — 1.38 (t, 3H), 4.57 (q, 3,6-di- 2H), 7.09-7.14 (m, 1H), F-phenyl- 7.20-7.26 (m, 1H), 8.16 (bs, 1H), 8.48 (d, 1H), 8.72 (d, 1H). D3 H H Me 2,4-di- — 3.78 (s, 3H), 7.27 (s, Cl-phenyl- 2H), 7.44 (s, 1H), 8.38 (s, 1H), 8.62 (s, 1H). D4 H H Me 2-Cl-6- — 3.82 (s, 3H), 7.42 (m, F-3- 1H), 8.07 (m, 1H), 8.60 O₂N-phenyl- (d, 1H), 8.72 (d, 1H). D5 H H Et 2- — 1.38 (t, 3H), 4.55 (q, F₃CO-phenyl- 2H), 7.35-7.42 (m, 3H), 7.47-7.52 (m, 1H), 8.65 (d, 1H), 8.59 (d, 1H). D6 H H Me 2-Cl- 5-N-oxide 3.80 (s, 3H), 7.03 (m, 3,6-di- 1H), 7.19 (m, 1H), 8.00 F- (d, 1H), 8.49 (d, 1H), phenyl- 14.0 (s, 1H). D7 H H Me 2,4,6- — 2.11 (s, 6H), 2.31 (s, tri-Me- 3H), 3.82 (s, 3H), 6.97 phenyl- (bs, 2H), 7.76 (bs, 1H), 8.41 (d, 1H), 8.64 (d, 1H). D8 H H Me 6-F-2- — 3.81 (s, 3H), 7.49 (t, F₃C- 1H), 7.72 (d, 2H), 8.02 phenyl- (bs, 1H), 8.43 (d, 1H), 8.69 (d, 1H). D9 H H Me 2-Cl-5- — 3.62 (s, 3H), 7.58-7.66 F₃C- (m, 3H), 844 (d, 1H), phenyl- 8.70 (d, 1H). D10 H H Et 2-Cl-5- — 1.35 (t, 3H), 4.54 (q, F₃C- 2H), 7.57-7.69 (m, 3H), phenyl- 8.11 (bs, 1H), 8.44 (d, 1H), 8.69 (d, 1H). D11 H H Et 2,6-di- — (CD₃OH): 1.33 (t, 3H), Cl-4- 4.56 (q, 2H), 7.48 (t, F₃CO- 1H), 7.68 (d, 1H), 8.63 phenyl- (d, 1H), 8.78 (d, 1H). D12 H H Me 6-Me- — 2.30 (s, 3H), 3.81 (s, 2-O₂N- 3H), 7.46 (m, 1H), 7.57- phenyl- 7.59 (d, 1H), 7.96-7.98 (d, 1H), 8.48 (d, 1H), 8.59 (d, 1H). D13 H H Me 3-Br-2- — 3.82 (s, 3H), 7.02 (t, Cl-6-F- 1H), 7.68 (dd, 1H), 8.44 phenyl- (d, 1H), 8.70 (d, 1H). D14 H H Me 2-Cl-6- — 0.40 (m, 2H), 0.68 (m, F-3-(6′- 2H), 1.33 (m, 1H), 3.85 cyclo- (s, 3H), 4.20 (d, 2H), propyl- 6.98 (d, 1H), 7.21 (t, methoxy- 1H), 7.39 (dd, 1H), 7.98 pyrid- (dd, 1H), 8.32 (bs, 1H), 3′-yl)- 8.35 (bs, 1H), 8.48 (d, phenyl 1H), 8.72 (d, 1H). D15 H H N≡C—CH₂— 2-Cl- — (d₆-DMSO): 5.38 (s, 3,6-di- 2H), 7.39-7.47 (m, 1H), F- 7.57-7.63 (m, 1H), 8.78 phenyl- (d, 1H), 8.91 (d, 1H). Key: s = singlet; d = doublet; t = triplet; q = quartet; bs = broad singlet; dd = double doublet; m = multiplet.

BIOLOGICAL EXAMPLES Example B1 Herbicidal Action

Seeds of a variety of test species were sown in sterilised standard soil in seed trays each having 96 cells. After cultivation for 8 to 9 days cultivation (post-emergence) under controlled conditions in a climatic chamber (cultivation at 23/1 7° C., day/night; 13 hours light; 50-60% humidity), the plants were treated with an aqueous spray solution of 1000 mg/l of the active ingredient dissolved in 10% DMSO (dimethyl sulfoxide, CAS RN 67-68-5) as a solvent, equivalent to 1000 g/ha. The plants were grown in the climatic chamber after application at (24/19° C., day/night; 13 hours light; 50-60% humidity) and watered twice daily. After 9 days until the test was evaluated (100=total damage to plant, 0=no damage to plant)

TABLE B1 Application post-emergence Stellaria Nasturtium Amaranthus Solanum Compound media officinale retroflexus nigrum Number (STEME) (NAAOF) (AMARE) (SOLNI) A1 7 5 0 0 A2 2 2 6 0 A3 3 4 8 0 A4 1 2 5 2 A5 3 6 3 3 A6 0 0 0 5 A8 2 7 5 0 A9 8 3 7 4 A10 2 2 9 0 A11 2 3 0 0 A13 3 0 5 0 A14 7 7 6 0 A15 0 2 0 0 A17 5 7 8 5 A18 4 9 6 6 A19 5 5 6 7 A20 0 2 — — A21 3 6 7 5 A26 2 0 0 0 A27 2 0 0 0 A28 2 3 2 0 A29 3 0 2 2 A30 4 3 7 0 A31 3 3 5 0 A32 0 0 0 2 A33 3 2 4 3 A34 4 4 6 2 A35 0 3 4 4 B1 3 0 8 0 B2 0 0 5 0 B3 2 0 8 0 B4 2 3 8 0 B5 2 3 8 0 B8 3 3 1 2 B10 0 6 8 0 B11 1 3 8 0 B15 2 7 0 0 B17 0 0 0 2 B33 3 5 5 0 B37 5 0 0 0 B38 0 4 4 0 B40 1 0 6 0 B41 1 2 2 2 C3 6 7 0 5 C5 8 7 7 2 C6 9 8 8 5 C9 2 2 0 3 C11 8 8 9 5 C12 8 6 6 0 C13 8 8 8 2 C14 8 8 7 4 C15 5 6 0 1 C16 7 7 0 7 C18 7 5 3 0 C19 6 4 0 3 C20 5 7 0 0 C21 8 8 8 0 C22 5 8 1 2 C23 0 0 0 4 C24 3 4 0 3 C25 2 0 0 0 C26 2 0 0 0 C27 5 7 7 6 C28 7 7 2 2 C29 0 2 0 4 C30 8 8 8 4 C31 8 8 8 4 C32 8 8 8 2 C33 6 7 3 6 C34 6 5 2 0 C35 7 7 2 0 C36 5 7 5 6 C37 5 7 5 6 C38 7 7 5 7 C39 6 6 7 7 C40 2 2 3 2 C41 2 2 2 0 C43 5 5 3 3 C44 6 4 8 2 C45 9 8 8 6 C46 1 1 0 4 C47 0 1 4 3 C48 1 0 0 1 C49 3 0 3 0 C50 7 7 4 4 C51 7 7 7 0 C52 3 3 0 0 C53 5 7 7 3 C54 5 5 7 0 C55 4 0 4 0 C56 7 7 8 0 C57 7 6 5 2 C58 8 7 6 0 C59 7 7 6 0 C60 5 8 7 7 C61 8 8 8 2 C62 8 8 7 1 C63 8 9 5 5 C64 10 10 6 8 C65 6 7 4 3 C66 7 7 0 0 C67 6 8 4 0 C68 5 5 0 0 C69 6 5 0 0 C70 3 4 0 0 C71 8 7 0 2 C72 2 8 0 0 C73 4 6 4 0 C75 7 6 3 7 C76 6 6 7 4 C78 6 8 6 4 C79 7 5 6 6 C80 8 6 7 2 C81 8 8 5 4 C82 0 0 4 0 C83 0 0 0 1 C84 7 5 6 8 C85 4 3 5 4 C86 6 6 7 7 C87 2 4 6 6 C89 5 5 5 4 C90 7 6 3 8 C91 8 4 7 8 C92 6 2 5 7 C94 6 7 5 4 C95 7 7 6 5 C96 6 3 5 3 C98 1 2 5 2 C100 3 6 6 5 C101 2 3 7 4 C102 7 7 4 7 C103 7 6 4 7 C104 0 4 2 0 C105 8 6 5 5 C108 5 5 6 3 C109 0 4 3 6 C110 7 6 7 6 C111 1 3 5 0 C112 7 5 6 7 C113 8 6 7 6 C114 6 5 2 2 C115 8 7 4 4 C116 4 2 0 4 C117 1 0 0 5 C118 8 7 6 6 C119 8 7 7 6 C120 7 6 5 7 C121 7 6 5 7 C122 7 4 6 6 C123 6 4 4 6 C124 8 8 9 7 C125 7 7 2 8 C126 7 6 6 7 C127 7 6 2 7 C128 6 6 3 7 C178 7 6 4 2 C184 6 6 5 4 C185 10 8 4 4 D1 2 3 0 0 D2 8 8 6 8 D3 8 8 0 8 D5 6 7 3 — D6 6 7 5 3

Compound No. A7, A12, A16, B6-B7, B9, B12-B14, B16, B18-B32, B34-B36, B39, C42 and C106 were tested using the same protocol and showed no damage to the test plants under the test conditions.

Example B2 Herbicidal Action

Seeds of a variety of test species were sown in standard soil in pots. After 8 days cultivation (post-emergence) under controlled conditions in a glasshouse (at 24/16° C., day/night; 14 hours light; 65% humidity), the plants were sprayed with an aqueous spray solution derived from the formulation of the technical active ingredient in acetone/water (50:50) solution containing 0.5% Tween 20 (polyoxyethylene sorbitan monolaurate, CAS RN 9005-64-5). The test plants were then grown in a glasshouse under controlled conditions in a glasshouse (at 24/16° C., day/night; 14 hours light; 65% humidity) and watered twice daily. After 13 days, the test was evaluated (100=total damage to plant; 0=no damage to plant).

TABLE B2 Application post-emergence Solanum Amaranthus Setaria Echinochloa Ipomea nigrum retroflexus faberi crusgalli hederaceae Compound Number (SOLNI) (AMARE) (SETFA) (ECHCG) (IPOHE) A24 9 10 6 4 6 A36 8 7 8 10 0 A37 6 4 7 7 1 A38 9 10 9 8 0 A39 6 8 7 8 0 A40 8 9 9 5 0 B42 5 0 8 1 0 B44 3 7 0 3 — B45 9 4 8 8 0 B46 10 10 6 4 9 B47 3 2 4 3 1 B49 9 10 7 3 8 B50 9 10 8 8 8 B51 7 3 6 3 0 B59 2 0 4 0 3 C129 10 10 6 4 9 C131 2 0 0 0 0 C133 9 9 4 6 3 C134 10 9 2 0 6 C135 10 8 0 2 0 C136 10 9 8 9 — C137 0 9 0 0 5 C138 8 8 4 2 8 C139 10 10 10 10 10 C140 9 8 0 3 2 C142 10 10 7 8 9 C143 10 10 8 7 9 C144 10 10 2 4 9 C145 9 7 0 1 6 C146 8 9 6 5 7 C147 4 2 0 0 2 C148 6 9 4 6 7 C149 7 9 3 3 5 C150 10 10 6 3 9 C151 6 7 0 0 4 C152 9 10 2 4 6 C153 8 9 1 1 5 C154 10 10 0 3 9 C155 10 10 0 3 9 C159 8 9 7 9 2 C160 9 10 6 8 7 C162 10 9 7 8 7 C163 9 6 0 1 9 C164 8 9 4 3 8 C165 10 9 2 1 7 C167 9 10 2 5 5 C168 8 10 2 3 5 C169 9 9 0 0 7 C170 6 8 7 8 4 D7 10 10 10 10 9 D11 10 10 9 10 10

Compound No. A22, B48 and C137 were tested using the same protocol and showed no damage to the test plants under the test conditions.

Example B3 Herbicidal Action

Seeds of a variety of test species were sown in sterilised compost in small pots. After cultivation for seven days (post-emergence) in controlled conditions in the glasshouse (at 24/16° C., day/night; 14 hours light; 65% humidity) the plants were sprayed with 1 mg of the active ingredient, formulated in 2.5 ml acetone/water (50:50) solution, which is equivalent to 1000 g/ha. Once the foliage was dry, the pots were kept in the glasshouse (at 24/16° C., day/night; 14 hours light; 65% humidity), and were watered twice daily. After 13 days the test was evaluated (100=total damage to plant, 0=no damage to plant).

TABLE B3 Application post-emergence Amaranthus Alopecurus Digitaria Chenopodium Compound retroflexus myosuroides sanguinalis album Number (AMARE) (ALOMY) (DIGSA) (CHEAL) A41 0 3 6 6 A43 7 0 0 8 B54 3 0 0 8 C7 9 0 3 7 C107 10 0 2 10 C132 10 0 0 8 C141 10 0 0 7 C156 0 8 3 0 C157 6 0 0 8 C158 9 0 0 10 C161 6 0 5 2

Compound No. A42, A44-A45, B43, B52-B53, B55-B57 and D12 were tested using the same protocol and showed no damage to the test plants under the test conditions. 

1. A method of controlling plants which comprises applying to the plants or to the locus thereof a herbicidally effective amount of a compound of formula (I)

wherein R¹ and R² are independently hydrogen, C₁-C₄alkyl, C₁-C₄haloalkyl, halo, cyano, hydroxy, C₁-C₄alkoxy, C₁-C₄alkylthio, aryl or aryl substituted by one to five R⁶, which may be the same or different, or heteroaryl or heteroaryl substituted by one to five R⁶, which may be the same or different; R³ is hydrogen, C₁-C₁₀alkyl, C₂-C₁₀alkenyl, C₂-C₁₀alkynyl, C₃-C₁₀cycloalkyl, C₃-C₁₀cyclo-alkyl-C₁-C₆alkyl-, C₁-C₁₀alkoxy-C₁-C₆alkyl-, C₁-C₁₀cyanoalkyl-, C₁-C₁₀alkoxycarbonyl-C₁-C₆alkyl-, N—C₁-C₃alkyl-aminocarbonyl-C₁-C₆alkyl-, N,N-di-(C₁-C₃alkyl)-aminocarbonyl-C₁-C₆alkyl-, aryl-C₁-C₆alkyl- or aryl-C₁-C₆alkyl- wherein the aryl moiety is substituted by one to three R⁷, which may be the same or different, or heterocyclyl-C₁-C₆alkyl- or heterocyclyl-C₁-C₆alkyl- wherein the heterocyclyl moiety is substituted by one to three R⁷, which may be the same or different; R⁴ is aryl or aryl substituted by one to five R⁸, which may be the same or different, or heteroaryl or heteroaryl substituted by one to four R⁸, which may be the same or different; R⁵ is hydroxy, R⁹-oxy-, R¹⁰-carbonyloxy-, tri-R¹¹-silyloxy- or R¹²-sulfonyloxy-, each R⁶, R⁷ and R⁸ is independently halo, cyano, nitro, C₁-C₁₀alkyl, C₁-C₄haloalkyl, C₂-C₁₀alkenyl, C₂-C₁₀alkynyl, hydroxy, C₁-C₁₀alkoxy, C₁-C₄haloalkoxy, C₁-C₁₀alkoxy-C₁-C₄alkyl-, C₃-C₇cycloalkyl, C₃-C₇cycloalkoxy, C₃-C₇cycloalkyl-C₁-C₄alkyl-, C₃-C₇cycloalkyl-C₁-C₄alkoxy-, C₁-C₆alkylcarbonyl-, formyl, C₁-C₄alkoxycarbonyl-, C₁-C₄alkylcarbonyloxy-, C₁-C₁₀alkylthio-, C₁-C₄haloalkylthio-, C₁-C₁₀alkylsulfinyl-, C₁-C₄haloalkylsulfinyl-, C₁-C₁₀alkylsulfonyl-, C₁-C₄haloalkylsulfonyl-, amino, C₁-C₁₀alkylamino-, di-C₁-C₁₀alkylamino-, C₁-C₁₀alkylcarbonylamino-, aryl or aryl substituted by one to three R¹³, which may be the same or different, heteroaryl or heteroaryl substituted by one to three R¹³, which may be the same or different, aryl-C₁-C₄alkyl- or aryl-C₁-C₄alkyl- wherein the aryl moiety is substituted by one to three R¹³, which may be the same or different, heteroaryl-C₁-C₄alkyl- or heteroaryl-C₁-C₄alkyl- wherein the heteroaryl moiety is substituted by one to three R¹³, which may be the same or different, aryloxy- or aryloxy- substituted by one to three R¹³, which may be the same or different, heteroaryloxy- or heteroaryloxy- substituted by one to three R¹³, which may be the same or different, arylthio- or arylthio- substituted by one to three R¹³, which may be the same or different, or heteroarylthio- or heteroarylthio-substituted by one to three R¹³, which may be the same or different; R⁹ is C₁-C₁₀alkyl, C₂-C₁₀alkenyl, C₂-C₁₀alkynyl or aryl-C₁-C₄alkyl- or aryl-C₁-C₄alkyl-wherein the aryl moiety is substituted by one to five substituents independently selected from halo, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl or C₁-C₆alkoxy; R¹⁰ is C₁-C₁₀alkyl, C₃-C₁₀cycloalkyl, C₃-C₁₀cycloalkyl-C₁-C₁₀alkyl-, C₁-C₁₀haloalkyl, C₂-C₁₀alkenyl, C₂-C₁₀alkynyl, C₁-C₄alkoxy-C₁-C₁₀alkyl-, C₁-C₄alkylthio-C₁-C₄alkyl-, C₁-C₁₀alkoxy, C₂-C₁₀alkenyloxy, C₂-C₁₀alkynyloxy, C₁-C₁₀alkylthio-, N—C₁-C₄alkyl-amino-, N,N-di-(C₁-C₄alkyl)-amino-, aryl or aryl substituted by one to three R¹⁴, which may be the same or different, heteroaryl or heteroaryl substituted by one to three R¹⁴, which may be the same or different, aryl-C₁-C₄alkyl- or aryl-C₁-C₄alkyl- wherein the aryl moiety is substituted by one to three R¹⁴, which may be the same or different, heteroaryl-C₁-C₄alkyl- or heteroaryl-C₁-C₄alkyl- wherein the heteroaryl moiety is substituted by one to three R¹⁴, which may be the same or different, aryloxy- or aryloxy- substituted by one to three R¹⁴, which may be the same or different, heteroaryloxy- or heteroaryloxy- substituted by one to three R¹⁴, which may be the same or different, arylthio- or arylthio- substituted by one to three R¹⁴, which may be the same or different, or heteroarylthio- or heteroarylthio-substituted by one to three R¹⁴, which may be the same or different; each R¹¹ is independently C₁-C₁₀alkyl or phenyl or phenyl substituted by one to five substituents independently selected from halo, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl or C₁-C₆alkoxy; R¹² is C₁-C₁₀alkyl or phenyl or phenyl substituted by one to five substituents independently selected from halo, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl or C₁-C₆alkoxy; each R¹³ is independently halo, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl or C₁-C₆alkoxy; and each R¹⁴ is independently halo, cyano, nitro, C₁-C₁₀alkyl, C₁-C₄haloalkyl, C₁-C₁₀alkoxy, C₁-C₄alkoxycarbonyl-, C₁-C₄haloalkoxy, C₁-C₁₀alkylthio-, C₁-C₄haloalkylthio-, C₁-C₁₀alkylsulfinyl-, C₁-C₄haloalkylsulfinyl-, C₁-C₁₀alkylsulfonyl-, C₁-C₄haloalkylsulfonyl-, aryl or aryl substituted by one to five substituents independently selected from halo, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl or C₁-C₆alkoxy, or heteroaryl or heteroaryl substituted by one to four substituents independently selected from halo, cyano, nitro, C₁-C₆alkyl, C₁-C₆haloalkyl or C₁-C₆alkoxy; or salts or N-oxides thereof.
 2. A method according to claim 1 wherein R¹ is hydrogen, C₁-C₄alkyl, C₁-C₄haloalkyl, halo, cyano, hydroxy or C₁-C₄alkoxy.
 3. A method according to claim 1, wherein R² is hydrogen, C₁-C₄alkyl, C₁-C₄haloalkyl, halo, cyano, hydroxy or C₁-C₄alkoxy.
 4. A method according to claim 1 wherein R³ is hydrogen, C₁-C₁₀alkyl, C₂-C₁₀alkenyl, C₂-C₁₀alkynyl, C₃-C₁₀cycloalkyl, C₃-C₁₀cycloalkyl-C₁-C₆alkyl-, C₁-C₁₀alkoxy-C₁-C₆alkyl-, C₁-C₁₀cyanoalkyl-, C₁-C₁₀alkoxy-carbonyl-C₁-C₆alkyl-, N—C₁-C₃alkyl-aminocarbonyl-C₁-C₆alkyl-, N,N-di-(C₁-C₃alkyl)-aminocarbonyl-C₁-C₆alkyl-, benzyl or benzyl wherein the phenyl moiety is substituted by one to three R⁷, which may be the same or different, or phenethyl- or phenethyl- wherein the phenyl moiety is substituted by one to three R⁷, which may be the same of different.
 5. A method according to claim 1 wherein R⁴ is aryl or aryl substituted by one to five substituents R⁸, which may be the same or different.
 6. A method according to claim 1 wherein R⁵ is hydroxy, R⁹-oxy- or R¹⁰-carbonyloxy-.
 7. A compound of formula (Ia)

wherein R¹, R² and R⁴ are as defined for compounds of formula (I); or salts or N-oxides thereof, provided that if R¹ and R² are hydrogen, R⁴ is not 4-bromo-2,6-difluoro-phenyl, 2-bromo-phenyl, 2-chloro-4-fluoro-phenyl, 2-chloro-6-fluoro-phenyl, 4-chloro-2-fluoro-phenyl, 4-chloro-2-methyl-phenyl, 2-chloro-phenyl, 5-chloro-2-trifluoromethyl-phenyl, 2,4-dichloro-phenyl, 2,6-dichloro-phenyl, 2,6-difluoro-4-cyano-phenyl, 2,6-difluoro-4-methoxy-phenyl, 2,6-difluoro-4-methyl-phenyl, 2,3-difluoro-phenyl, 2,4-difluoro-phenyl, 2,5-difluoro-phenyl, 2,6-difluoro-phenyl, 2,4-dimethyl-phenyl, 2,6-dimethyl-phenyl, 2-fluoro-4-methyl-phenyl, 2-fluoro-phenyl, 2-fluoro-6-methoxy-phenyl, 2-fluoro-6-methyl-phenyl, 4-fluoro-2-methyl-phenyl, 4-fluoro-2-trifluoromethyl-phenyl, 5-fluoro-2-trifluoromethyl-phenyl, 2,3,4,5,6-pentafluoro-phenyl, 2,3,5,6-tetrafluoro-phenyl, 2,3,4-trifluoro-phenyl, 2,4,6-trifluoro-phenyl, 2,5,6-trifluoro-phenyl or 2,4,6-trimethyl-phenyl.
 8. A compound of formula (Ia)

wherein R¹, R² and R⁴ are as defined for compounds of formula (I); or salts or N-oxides thereof, provided that if R¹ and R² are hydrogen, R⁴ is not 2-bromo-4,6-difluoro-phenyl, 4-bromo-2,6-difluoro-phenyl, 2-bromo-6-fluoro-phenyl, 2-bromo-phenyl, 2-chloro-4,6-difluoro-phenyl, 2-chloro-4-fluoro-phenyl, 2-chloro-6-fluoro-phenyl, 4-chloro-2-fluoro-phenyl, 2-chloro-6-methyl-phenyl, 4-chloro-2-methyl-phenyl, 2-chloro-phenyl, 2-chloro-6-trifluoromethyl-phenyl, 5-chloro-2-trifluoromethyl-phenyl, 2,4-dichloro-6-fluoro-phenyl, 2,6-dichloro-4-fluoro-phenyl, 2,4-dichloro-phenyl, 2,6-dichloro-phenyl, 2,6-difluoro-4-cyano-phenyl, 2,4-difluoro-6-methoxy-phenyl, 2,6-difluoro-4-methoxy-phenyl, 2,4-difluoro-6-methyl-phenyl, 2,6-difluoro-4-methyl-phenyl, 2,3-difluoro-phenyl, 2,4-difluoro-phenyl, 2,5-difluoro-phenyl, 2,6-difluoro-phenyl, 2,4-difluoro-6-trifluoromethyl-phenyl, 2,6-dimethoxy-phenyl, 2,4-dimethyl-phenyl, 2,6-dimethyl-phenyl, 2,6-di(trifluoromethyl)-phenyl, 2-fluoro-6-methoxy-phenyl, 2-fluoro-4-methyl-phenyl, 2-fluoro-6-methyl-phenyl, 4-fluoro-2-methyl-phenyl, 2-fluoro-phenyl, 2-fluoro-6-trifluoromethyl-phenyl, 4-fluoro-2-trifluoromethyl-phenyl, 5-fluoro-2-trifluoromethyl-phenyl, 2-methoxy-phenyl, 2,3,4,5,6-pentachloro-phenyl, 2,3,4,5,6-pentafluoro-phenyl, 2,3,5,6-tetrafluoro-phenyl, 2,3,6-trichlorophenyl, 2,4,6-trichlorophenyl, 2-trifluoromethyl-phenyl, 2,3,4-trifluoro-phenyl, 2,4,6-trifluoro-phenyl, 2,5,6-trifluoro-phenyl or 2,4,6-trimethyl-phenyl.
 9. A compound of formula (Ib)

wherein R¹, R² and R⁴ are as defined for compounds of formula (I) and R⁵ is R⁹-oxy, R¹⁰-carbonyloxy, tri-R¹¹-silyloxy or R¹²-sulfonyloxy; or salts or N-oxides thereof.
 10. A compound of formula (Ic)

wherein R¹, R² and R⁴ are as defined for compounds of formula (I) and R³ is C₁-C₁₀alkyl, C₂-C₁₀alkenyl, C₂-C₁₀alkynyl, C₃-C₁₀cycloalkyl, C₃-C₁₀cycloalkyl-C₁-C₆alkyl-, C₁-C₁₀alkoxy-C₁-C₆alkyl-, C₁-C₁₀cyanoalkyl-, C₁-C₁₀alkoxycarbonyl-C₁-C₆alkyl-, N—C₁-C₃alkyl-aminocarbonyl-C₁-C₆alkyl-, N,N-di-(C₁-C₃alkyl)-aminocarbonyl-C₁-C₆alkyl-, aryl-C₁-C₆alkyl or aryl-C₁-C₆alkyl substituted with one to three substituents R⁷, which may be the same or different, or heterocyclyl-C₁-C₆alkyl or heterocyclyl-C₁-C₆alkyl substituted with one to three substituents R⁷, which may be the same or different; and R⁵ is R⁹-oxy, R¹⁰-carbonyloxy, tri-R¹¹-silyloxy or R¹²-sulfonyloxy; or salts or N-oxides thereof.
 11. A compound of formula (Id)

wherein R¹, R² and R⁴ are as defined for compounds of formula (I) and R³ is C₁-C₁₀alkyl, C₂-C₁₀alkenyl, C₂-C₁₀alkynyl, C₃-C₁₀cycloalkyl, C₃-C₁₀cycloalkyl-C₁-C₆alkyl-, C₁-C₁₀alkoxy-C₁-C₆alkyl-, C₁-C₁₀cyanoalkyl-, C₁-C₁₀alkoxycarbonyl-C₁-C₆alkyl-, N—C₁-C₃alkyl-aminocarbonyl-C₁-C₆alkyl-, N,N-di-(C₁-C₃alkyl)-aminocarbonyl-C₁-C₆alkyl-, aryl-C₁-C₆alkyl or aryl-C₁-C₆alkyl substituted with one to three substituents R⁷, which may be the same or different, or heterocyclyl-C₁-C₆alkyl or heterocyclyl-C₁-C₆alkyl substituted with one to three substituents R⁷, which may be the same or different; or salts or N-oxides thereof.
 12. A compounds of formula (5)

wherein R¹ and R² are as defined for compounds of formula (I) and R¹⁷ is C₁-C₆alkyl; or salts or N-oxides thereof.
 13. A compound of formula (6)

wherein R¹ and R² are as defined for compounds of formula (I); or salts or N-oxides thereof.
 14. A process for preparing a compound of formula (If)

wherein R¹, R², R³, R⁴ and R¹⁰ are as defined in claim 1 by reacting a compound of formula (4)

wherein R¹, R² and R⁴ are as defined in claim 1 and R¹⁶ is C₁-C₆alkyl with a compound of formula R³LG wherein R³ is as defined in claim 1 and LG is a leaving group in the presence of a base, followed by reaction with an acid chloride of formula R¹⁰COCl or an acid anhydride of formula (R¹⁰CO)₂O wherein R¹⁰ is as defined in claim 1, in the same reaction pot.
 15. A herbicidal composition which comprises a herbicidally effective amount of a compound of formula (I) in addition to formulation adjuvants.
 16. A herbicidal composition which comprises a herbicidally effective amount of a compound of formula (I), one or more further herbicides and optionally one or more safeners. 